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Abstract
The testis has two main functions, the synthesis of steroid hormones and the production
of spermatozoa. The adult testis contains three main somatic cell types, namely Sertoli
cells, Leydig cells and peritubular myoid cells, as well as germ cells at all stages of
maturation. Interactions between these cells and the steroid hormones produced by the
testis are responsible for the regulation and maintenance of spermatogenesis and
fertility. Depletion or exposure to high levels of oestrogens, or androgens, both have an
adverse impact on male reproductive function. In the testis, as well as in other organs,
steroid hormone action is mediated by ligand-activated receptors. A single androgen
receptor (AR) and two oestrogen receptors (ERa and ER|3) have been identified.
The aims of this study were to investigate the role of steroid hormones, in particular
oestrogens, in murine spermatogenesis. A major focus of these investigations was the
role played by ER(3 in the modulation of germ cell and somatic cell function. Studies
were conducted both using a transformed murine Sertoli cell line (SK11), which has
maintained a differentiated Sertoli cell phenotype and spermatogonial stem cells, which
were successfully isolated and characterised. Steroid hormone receptor status, steroid
responsiveness and the impact of targeted deletion using RNAi were all assessed.
Characterisation of the SKI 1 cell line, which was cultivated under conditions which
maintained them in an undifferentiated or differentiated state, revealed they retain many
features of Sertoli cells in vivo. ER|3 mRNA and protein were shown to be expressed in
the SK11 cells both in the undifferentiated and differentiated states. Transient
transfections using ERE or ARE-luciferase reporter constructs and stimulation with
steroid ligands revealed that the cells contained functional steroid hormone receptors.
Knockdown of ER|3 mRNA and protein was achieved in the cells after targeted deletion
using a short hairpin RNAi containing vector; this blunted the ability of the cells to
respond to oestrogen.
Abstract iv
Isolation of spermatogonial stem cells was carried out using immunomagnetic beads.
The stem cell population were shown to express Oct-4 and GFRa-1 mRNAs, both of
which are stem cell markers, but not c-kit, which is a marker of differentiated germ
cells. Taqman Q-RT-PCR demonstrated that the stem cell population expressed ER(3.
Oct-4 mRNA expression was shown to be reduced by RNAi; this induced the cells to
undergo differentiation in vitro characterised by increased expression of c-kit.
In conclusion, the current studies have extended our understanding of the impact of
steroid hormones on testicular function and have revealed for the first time that
spermatogonial stem cells are ER|3 positive. The SKI 1 cell line has been found to
provide a suitable model system for the study of steroid regulation of Sertoli cell
function. In addition, the use of RNAi has provided an exciting new avenue by which to
manipulate gene expression levels in testicular germ and somatic cells.
V
Presentations relating to this thesis
ER1J expression in a transformed Sertoli cell line (SK11)
th
Presented at the 13 European Testis Workshop, Dunblane Scotland, April 2004
Oestrogen receptor J3 expression in spermatogonia! stem cells
Poster presented at the International Congress of Endocrinology, Lisbon, September
2004.
Isolation, characterisation and in vitro differentiation of murine spermatogonial
stem cells







Presentations relating to this thesis v
Contents vi
List of figures xii





1.2 General organisation of the testis 1
1.2.1 Seminiferous epithelium 3
1.2.2 Interstitium 5
1.3 Germ cells 6
1.4 Sertoli cells 9
1.5 Germ cell-Sertoli cell interactions 15
1.6 Germ cells in vitro and in vivo 15
1.6.1 Germ cell cultures 16
1.6.1.1 Germ cell lines 17
1.6.1.2 Retroviral immortalisation of germ cells 18
1.6.2 Spermatogonial stem cell transplatation 18
1.6.2.1 Stem cell niche 21
1.6.2.2 Enrichment of the stem cell population 22
1.6.3 Manipulation of stem cells 24
1.7 Steroidogenesis 24
1.7.1 Hormonal regulation ofmale fertility 26
1.7.1.1 FSH and LH 29
1.7.1.2 Androgens 30
1.7.1.3 Oestrogens 31
1.8 Steroid hormone receptors 32
1.8.1 Expression of steroid hormone receptors within the testis 34
1.8.1.1 Oestrogen receptor alpha (ERa) 34
1.8.1.2 Oestrogen receptor beta (ER(3) 35
1.8.1.3 Androgen receptor 36
1.9 Mouse knockout models 36
1.9.1 Oestrogen receptor knockout mice 37
1.9.1.1 Oestrogen receptor a mice (ERKO) 37
1.9.1.2 Oestrogen receptor |3 mice ((3ERKO) 38
Contents vii
1.9.1.3 a/(3ERKO mice 39
1.9.2 Androgen receptor knockout mice 40
1.9.3 Aromatase knockout mice 42
1.9.4 Oestrogen sulphotransferase knockout mice 43
1.9.5 Follicle stimulating hormone knockout mice 44
1.9.5.1 FSHpKO mice 44
1.9.5.2 FSHRKO mice 44
1.9.6 Luteinising hormone receptor knockout mice 46
1.10 RNA interference 46
1.10.1 Overview of the method 46
1.10.2 Mammalian siRNA 49
1.10.3 Vector delivery systems 49
1.11 Aims of the project 51
Chapter 2
Materials and Methods
2.1 Animal experimentation 52
2.1.1 Tissue collection and fixation 52
2.2 Immunohistochemistry 52
2.2.1 Tissue processing and sectioning 53
2.2.2 Antigen retrieval 53
2.2.3 Methanol/peroxide block 53
2.2.4 Avidin-biotin block 53
2.2.5 Primary antibodies 54
2.2.6 Secondary antibodies 54
2.2.7 Florse-radish peroxidase 55
2.2.8 Developing, counterstaining and mounting 55
2.2.9 Immunohistochemistry on cultured cells 56
2.2.10 Fluorescent immunohistochemistry 56
2.2.11 Imaging 57
2.3 Cell culture 57
2.3.1 Cell lines 57
2.3.2 Passaging of cells 58
2.3.3 Transient transfection of cells 58
2.3.3.1 JetPEI 59
2.3.4 Ligands 59
2.4 Dual-Luciferase reporter gene assay 60
2.4.1 Cell lysis 60
2.4.2 Reporter assay 61
2.4.3 Data analysis 61
2.5 RNA extraction from cells and tissues 62
2.6 Oligo (dT) primed reverse transcription PCR (RT-PCR) 62
2.6.1 cDNA synthesis 63
2.6.2 Polymerase chain reaction 63
2.6.2.1 Primer design and oligonucleotide synthesis 63
2.6.2.2 PCR reaction 65
2.7 Agarose gel electrophoresis 66
Contents vhi
2.8 Cloning 66
2.8.1 Cloning ofPCR products 67
2.8.2 Restriction enzyme digestion ofDNA 67
2.8.3 Extraction ofDNA fragments from agarose gels 67
2.8.4 Ligation ofDNA inserts into plasmid vectors 68
2.8.5 Transformation of competent E.coli 68
2.8.6 Small scale preparation of plasmid DNA 68
2.9 Sequence analysis 69
2.9.1 Glycerol stocks 70
2.10 Caesium chloride preparation of plasmid DNA 70
2.10.1 GeneQuant analysis 73
2.11 RNA interference 73
2.11.1 Design of siRNA's 73
2.11.2 In vitro transcription of siRNA's 74
2.11.3 Transfection of siRNA's 77
2.11.3.1 Oligofectamine 77
2.11.4 Analysis of transfected cells by confocal microscopy 78
2.11.5 Preparation of plasmid vectors containing shRNA's 78
2.11.5.1 Hairpin siRNA oligonucleotide design 79
2.11.5.2 Ligation of hairpin siRNA inserts into pSilencer 81
2.11.5.3 Transformation and identification ofhairpin siRNA
containing clones 81
2.12 Quantitative RT-PCR 81
2.12.1 Principles of the TaqMan reaction 82
2.12.2 Taqman primers and probes 83
2.12.3 Optimisation of primers and probes 83
2.12.3.1 Primer optimisation 84
2.12.3.2 Probe optimisation 84
2.12.4 Assay on Demand 85
2.12.5 Preparation of cDNA pools for TaqMan analysis 86
2.12.6 Q-RT-PCR reaction 86
2.12.7 Analysis of results - comparative Ct method 87
2.12.8 Validation 89
2.13 Statistical analysis 90
2.14 Commonly used solutions 91
2.14.1 Immunohistochemistry 91
2.14.2 Tissue culture 91
2.14.3 Stem cell isolation and sorting 92
2.14.4 Molecular biology 92
2.14.5 Microbiology 93
Chapter 3
Steroid receptor expression and modulation in Sertoli cells
3.1 Introduction
3.1.1 Sertoli cell development and function





3.1.1.2 Regulation of Sertoli cell function 95
3.1.2 Steroid hormone receptors 96
3.1.3 Sertoli cells in vitro 98
3.1.4 RNA interference 99
3.1.5 Aims 99
3.2 Materials and methods 101
3.2.1 SKI 1 cell culture 101
3.2.2 Immunohistochemistry 101
3.2.2.1 Fluorescent immunohistochemistry 101
3.2.3 RT-PCR 102
3.2.4 Steroid treatment of SKI 1 cells 103
3.2.5 Q-RT-PCR 103
3.2.6 Transient transfections 103
3.2.6.1 Steroid treatment ofSKI 1 cells following transient
transfection 104
3.2.7 Cloning of an ER(3 fluorescent protein construct 105
3.2.7.1 PCR amplification ofmurine ER|3 105
3.2.7.2 Topo-TA cloning of ER(3 PCR product 106
3.2.7.3 Ligation into dsRed vector 106
3.2.8 RNA interference 107
3.2.8.1 Design and construction of siRNA's 107
3.2.8.2 Fluorescent labelling of siRNA's 108
3.2.8.3 Transient transfection of siRNA's using a fluorescently labelled
reagent 108
3.2.8.4 Transfection of siRNA's into SKI 1 cells 109
3.2.8.5 Immunohistochemistry of siRNA transfected cells 109
3.2.9 Preparation of plasmid vectors containing shRNA's 110
3.3 Results 111
3.3.1 Immunolocalisation ofERa, ER(3 and AR in the immature
and adult mouse testis 111
3.3.2 Characterisation of the SKI 1 cell line 113
3.3.2.1 Differentiation of the SKI 1 cell line 115
3.3.2.2 Expression of Sertoli cell product mRNA's in SK11 cells 115
3.3.2.3 Expression of Sertoli cell specific proteins in SK11 cells 115
3.3.3 Expression of steroid hormone receptors in SKI 1 cells 118
3.3.3.1 Steroid hormone receptor mRNA expression 118
3.3.3.2 Steroid hormone protein expression 119
3.3.4 Steroid responsiveness ofSKI 1 cells 121
3.3.4.1 Impact of steroid hormones on expression of steroid hormone
receptor mRNA's 121
3.3.4.2 Activation of an oestrogen response element reporter in
SKI 1 cells 123
3.3.4.2.1 Natural oestrogenic ligands 123
3.3.4.2.2 Phytoestrogens 123
3.3.4.2.3 Synthetic ligands 123
3.3.4.3 Activation of an androgen response element in SKI 1 cells 129
3.3.5 Sequence specific knockdown using RNAi 131






3.3.6 siRNA labelling 137
3.3.6.1 Visualisation of the entry of fluorescently labelled siRNA's
into SKI 1 cells 137
3.3.6.2 Visualisation of the movement of siRNA's into SKI 1 cells
using a fluorescently labelled transfection reagent 137
3.3.7 Targeted knockdown of ER(3 in SKI I cells 140
3.3.7.1 Knockdown of ERE response using RNAi in SKI 1 cells 145
3.3.7.1.1 Linear siER(3 145
3.3.7.1.2 shERB 145





Isolation, characterisation and in vitro differentiation of murine
spermatogonia! stem cells
4.1 Introduction
4.1.1 Development of spermatogonia





4.1.2.5 Oestrogen receptor P
4.1.3 Identification and enrichment of spermatogonial stem cells
4.1.4 Germ cell lines
4.1.5 RNA interference
4.1.6 Aims
4.2 Materials and methods
4.2.1 Cell culture
4.2.2 Sterile isolation of spermatogonial stem cells
4.2.3 Immunomagnetic bead sorting
4.2.3.1 Cell separation-indirect technique
4.2.4 RNA extraction from cultured cells, d8 mouse testis and
immunomagnetically sorted cell populations
4.2.5 RT-PCR and nested RT-PCR
4.2.6 TaqMan Q-RT-PCR
4.2.7 Immunohistochemistry
4.2.8 Culture of sorted cell populations
4.2.8.1 Mitomycin C treatment
4.2.9 RNA interference



























4.2.9.2 Transfection of spermatogonial stem cells with shOct-4 using
oligofectamine 178
4.2.9.3 Culture of spermatogonial stem cells with shOct-4 178
4.2.9.4 Electroporation of spermatogonial stem cells with
shRNA vectors 179
4.3 Results 180
4.3.1 Germ cell development during the first wave of spermatogenesis 180
4.3.2 Immunohistochemical localisation of germ cell markers in the
immature mouse testis 180
4.3.2.1 Expression of germ cell markers in GC-1 and GC-2 cells 180
4.3.3 Isolation of spermatogonia using immunomagnetic beads 184
4.3.4 Quantification ofmRNA's in sorted compared to unsorted
germ cell populations 187
4.3.4.1 Oct-4 mRNA expression 187
4.3.4.2 c-kit mRNA expression 187
4.3.4.3 ERp mRNA expression 187
4.3.5 Oct-4, c-kit and ER(3 expression in sorted cells after culture 189
4.3.6 Impact of ligands, growth factors and feeder cells on the
differentiation status of the spermatogonial stem cell 191
4.3.6.1 LIF 191
4.3.6.2 SCF 191
4.3.6.3 17(3 oestradiol 191
4.3.6.4 Co-culture with STO cells 192
4.3.7 Impact of shRNA knockdown on the differentiation status of the
spermatogonial stem cell 197
4.3.7.1 Oct-4 shRNA 197





5.2 Role of steroid hormones in spermatogenesis 212
5.3 Findings of this thesis 214









Figure 1.1 Diagram of a Sertoli cell with its associated germ cells 2
Figure 1.2 Spermatogenic cycle in the mouse 3
Figure 1.3 Stem cell renewal and spermatogonial differentiation in the mouse 8
Figure 1.4 The role of the Sertoli cell in spermatogenesis 10
Figure 1.5 Illustration of the two compartments of the seminiferous tubule 12
Figure 1.6 SCF is synthesised in the Sertoli cells as one of two isoforms 14
Figure 1.7 Steroid synthesis from cholesterol 26
Figure 1.8 Hormonal control of the male reproductive tract 28
Figure 1.10 Domain structure of a steroid hormone nuclear receptor 33
Figure 1.11 The mechanism ofRNA interference 48
Figure 1.12 siRNA synthesised from a DNA template 50
Chapter 2
Materials and methods
Figure 2.1 ABC-HRP reaction 55
Figure 2.2 In vitro transcription of siRNAs using the Silencer siRNA 75
Figure 2.3 pSilencer 3.0 HI vector 79
Figure 2.4 ER|3 DNA oligonucleotide sequences for hairpin insert and
resulting hairpin structure 80
Figure 2.5 Reporter-quencher proximity results in suppression of
fluorescence 82
Figure 2.6 Cleavage of the reporter from the quencher 83
Figure 2.7 ER|3 probe optimisation 85
Figure 2.8 Example of an amplification plot after a successful Taqman
RT-PCR reaction 88
Figure 2.9 Plot of log input RNA amount versus ACt 90
List of Figures xiii
Chapter 3
Steroid receptor expression and modulation in Sertoli cells
Figure 3.1 Sequence of the 3xERE 103
Figure 3.2 Sequence of the ARE-1 and ARE-2 from the pem-Luc reporter
construct 104
Figure 3.3 Immunohistochemical analysis ofERa, ER|3 and AR protein
expression in the mouse testis 112
Figure 3.4 Confocal image of the conditionally immortalised SKI 1
Sertoli cell line 114
Figure 3.5 (3-actin mRNA expression in SKI lcells 114
Figure 3.6 Expression of SGP-1, SGP-2 and GATA-1 in testis and SKI 1
cells 116
Figure 3.7 Expression of Testatin and Dax-1 in mouse testis and SKI 1 cells 116
Figure 3.8 Immunohistochemical analysis of SGP-1 and GATA-1 protein
expression in undifferentiated and differentiated SKI 1 cells 117
Figure 3.9 RT-PCR using primers specific for ERa, ER(3 and AR 118
Figure 3.10 Immunohistochemical analysis ofERa, ER|3 and AR protein
expression in undifferentiated and differentiated SKI 1 cells 120
Figure 3.11 Steroid responsiveness in the SKI 1 cell line 122
Figure 3.12 Dose response in SKI 1 cells after E2 and 3(3Adiol treatment 125
Figure 3.13 Dose response in SKI 1 cells after genistein treatment 126
Figure 3.14 Dose response in SKI 1 cells after DPN and PPT treatment 127
Figure 3.15 Dose response in SKI 1 cells after DES treatment 128
Figure 3.16 Androgen response in SKI 1 cells after ligand treatment 130
Figure 3.17 Knockdown ofGFP expression in SKI 1 cells 133
Figure 3.18 SKI 1 cells immunostained using an anti-lamin antibody 134
Figure 3.19 SKI 1 cells immunostained using an anti-a-tubulin antibody 135
Figure 3.20 SK11 cells immunostained using an anti-(3-tubulin antibody 136
Figure 3.21 SKI 1 cells transfected with FAM labelled siER|3 138
Figure 3.22 SKI 1 cells transfected with siER|3 using a rhodamine labelled
transfection reagent 139
List of Figures xiv
Figure 3.23 Knockdown ofER|3 protein using a siRNA to ER(3 142
Figure 3.24 Sequence of the shER(3 hairpin containing pSilencer vector 143
Figure 3.25 Knockdown of ER(3 using a shRNA to ER|3 144
Figure 3.26 Knockdown ofERE response in SKI 1 cells after transfection
with siER(3 147
Figure 3.27 Effect on ER|3 mRNA expression after transfection with a
3xERE-Luc reporter construct and siER(3 148
Figure 3.28 Knockdown ofERE response in SKI 1 cells after transfection
with shER|3 149
Figure 3.29 Knockdown of ERE response to E2 in SKI 1 cells 150
Figure 3.30 Reduction in ER(3 mRNA levels in SKI 1 cells after transfection
with siER|3 152
Figure 3.31 Reduction in ER|3 mRNA levels in SKI 1 cells after transfection
with shERP 153
Chapter 4
Isolation, characterisation and in vitro differentiation of murine
spermatogonia! stem cells
Figure 4.1 Scheme of the development of the spermatogenic lineage 162
Figure 4.2 Immunomagnetic sorting of spermatogonial stem cells using
anti a-6 integrin 173
Figure 4.3 Time scale of isolation, electroporation and RNA extraction in
spermatogonial stem cells electroporated with an shRNA vector 179
Figure 4.4 RT-PCR ofmouse testis samples 181
Figure 4.5 Immunohistochemistry on 8 day old mouse testis 182
Figure 4.6 Expression germ cell markers expressed in GC-1 and GC-2 cells
by RT-PCR 183
Figure 4.7 Spermatogonial stem cells bound to immunomagnetic beads 185
Figure 4.8 RT-PCR analysis of sorted spermatogonial cells 186
Figure 4.9 Relative amounts ofOct-4 mRNA in sorted spermatogonial
stem cells 188
Figure 4.10 Effect of culturing the spermatogonial cells 190
List of Figures xv
Figure 4.11 Effect of 7 days of LIF treatment 193
Figure 4.12 Effect of 7 days of SCF treatment 194
Figure 4.13 Effect of 7 days of 17(3 oestradiol treatment 195
Figure 4.14 Effect of 7 days of culture with or without STO feeder cells 196
Figure 4.15 Sequence of the shOct-4 hairpin containing pSilencer vector 199
Figure 4.16 Treatment of sorted cells with shOct-4 200
Figure 4.17 Electroporation with shOct-4 201
Figure 4.18 ER|3 mRNA levels after electroporation with shER|3 203





Table 2.1 Primary antibodies 54
Table 2.2 Secondary antibodies 54
Table 2.3 Primary and fluorescently labelled secondary antibodies
used on cultured cells 57
Table 2.4 Cell number plated onto various culture vessels 59
Table 2.5 RT-PCR primer sequences 64
Table 2.6 Sequencing primers 70
Table 2.7 siRNA target sequences 74
Table 2.8 Taqman primer/probe sequences 83
Table 2.9 Primer Optimisation Matrix 84
Chapter 3
Steroid receptor expression and modulation in Sertoli cells
Table 3.1 Antibodies used for immunohistochemistry of cultured SKI 1 cells
and testis tissue sections 101
Table 3.2 Primary and secondary antibodies used for fluorescent
immunohistochemistry 102
Table 3.3 Primer sequences and product sizes 102
Table 3.4 Sequence of primers used to amplify murine ER(3 cDNA 106
Table 3.5 Sequence of siRNA's 107
Table 3.6 Antibodies used in fluorescent immunohistochemistry 110
Table 3.7 ER|3 shRNA oligonucleotide sequence 110
Abbreviations xvii
Chapter 4
Isolation, characterisation and in vitro differentiation of murine
spermatogonia! stem cells
Table 4.1 Antibodies and dynabeads used for immunomagnetic cell sorting 171
Table 4.2 RT-PCR primer sequences 174
Table 4.3 Nested RT-PCR primer sequences 175
Table 4.4 Oct-4 and ER|3 shRNA oligonucleotide sequences 178
xviii
Abbreviations




BSA Bovine serum albumin
cAMP Cyclic AMP








DMEM Dulbeccos modified Eagles media
DTT Dithiothreitol
EDTA Ethylenediaminetetracetic acid
EGFP Enhanced green fluorescent protein
ERa Oestrogen receptor alpha
ERp Oestrogen receptor beta
EtOH Ethanol
FCS Foetal calf serum
FSH Follicle stimulating hormone
FITC Fluorescein isothiocyanate conjugate
GnRH Gonadotrophin releasing hormone




LIF Leukaemia inhibitory factor






PBS Phosphate buffered saline
PCNA Proliferating cell nuclear antigen
PCR Polymerase chain reaction
PGC Primordial germ cell




rpm Revolutions per minute
RT Reverse transcription
SAP Shrimp alkaline phosphatase
SCF Stem cell factor
SDS Sodium dodecyl sulphate
SEM Standard error of the mean
shRNA Short hairpin RNA
siRNA Short interfering RNA
TBS Tris buffered saline
v/v Volume to volume ratio




In the adult testis, the process of spermatogenesis is controlled by a complex system
of endocrine and paracrine signals acting upon, and within the seminiferous
epithelium. The testis is unusual in that it is the only organ in the adult, which
contains cells undergoing meiosis. The testis determines the phenotype of an
individual based on its endocrine activity (Schlatt et al., 1997) and it is the steroid
hormones that are key regulators of spermatogenesis and male fertility (Sharpe,
1994).
Spermatogenesis is an important process, as without the production of spermatozoa,
genetic information would not be passed on (Sharpe, 1994). The testis contains
totipotent stem cells, which continually repopulate the testis with germ cells.
Approximately 50% of human infertility is due to problems with the male and 70-
90% of these cases are due to disruption of spermatogenesis. Better understanding of
the process of spermatogenesis and its regulation by steroid hormones could lead to
increased knowledge about the formation of testicular tumours, ways to improve
treatments for male infertility, and perhaps provide methodology to produce novel
male contraceptives.
1.2. General organisation of the testis
The testis has two main functions, the production of spermatozoa and the production
of hormones (Schlatt et al., 1997). The adult testis contains two distinct
compartments, the seminiferous tubules, which contain the Sertoli cells and the germ
cells (Figure 1.1) and the interstitium, which comprises of the Leydig cells,
peritubular myoid cells, macrophages and blood vessels. These compartments are
structurally and physiologically distinct, separated by cellular barriers, which limit
the exchange ofwater-soluble materials (Sharpe, 1994).
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Spermatids
Spermatocytes
Figure 1.1 Diagram of a Sertoli cell with its associated germ cells. Spermatogonia and
spermatocytes are situated in the basal compartment of the testis while the more mature germ
cells; the spermatids and the spermatozoa are found in the adluminal compartment. The two
compartments are separated by the tight junctions of the Sertoli cell. Adapted from Cooke
and Saunders (2002).
Differentiating germ cells are not arranged at random in the seminiferous epithelium
(Sharpe, 1994), but in specific associations known as "stages". The cycle of the
seminiferous epithelium was first defined in the rat by Leblond and Clermont
(Leblond and Clermont, 1952). They defined 14 stages in the rat cycle based on the
19 phases of spermiogenesis as identified by periodic acid Schiff (PAS) staining. A
stage is defined as a grouping of germ cell types at particular phases of development
in cross sectioned tubules (Russell et al., 1990). The 1994 review by Sharpe
describes in detail, the spermatogenic cycle of various species. The cycle charts the
progress of a single spermatogonia through successive mitoses, meiosis, and
spermiogenesis, finishing with the release of a mature spermatozoa. Initiation of
spermatogenesis is cyclical. The cycle of the seminiferous epithelium lasts
approximately 16 days in man and 8.6 days in the mouse, therefore 4.6 and 4.06
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differentiation until it is released from the seminiferous epithelium as a mature
spermatozoa in the human and the mouse respectively (Sharpe, 1994). Figure 1.2
shows how the germ cells are associated at different stages of the cycle in the mouse.
Figure 1.2 Spermatogenic cycle in the mouse. Taken from Russell et al. (1990).
Each vertical column represents a stage; each stage has a variety of germ cells
associated with the Sertoli cells. Each stage lasts for a fixed period of time and the
germ cells move from one stage to the next. In the diagram shown in Figure 1.2,
germ cells progress in stages from left to right. Once the germ cells reached the final
stage they progress back to stage I again, but this time are one row up (Sharpe,
1994).
1.2.1. Seminiferous epithelium
Germ cell maturation occurs within the seminiferous epithelium which is organised
into long tubules, maximising the area for sperm production. Close morphological
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associations between Sertoli cells and germ cells at different stages of their
development (spermatogonia, spermatocytes, round spermatids, and elongated
spermatids) exist (Figure 1.1) and as a result of these associations, extensive
interactions and communications take place between these cells throughout
spermatogenesis both at the biochemical and molecular level (Cheng and Mruk,
2002). Within the seminiferous tubules, immature germ cells are positioned on the
basement membrane. As the germ cells differentiate, they move through the tubule
towards the apical surface gradually maturing before being released into the tubule
lumen as mature spermatozoa. This results in the seminiferous epithelium containing
several layers of germ cells at different stages of development at any one time
(Sharpe, 1994).
Russell demonstrated the progressive movement of primary spermatocytes from the
basal to the adluminal compartment of the seminiferous tubule during investigations
into the integrity of the seminiferous epithelium. He concluded that the Sertoli cells
play an active role in the transfer of spermatocytes to the adluminal compartment and
suggested that a transient intermediate compartment existed within the seminiferous
tubule, which allowed the continual maintenance of the blood-testis barrier during
transit of spermatocytes from the basal to the adluminal compartment (Russell,
1977).
Chiarini-Garcia et al. (2001) reported that spermatogenesis in the mouse occurs in a
uniform pattern and the spermatogonia are distributed in a non-random manner
(Chiarini-Garcia et al., 2001). They showed that spermatogonia were spaced
throughout the seminiferous epithelium in such a way that the initiation of
spermatogenesis is evenly distributed. The same group also demonstrated that in the
mouse, extensive tubule-to-tubule contact occurred with three to seven tubules being
in contact within the seminiferous epithelium. In the rat, the positioning of the
spermatogonia is similar but there is less tubule-to-tubule contact seen (Chiarini-
Garcia et al., 2003). There is a fixed germ cell to Sertoli cell ratio within the testis.
This varies between species (Sharpe, 1994) and results in the widely differing
spermatozoa outputs in different species.
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1.2.2. Interstitium
The seminiferous tubules are separated from one another by the interstitium of the
testis. This region contains the hormone secreting Leydig cells and the peritubular
myoid cells as well as macrophages, blood vessels and endothelial cells (Saez, 1994).
The endocrine function of the testis lies primarily within the Leydig cells, which are
heterogeneous in respect to their physiological and structural features (Schlatt et al.,
1997). In the human, they are steroidogenically active in the period of early
differentiation of the male embryo. In the rodent, there is a surge in the levels of the
pituitary gonadotrophin luteinising hormone (LH) and testosterone at about
embryonic day 20 (Chemes et al., 1979). At puberty, gonadotrophin release from the
pituitary stimulates androgen secretion by the Leydig cells (Haider, 2004). Similarly,
in the mouse, two populations of Leydig cells exist. The first, a fetal population, is
seen at about 12.5 days postcoitum, soon after testis differentiation. This population
is essential for masculinisation of the fetus. The second population is found after
birth in the mouse. These cells are the testosterone secreting population and they act
to induce male behaviour and secondary sexual characteristics (Baker and
O'Shaughnessy, 2001; O'Shaughnessy et al., 2002).
Testosterone biosynthesis is under the control of LH. LH stimulates the production
of cyclic AMP (cAMP) by binding to receptors on the Leydig cell surface (Cooke et
al., 1981). cAMP has two principal activities in the control of Leydig cell
steroidogenesis: The first action of cAMP is the stimulation of testosterone
biosynthesis via the transport of cholesterol into the steroidogenic pathway. The
second action of cAMP in Leydig cells is the stimulation of gene expression of the
steroidogenic enzymes and up-regulation of their activity (Stocco and Clark, 1996).
Steroid biosynthesis is described in more detail in section 1.7.
Also present in the interstitium of the testis is a layer of contractile peritubular myoid
cells, which surround the tubules. These cells are modified myofibroblast cells and
they lie external to the basement membrane of the seminiferous tubule. These cells
do not provide a tight diffusion barrier into the tubule but they are responsible for the
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irregular contractions of the seminiferous tubules which propel fluid secreted by the
Sertoli cells, together with the spermatids into the lumen and through the tubule to
the rete testis (Clermont, 1958; Schlatt et al., 1997). Peritubular myoid cells also
maintain mesenchymal-epithelial interactions with the Sertoli cells by deposition of
extracellular matrix elements (Verhoeven et al., 2000), this separates the testicular
cords from the interstitial compartment (Martineau et al., 1997; Tilmann and Capel,
1999; Tung et al., 1984). The peritubular myoid cells express androgen receptor
(Zhou et al., 2002) and produce PmodS (Peritubular factor that Modulates Sertoli cell
function). PmodS production is stimulated by androgens and is involved in the
regulation of androgen mediated Sertoli cell functions (Norton and Skinner, 1989;
Verhoeven et al., 2000). Vascular smooth muscle cells, endothelial cells and
macrophages are also present in the interstitial space of the testis.
1.3. Germ cells
Spermatogonial stem cells originate from primordial germ cells (PGCs) derived from
the epiblast of the embryo. During fetal development, the PGCs migrate to the
genital ridges and in the case of the male, become enclosed by the differentiating
Sertoli cells and the seminiferous cords form. Once in the cords, PGCs are termed
gonocytes and are morphologically different from the PGCs. Gonocytes then
undergo a period of proliferation before becoming quiescent (Clermont and Perey,
1957; Huckins and Clermont, 1968). In the mouse and the rat, the gonocytes
differentiate shortly after birth and give rise to the spermatogonial stem cells (Bellve
et al., 1977; Clermont and Perey, 1957; Huckins and Clermont, 1968). The
production of mature sperm from a single spermatogonia takes approximately 75
days in man and approximately 35 days in mice (Cooke and Saunders, 2002).
Spermatogenesis begins with a series of mitotic divisions of the spermatogonia
(Figure 1.3) and the spermatogenic process continues throughout the lifespan of the
male. Upon division, spermatogonial stem cells can give 2 types of daughter cells.
One of these cells is capable of self-renewal and maintains the stem cell population
while the other cell type becomes the type A spermatogonia (de Rooij, 2001; de
Rooij and Russell, 2000). The dual capacity of the stem cells ensures the long-
Chapter 1 Literature Review 7
standing ability to produce spermatozoa. Most of our understanding of the
development of spermatogenesis comes from detailed studies in rodents. The
spermatogonial stem cells (As) are located on the basement membrane of the
seminiferous tubule and will be further discussed in section 1.6. According to the
system proposed by Oakberg (Oakberg, 1971), the non self-renewing cell produced
by the division of the spermatogonial stem cell divides into a pair of cells that stay
connected by an intercellular bridge (Apr spermatogonia). Although cytokinesis is
incomplete within these cells, nuclear division has occured. The cells then further
divide to form chains of A-aligned (Aai spermatogonia). It is thought that the As, Apr
and Aai spermatogonia are morphologically similar and have similar patterns of
regulation (De Rooij and Grootegoed, 1998). These cells undergo a change in cell
cycle and differentiate to become the A1 spermatogonia (Chiarini-Garcia and
Russell, 2001). The As, Apr and Aai spermatogonia cycle at random but the A1 and
subsequent generations of spermatogonia proliferate at a fixed rate. In the mouse,
there are around 10 spermatogonial divisions between stem cells and the formation
of spermatocytes (de Rooij and Russell, 2000), as shown in Figure 1.3.


















Figure 1.3 Stem cell renewal and spermatogonial differentiation in the mouse. The scheme
begins with the spermatogonial stem cell which can either self renew or differentiate to
produce Apr spermatogonia, which will continue mitotically dividing until the spermatocytes
are formed. Adapted from de Rooij, 2001.
In primates the undifferentiated spermatogonia can be subdivided into A pale (Ap)
and A dark (Ad) spermatogonia. Both Ap and Ad are arranged in clones of 1 or 2n
cells within the seminiferous epithelium. The Ad spermatogonia do not proliferate,
but if cell loss occurs in the testis, they can transform into Ap spermatogonia that
start to proliferate. The Ap spermatogonia only divide once every epithelial cycle,
undergoing self-renewal and differentiation into B spermatogonia (De Rooij et al.,
1989).
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The proliferative phase of spermatogenesis takes place in the basal intratubular
compartment of the testis. This process commences when Type B spermatogonia
lose their contact with the basement membrane to form preleptotene primary
spermatocytes. The last mitotic division of the spermatogonia results in the
production of the spermatocytes. The spermatocytes push into the adluminal
intratubular compartment and enter a lengthy meiotic prophase followed by 2 further
rounds ofmeiotic divisions giving rise to haploid spermatids. This is followed by the
transformation of round spermatids into spermatozoa, a process referred to as
spermiogenesis. No cell division occurs but the round cell elongates and transforms
into a spermatozoa with the capacity for motility. The basic steps in this process are
consistent between all species and consists of (a) the formation of the acrosome (b)
reorganisation and condensation of nuclear DNA (c) the development of the
flagellum (d) the reorganisation of the cytoplasm and cell organelles and (e) the
release of the elongate spermatozoa from the Sertoli cell into the tubule lumen
(Clermont, 1972; De Rooij etal., 1989; Sharpe, 1994).
1.4. Sertoli cells
The Sertoli cell plays a central role in the development of the testis and in the
regulation of spermatogenesis (Sharpe et al., 2003). The Sertoli cells are the first
cells to differentiate in the fetal gonad and they are responsible for the organisation
of the gonocytes into the seminiferous cords and they prevent the gonocytes from
entering into meiosis (Mackay, 2000). Following this, the Sertoli cells continue to
proliferate until the initiation of the first wave of spermatogenesis when the Sertoli
cells undergo a final differentiation (Griswold, 1998). Sertoli cells provide structural
support for the seminiferous epithelium (de Kretser and Kerr, 1988) as well as
paracrine factors such as growth factors and other nutrients and provide a unique
environment by the formation ofjunctional barriers (Griswold, 1998).
The regulation of spermatogenesis is mediated via the effects of follicle stimulating
hormone (FSH) and testosterone on the Sertoli cells (Figure 1.4). For example, FSH
stimulates the Sertoli cells to increase protein synthesis (Griswold, 1998). A key role
of FSFI during early life is in regulating Sertoli cell number. Experimental studies
Chapter 1 Literature Review 10
have shown that elevated FSH levels can increase Sertoli cell number and thereby
increase the spermatogenic output of the testis. (Orth, 1984; Orth et al., 1988).
Figure 1.4 The role of the Sertoli cell in Spermatogenesis. Gonadotrophins LH and FSH
produced by the pituitary act on the Leydig cells and the Sertoli cells respectively. FSH
action on the Sertoli cell leads to the production of testosterone. The many roles of the
Sertoli cell in the testis are shown. Adapted from Griswold et al. (2001).
Sertoli cells are capable of supporting only a fixed number of germ cells and
therefore the number of Sertoli cells in the testis determines testicular size and the
amount of spermatozoa produced (Russell and Peterson, 1984; Sharpe, 1994). There
have been no reports of testes that contain germ cells but no Sertoli cells and the
ability of germ cells to survive in culture without co-culture with somatic cells is
limited (Griswold, 1995; Griswold, 1998). Increasing Sertoli cell number by
prolonging the period of proliferation using thyroid hormone also resulted in testis
that were larger than normal (Orth et al., 1988). The number of germ cells that each
Sertoli cell supports varies between species (Griswold et al., 2001). In rodents and
men, Sertoli cells begin to proliferate during fetal development. After birth, the
number of Sertoli cells in the rat testis increases 30-fold, which corresponds to a
series of approximately five divisions over this period (Wang et al., 1989). The rate
of Sertoli cell proliferation decreases steadily after birth in rats and mice from day 5
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to 15. In humans and primates with the exception of the rhesus monkey, Sertoli cell
proliferation also occurs in the neonatal period with a further proliferative period at
puberty (Sharpe et ah, 2003). In the rhesus monkey, there is a slightly difference in
that it shows the greatest rate of proliferation in the peripubertal period (Marshall and
Plant, 1996). After the proliferative period, the Sertoli cells differentiate resulting in
morphological changes with the nucleolus becoming more prominent. At the same
time, the formation of specialized tight junctions between Sertoli cells establish the
blood-testis barrier (Gondos and Berndston, 1993).
The Sertoli cells have a role in regulating the internal environment of the
seminiferous tubule. This is facilitated by specialised inter-Sertoli cell junctions
which are formed at the sites where processes of Sertoli cell cytoplasm from adjacent
cells meet (Dym and Fawcett, 1970). As a result of these junctions, intercellular
transport between the Sertoli cell and spermatogonia is possible. The cell junctions
divide the seminiferous epithelium into a basal compartment which contains the
bases of the Sertoli cells and spermatogonia and an adluminal compartment
containing the central regions of the Sertoli cell and the other germ cell types (Figure
1.5). As Type B spermatogonia migrate from the basement membrane of the tubule
into the adluminal compartment, the tight junctions open up to allow cellular
migration to take place and reform beneath the Type B spermatogonia which have
now left the basement membrane to form preleptotene spermatocytes (Lui et al.,
2003).











Figure 1.5 Illustration of the two compartments of the seminiferous tubule and the tight
junctions between the Sertoli cells in the basal compartments of the testis. Adapted from Lui
et al (2003).
Sertoli cells produce more than 100 different proteins and many of these have been
identified and characterised (Jegou 1992). For example, Sertoli cells synthesise and
secrete inhibins and activins (Roberts et al., 1989); inhibin acts as a negative
regulator ofFSH secretion by the pituitary and in most species, there is a relationship
between the number of Sertoli cells and inhibin concentration (de Kretser et al.,
2001).
Androgen receptor (AR) expression is detected in mature Sertoli cells. The AR
protein is expressed in a stage specific manner in rats and humans (Bremner et al.,
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1994; Suarez-Quian et al., 1999). The expression of AR is switched on prior to final
maturation of the Sertoli cell in many species suggesting it may play a role in Sertoli
cell maturation (Sharpe et al., 2003). Anti-mullerian hormone (AMH) is among the
first genes to be switched on in Sertoli cells (Mackay, 2000). AMH expression in the
Sertoli cells continues until puberty, at the time of Sertoli cell maturation when it is
down-regulated (Rajpert-De Meyts et al., 1999). In mice, GATA-1 expression is
also seen in a stage dependant manner in mature cells (Yomogida et al., 1994).
GATA-1 and AMH expression are inversely related and some reports suggest that
GATA-1 is responsible for the down-regulation of AMH in Sertoli cells (Beau et al.,
2000).
Differentiation of Sertoli cells is also marked by the onset of expression of novel
gene products such as transferrin and androgen-binding protein (ABP). ABP acts as a
paracrine factor during spermatogenesis and it is known to be involved in
testosterone binding and transport (Ritzen et al., 1982). Mature Sertoli cells also
secrete sulphated glycoprotein 1 and 2 (SGP-1 and SGP-2) (Collard and Griswold,
1987; Collard et al., 1988).
In most species investigated including rodents and primates, c-kit receptors are
expressed on the germ cells. The ligand for the c-kit receptor, known as Steel factor,
kit ligand or stem cell factor (SCF) is synthesised by the Sertoli cell. Two forms of
SCF have been identified, a soluble and membrane bound form and these are shown
in Figure 1.6. In the mouse testis at birth, the membrane bound SCF is the most
abundant form found but as development progresses, the soluble form becomes more
prevalent (Manova et al., 1993). The c-kit-SCF relationship is important in the
regulation of spermatogonial stem cell proliferation and differentiation (de Rooij,
2001; Loveland and Schlatt, 1997) and is discussed further in Chapter 4.
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Figure 1.6 SCF is synthesised in the Sertoli cells as one of two isoforms, one form contains a
site that can be cleaved with proteases to release a soluble SCF protein while the other form
remains membrane bound. SCF (black bars) interacts with c-kit receptor protein (white bars)
and this results in phosphorylation (P) of c-kit to effect signal transduction. (Adapted from
Loveland and Schlatt 1997).
Pem is expressed in adult mouse Sertoli cells, its gene expression has been shown to
be androgen and gonadotrophin dependent (Lindsey and Wilkinson, 1996; Sutton et
al., 1998). Pem is a transcription factor that mediates androgen regulated events in
spermatogenesis and is dramatically induced at the initiation of meiosis during the
first wave of spermatogenesis (Wayne et ah, 2002). Pem knockout mice show
normal development and spermatogenesis suggesting that the role of Pem is not
critical in normal spermatogenesis (Pitman et ah, 1998). However studies on Pem
overexpression mice in Wayne et ah (2002) have suggested that Pem regulates the
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expression of Sertoli cell proteins that control DNA modification events in germ
cells. The results showed that constitutively expressing Pern in Sertoli cells in all
stages of the seminiferous epithelial cycle, results in a dramatic increase in the
number of DNA-strand breaks in specific germ cell populations (Wayne et al., 2002).
1.5. Germ cell - Sertoli cell interactions
The fact that the testis has a dual function with the production of hormones and the
production of spermatogenesis suggests a large amount of cell-to-cell
communication is occurring in the testis (Schlatt et al., 1997). Germ cells and Sertoli
cells begin to interact with each other very early during testicular development and
this essential relationship continues throughout spermatogenesis to the production of
spermatozoa (Griswold, 1995; Griswold, 1998; Saunders, 2003). One of the most
important roles of Sertoli cells is the regulation of the intratubular and intercellular
environment. Paracrine and autocrine factors from Sertoli and germ cells are
important in the functioning of both cell types. The primary endocrine regulation of
spermatogenesis is via FSH and testosterone acting upon the Sertoli cells (Griswold,
1995) and this is discussed later in this chapter (section 1.7.1.1). The relationship
between the c-kit receptor found on the germ cells and its Sertoli cell expressed
ligand SCF, which is discussed further in Chapter 4 and in section 1.4, is also very
important in the regulation of spermatogenesis (Loveland and Schlatt, 1997; Manova
et al., 1993).
It has recently been shown that germ cells from mice deficient in the enzyme
encoding alpha-mannosidase llx failed to adhere to Sertoli cells and underwent
premature release into the epididymis implicating both a role for carbohydrates in the
interactions between germ cells and Sertoli cells but also the importance of the role
that the Sertoli cell plays in the physical support of the germ cell (Akama et al.,
2002).
1.6. Germ cells in vitro and in vivo
In the adult mouse testis there are around 35,000 stem cells which accounts for
0.03% of all germ cells (Tegelenbosch and de Rooij, 1993). Very little is known
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about these cells due mainly to a lack of specific markers. Various methods have
been used to purify or enrich the stem cell population, for example, cells have been
isolated from vitamin A deficient rats (van Pelt et al., 1996). In these rats,
spermatogenesis is arrested at the differentiation step of Aai into Ai spermatogonia so
only As, Apr and Aai spermatogonia are present within the testis. Brinster and
Shinohara showed that the stem cell population express the cell surface markers a-6
integrin and (3-1 integrin (Shinohara et al., 2000b) and this information has been
important in studies which have attempted to enrich the stem cell population, which
are described in section 1.6.2.2.
1.6.1. Germ cell cultures
Mammalian spermatogenesis has yet to be demonstrated in full in a cell culture
system. Although germ cells are able to survive in culture for long periods of time,
attempts to expand and proliferate germ cells in culture have proved on the whole
unsuccessful. Initial studies by Brinster and colleagues showed long term survival of
stem cells when they were cultured in the presence of serum and on a STO feeder
layer (Nagano et al., 1998). No proliferation of the stem cell population was
observed and the survival rate of the cells fell dramatically with only 10-20% of the
stem cells remaining in culture after a week (Nagano et al., 1998). However, after
germ cell transplantation (section 1.6.2), the cells were able to re-populate a sterile
recipient mouse showing that long term culture of stem cells did not result in
differentiation of the cells or loss of stem cell characteristics (Nagano et al., 1998).
Long term survival of the stem cells and more importantly, proliferation of the stem
cell population has also been shown when the cells are co-cultured with Sertoli cells
(van der Wee et al., 2001)
Attempts to immortalise stem cells using telomerase and SV40 T antigen have also
been made with proliferation of the cells being reported (Feng et al., 2002; van Pelt
et al., 2002). It is unclear however whether these cells retain true stem cell potential
as to date, no transplantation assays have been performed on these cells. A study by
Kanatsu-Shinohara and colleagues (2003) showed that long-term culture of cells with
various growth factors could proliferate and restore fertility in mice transplanted with
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these cells. They found that a combination of growth factors (GDNF, bFGF, EGF
and LIF) could induce the proliferation of stem cells in vitro. After long term culture,
they found that the cells still expressed a-6 and (5-1 integrin (Kanatsu-Shinohara et
al., 2003), known to be markers of spermatogonial stem cells (Shinohara et al.,
1999), and were negative for c-kit (Schrans-Stassen et al., 1999), which is a marker
of differentiated spermatogonia in the mouse. The cells were also negative for
SSEA-1, which is a PCG marker (Resnick et al., 1992), indicating that the cells were
undifferentiated spermatogonial stem cells.
1.6.1.1. Germ cell lines
The establishment of germ cell lines could be very useful in the study of germ cell
function during the process of spermatogenesis. Attempts have been made to
immortalise germ cell cultures with varying amounts of success. The GC-1 cell line
(Hofmann et al., 1992) was made by immortalising mouse germ cells using the SV40
large-T antigen. These cells corresponded to a stage between B type spermatogonia
and primary spermatocytes and were found to express testicular cytochrome ct and
lactate dehydrogenase^ (LDH-C4), both markers of meiotic and post meiotic cells.
These cells failed to differentiate in vitro and this was thought to be due to the
presence of the large T antigen. The same group reported two years later, that a
second germ cell line, GC-2 could undergo meiosis in vitro. These cells were
immortalised using the SV40 large T antigen together with the gene encoding the
temperature sensitive p53 mutant. At the non-permissive temperature of 39°C, p53 is
inactive. Culture at 37°C or below abolishes the proliferative function of the large T
antigen allowing the cells to differentiate. The GC-2 cells had the morphologic and
biochemical appearance of round spermatids (Flofmann et al., 1994). At 39°C the
markers testicular cytochrome ct and LDH-C4 are expressed weakly. Dropping the
temperature to 37°C or 32°C, resulted in increased expression of these markers
indicating that the cells had differentiated and entered meiosis. However, subsequent
investigation of these cells (Wolkowicz et al., 1996) found that over time, the cells
had become arrested and were no longer capable of differentiation. Although not
strictly a differentiating cell line, they still represent a useful tool in studying germ
cells.
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1.6.1.2. Retroviral immortalisation of germ cells
Martin Dym's group reported the development of a new immortalised germ cell line
in 2002 (Feng et al., 2002). In their studies, undifferentiated mouse spermatogonia
were retrovirally transfected with mTERT. The male germline stem cell expresses
high levels of telomerase activity, but this expression decreases during germ cell
differentiation (Ravindranath et al., 1997). It has been shown that telomerase
deficiency in mice leads to a depletion of male germ cells (Lee et al., 1998) and that
ectopic expression of the telomerase catalytic component, TERT, in certain cell types
can extend their life-span and immortalize them (Hahn et al., 1999; Morales et al.,
1999). From this information, it was suggested that spermatogonia may be
maintained in an undifferentiated status by overexpression of TERT in vitro (Feng et
al., 2002). After 2 months in culture, the cells were still capable of proliferation
while still exhibiting type A spermatogonia morphology. The cells expressed Oct-4,
Dazl and c-kit, all markers of spermatogonia. Culture of the cells in media containing
mSCF induced the cells to enter meiosis, thereafter cells expressed LDH-C4, and the
spermatid markers SP-10 and protamine-2 (Feng et al., 2002).
1.6.2. Spermatogonia! stem cell transplantation
Undifferentiated spermatogonia remain totipotent and undergo self-renewal. The
method of stem cell transplantation was pioneered in mice by Ralph Brinster and his
group in 1994 (Brinster and Avarbock, 1994; Brinster and Zimmermann, 1994) and
provided a functional assay of whether a putative stem cell population are true
"stem" cells.
The method of germ cell transplantation involves the isolation of testicular cells from
a fertile mouse and the subsequent transplantation of the cells back into the lumen of
the testis of an infertile recipient mouse with a similar genetic background. The
transplanted donor stem cells then repopulate the seminiferous epithelium of the
recipient testis reinitiating spermatogenesis (Brinster and Zimmermann, 1994). The
initial experiments carried out by Brinster transplanted cells from young mice
between 4 and 12 days old as these contain a higher proportion of spermatogonia
compared with adults. Two different strains of mice were used as recipients, the first,
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W mutant mice, were selected as these mice are sterile because of the lack of
differentiated germ cells and spermatogonial stem cells due to a mutation in the c-kit
locus (Besmer et al., 1993; Brinster and Zimmermann, 1994). The second group of
mice were made infertile following treatment with busulphan. Treatment with
busulphan, which is a chemotoxic agent results in destruction of the spermatogenic
stem cells (Bucci and Meistrich, 1987). Four weeks after busulphan treatment, no
signs of spermatogenesis are present and testis size is significantly reduced to about
10-15% of a size of normal (Brinster and Zimmermann, 1994). Chemical sterilisation
of the testis by treatment with busulphan has to be treated with caution, as this
method is not always 100% effective in eliminating all the stem cells. To overcome
this, donor mice expressing lac-z (Rosa) (Zambrowicz et al., 1997) or GFP within
their germ cells (Okabe et al., 1997) have been useful in identifying whether the
germ cell colonies formed after transplantation are donor derived or from re¬
initiation of endogenous spermatogenesis.
In order to perform transplantation, donor cells are isolated by enzymatic digestion
and the resulting single cell suspension is injected into the testis via the efferent ducts
(Brinster and Zimmermann, 1994). Transplanted cells then move from the lumen of
the tubule to the basal compartment of the testis where a stem cell niche is believed
to exist, the stem cell niche is described further in section 1.6.2.1 (Brinster, 2002).
Germ cell movement is thought to be mediated by the Sertoli cells, which transport
the transplanted cells into their usual position in the tubule. This involves movement
of the stem cells through the blood testis barrier in the opposite direction from
normal. The blood testis barrier consists largely of inter-Sertoli cell tight junctions
and is shown in Figure 1.5. As this process must involve breaking down and re¬
forming tight junctions between Sertoli cells it seems likely that the Sertoli cells are
able to recognise spermatogonial stem cells (Griswold, 1998).
After the initial success of the transplantation experiments, it was found that
spermatozoa from donor-derived colonies were capable of fertilising oocytes and
producing progeny which carried the donor haplotype (Brinster, 2002; Brinster and
Avarbock, 1994). Additional studies reported that germ cell suspensions could be
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frozen and successfully transplanted at a later date (Avarbock et al., 1996). This has
given hope that this technique could be used as a treatment for infertility resulting
from treatments such as radio- or chemotherapy, which destroy endogenous stem
cells rendering patients infertile. For example, testicular germ cells could be
recovered from pre-pubescent boys, frozen until required and then thawed and
transplanted at a later day. This proposal is not without controversy, the major
concern being that cancerous cells could be reintroduced.
Since the first report of a successful spermatogonial cell transplant, many
modifications to the procedure have been carried out, both improving the efficiency
of the procedure and also establishing the technique in other species. Enrichment of
the stem cell population to improve colonisation rates has been very successful and
methods used in achieving this are discussed in section 1.6.2.2. To overcome the
problems associated with the use of busulphan, many groups have moved towards
using mouse models of infertility. Many mouse models showing arrested
spermatogenesis have been described (Cooke and Saunders, 2002) and several of
these have been successfully used as recipients for transplantation including the Steel
and Dazl mouse mutants (Ogawa et al., 2000b; Rilianawati et al., 2003). Transplants
have also been undertaken in other species including rats, hamsters and primates
(Jiang and Short, 1995; Schlatt, 2002; Schlatt et al., 1999). Modifications to the
transplant procedure had to be undertaken in primates with the cells being injected
into the rete testis guided by ultrasound (Schlatt et al., 2002; Schlatt et al., 1999).
As spermatogonial stem cells appear to be similar in many species (Russell et al.,
1990), the ability of spermatogonia to colonise seminiferous tubules of another
species has been investigated with colonisation of transplanted donor cells being
observed in rat to mouse, mouse to rat, hamster to mouse, primate to mouse, and
rabbit to mouse transplants (Clouthier et al., 1996; Dobrinski et al., 1999; Nagano et
al., 2001b; Ogawa et al., 1999; Schlatt et al., 1999; Zhang et al., 2003). The most
successful intra-specific transplants that have been reported have been from the
mouse to the rat. Cells from transgenic mice were transplanted to the testes of
immunodeficient rats, resulting in restoration of spermatogenesis with the production
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of spermatozoa with normal mouse morphology being seen in the epididymis of the
rat (Clouthier et al., 1996; Zhang et al., 2003). This was an important development as
it showed rat germ cells retained their 52-day cycle after transfer to the mouse testis
and it confirmed reports claiming it is the germ cells and not the Sertoli cell
environment that controls the length of the spermatogenic cycle (Franca et al., 1998;
Russell and Brinster, 1996). Other intraspecific transplants have been less successful.
Ogawa et al. (1999) reported that hamster spermatogenesis could be produced in an
immunodeficient mouse recipient. However, this resulted in the production of
elongated spermatids with abnormal head shapes (Ogawa et al., 1999). No
spermatozoa were produced from xenogeneic transplantations from rabbit to mouse
and from dog to mouse The transplanted cells, moved to the basal compartment but
did produce mature germ cells. (Dobrinski et al., 1999). It has been hypothesized that
the success of transplants is correlated to the degree of evolutionary relatedness of
the species (Johnston et al., 2000).
Although intraspecies transplantation represents a significant step forward in the
application of the methods to human patients, success has so far been limited. One of
the first attempts to transplant human germ cells into testes of immunodeficient mice
showed that no human germ cells survived in mouse testes, possibly due to
immunological rejection or incompatibility between human germ cells and mouse
somatic cells (Reis et al., 2000). A subsequent study by Nagano (2002) demonstrated
colonisation of human spermatogonial stem cells within the testes of
immunodeficient mice for at least 6 months after transplantation but did not
differentiate beyond undifferentiated spermatogonia in mouse testes (Nagano et al.,
2002).
1.6.2.1. Stem cell niche
In the haematopoietic system, stem cell microenvironments termed "niches" were
described (Schofield, 1978). A niche is considered to be a subset of cells and
extracellular substrates that can indefinitely house stem cells and control their self-
renewal and progeny production. Demonstration that a niche is present requires that
after stem cells removal, transplanted cells will begin to repopulate the tissue. It is
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said that a niche should persist in the absence or removal of stem cells and support
the stem cell activity of competent exogenous cells (Spradling et al., 2001). The
existence of such a niche in the testis was demonstrated when the process of germ
cell transplantation was developed (Shinohara et al., 2001). Once cells are
transplanted, they migrate down into the tubule and pass through the Sertoli cell tight
junctions and colonise sites on the basement membrane of the tubule. It is thought
that these cells occupy empty niches that lie in abundance along the depleted basal
layer (Spradling et al., 2001). Each colony seems to be established from an
individual spermatogonial stem cell. It has been proposed that the number of
colonies formed was representative of the number of niches that exist along the
basement membrane of the seminiferous tubule (Spradling et al., 2001).
Niche number and quality seem to change during development (Spradling et al.,
2001). Evidence for this comes from studies involving the W mutant mice, which
lack c-kit function and exhibit abnormal spermatogenesis (Shinohara et al., 2001).
When these mice are used as recipients for germ cell transplantation, their testes
support more colonies of donor-derived germ cells when they are prepubertal
(between days 5-15) compared with recipients used in adulthood, regardless of the
age of the donor cells. This suggests that niches may be more abundant or easier to
access in younger animals (Ohta et al., 2000; Shinohara et al., 2001). Integrins (ct6 /
Pi) are enriched in the basal component of the seminiferous tubule (Shinohara et al.,
1999) and it has been proposed that these molecules may aid attachment of the
spermatogonial stem cells to laminin in the basement membrane and thereby
participate in the niche.
1.6.2.2. Enrichment of the stem cell population
The stem cell population in the adult mouse testis is small, representing only 1 in
4000 of the total germ cell complement (Tegelenbosch and de Rooij, 1993). Several
approaches have been used both to identify spermatogonial stem cell markers and in
the isolation of the stem cell population (Kubota et al., 2003). For example, cells
expressing surface markers have been isolated using immunomagnetic beads and
transplanted into recipient testes. It was found that selection of germ cells that
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expressed a-6 integrin and |31 integrin on their surface prior to transplantation
increased the number of colonies formed following transplantation by 166 fold
compared to an unselected population (Shinohara et al., 1999).
Enrichment of the stem cell population can also be achieved by isolating cells from
mutant mice such as the steel mutant, which are infertile as the testes of homozygous
mutants are virtually devoid of germ cells (Shinohara et al., 2000a) or vitamin A
deficient mice (VAD) which results in a loss of mature germ cells in the testis,
resulting in infertility (Griswold et ah, 1989; van Pelt and de Rooij, 1990). Cells
derived from steel mice have been used as successful donors for transplantation and
spermatogenesis could be restarted in the VAD mice after treatment with vitamin A.
This suggests that the stem cell population remains in these animals and the use of
these mice for isolation of germ cells would result in a population that is enriched for
the stem cell population. Other ways to enrich the stem cell population have been
achieved by making mice cryptorchid or exposing the testis to high temperatures
(McLean et ah, 2002; Shinohara et ah, 2000a). Cryptorchidism, either naturally
occurring or experimentally achieved by retaining the testis in the body cavity of the
mouse, results in the loss of mature germ cells (Nishimune and Aizawa, 1978;
Nishimune et ah, 1986). Similarly, testes of mice who underwent scrotal heating at
43 °C for 15 minutes lack meiotic and post meiotic germ cells (Chowdhury and
Steinberger, 1964). Transplantation of donor cells derived from the testes of
hyperthermic mice resulted in a 5.3 fold increase in the number of colonies and the
area of colonisation was increased 19 fold (McLean et ah, 2002). Transplantation of
cells isolated from cryptorchid testes resulted in a 25 fold increase in the number of
colonies and a 50 fold increase in the area of spermatogenesis compared with control
transplantations carried out with cells derived from normal animals (Shinohara et ah,
2000a). In contrast, the use of germ cell mixtures from VAD mice only resulted in a
2.5 fold increase in the number of colonies (McLean et ah, 2002) and the use of the
steel mutant mouse was reported as giving a modest increase in donor derived
colonies of spermatogenesis compared to control (Shinohara et ah, 2000a). The
results from these experiments tell us that the proportion of germ cells representing
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the stem cell population can be successfully enriched by the use of mouse models
that lack more mature germ cells.
1.6.3. Manipulation of stem cells
Genetic manipulation of the stem cells prior to transplantation could provide a
quicker and easier way of generating transgenic mice than traditional methods and
would allow transgenesis through the male germ line instead of the female. One of
the first successful reports using this approach used testicular cells that were cultured
with a retroviral vector before being used for transplantation. The viral vectors were
able to integrate into the chromosomal DNA of the stem cells and Nagano and co¬
workers reported that at least 1 in 300 stem cells were infected with the retrovirus
and virus expression remained detectable for more than 6 months (Nagano et al.,
2000). Following on from this study, retrovirally infected cells were transplanted into
infertile recipient mice resulting in stable integration of the transgene in 2-20% of the
stem cells and the transgene was transmitted through the germline to the offspring
(Nagano et ah, 2001a). Stem cells from the rat are also receptive to retroviral
infection with 0.5% of cultured then infected stem cells producing colonies of
spermatogenesis after germ cell transplantation (Orwig et ah, 2002).
1.7. Steroidogenesis
In the male, the testis is a major site of synthesis of steroid hormones, including
oestrogens and androgens. Steroid biosynthesis is summarised in Figure 1.7. The
pathway from cholesterol to androstenedione is the same in both the testis and the
adrenal gland and uses the same enzymes. Testicular testosterone is produced in the
Leydig cells. The enzyme 3B-hydroxysteroid dehydrogenase (3BHSD) is responsible
for the conversion of pregnenolone to progesterone, 17-hydroxypregnenolone
(170H-pregnenolone) to 17-hydroxyprogesterone (170H-progesterone),
dehydroepiandrosterone (DFIEA) to androstenedione, and androstenediol to
testosterone. P450cl7 is also necessary in the proximal stages of testosterone
synthesis. P450cl7 catalyzes the 17-hydroxylation of pregnenolone to 170H-
pregnenolone and progesterone to 170H-progesterone. The conversion of
androstenedione to testosterone in the testis is catalysed by 17BHSD type 3
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(17BHSDIII). The testosterone secreted from the Leydig cells can enter the Sertoli
cells where it can be further converted to dihydrotestosterone (DHT) by 5a reductase
(Holmes et al., 2004; Miller, 1988).
Although at first widely believed to be female specific hormones, there is now
evidence that oestrogens are synthesised in the male reproductive tract by the Sertoli
cells, the Leydig cells and the germ cells (Hess, 2003; Hess et al., 2001). In the male,
oestrogen is synthesised from testosterone by the enzyme cytochrome P450
aromatase or oestrone by 17|3-hydroxysteroid dehydrogenase (17|3-HSD) (Figure
1.7) in the brain and in the testis (de Ronde et al., 2003). It was the discovery of
aromatase in the testis that led to the suggestion that oestrogens might play a role in
male reproductive function (Hess, 2003). In mammals, cytochrome P450 aromatase,
a product of the CYP19 gene has been localised to the Leydig cells in many species
including man, mouse, rat, ram and pig (Carreau et al., 2003; Conley and
Hinshelwood, 2001; Inkster et al., 1995; Kurosumi et al., 1985; Nitta et al., 1993). In
the mouse, aromatase expression is also seen in the Sertoli cells and in the germ cells
(Nitta et al., 1993) and aromatase is present in the germ cells of both humans and
primates (Lambard et al., 2004; Turner et al., 2002).

























Figure 1.7 Steroid synthesis from cholesterol. Adapted from Holmes et al., 2004.
1.7.1. Hormonal regulation of male fertility
The hypothalamus, pituitary gland and gonads regulate the development of
reproductive function in mammals. Gonadotrophins and steroid hormones along with
other intratesticular modulators are responsible for the initiation and maintenance of
spermatogenesis in the mammalian testis (Carreau et al., 1999; Sharpe, 1993). Figure
1.8 summarises the interactions of the gonadotrophins and the steroid hormones in
the testis. The secretion of steroid hormones, especially testosterone is necessary for
the expression of secondary sexual characteristics and the production of
spermatozoa. Testosterone is essential for spermatogenesis demonstrating that
paracrine signals between testicular cell types is essential and suggests a role for AR
in spermatogenesis (Sharpe et al., 1988). The secretion of steroid hormones is
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dependant on stimulation by the gonadotrophins, FSH and LH (McLachlan et al.,
1996). The review by McLachlan (1996) gives examples of studies that show
spermatogenesis does not proceed normally if the testis is not stimulated by these
hormones. The hpg mouse is an example of this, a naturally occurring deletion in the
GnRH gene results in a model of hereditary hypogonadism (hpg), both sexes of these
mice are infertile due to immature gonads. The mice completely lack gonadotrophin
releasing hormone (GnRH), resulting in severely reduced levels of FSH and LH
within the pituitary (Cattanach et al., 1977). The consequence of this loss of
gonadotrophin secretion is a reduction in testosterone biosynthesis by the Leydig
cells.
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Figure 1.8 Hormonal control of the male reproductive tract. Taken from Cooke and
Saunders (2002).
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1.7.1.1. FSH and LH
LH and FSH both act through different specific G-protein coupled transmembrane
receptors (Simoni et al., 1997a; Simoni et al., 1997b). The hypothalamic secretion of
GnRH stimulates the anterior pituitary to release FSH and LH. LH travels through
the bloodstream and binds to the LH receptor present on Leydig cells where it
stimulates biosynthesis of testosterone. LH also stimulates the synthesis of
steroidogenic acute regulatory protein (StAR), which is involved in the acceleration
of the transfer of cholesterol from the outer to the inner mitochondrial membrane
prior to the first step in steroid biosynthesis. Inhibin B is a major hormonal product
of the testis (Illingworth et al., 1996). Inhibin B is produced in the Sertoli cells under
the stimulatory influence of FSH and acts to inhibit FSH secretion from the pituitary
(Anawalt et al., 1996).
Some studies have suggested that FSH is the primary endocrine hormone involved in
Sertoli cell regulation. As early as 1937, FSH was demonstrated to be able to
maintain spermatogenesis in hypophysectomised rats (Greep and Fevold, 1937). In
man, Matsumoto et al. (1986) reported that FSH treatment was able to restore sperm
counts in men who had suppressed spermatogenesis caused by a lack of
gonadotrophin secretion (Matsumoto et al., 1986). During development, FSH
stimulates seminiferous tubule growth and is a major determinant of adult testicular
size (Amory and Bremner, 2003) because FSH influences Sertoli cell number and the
induction and maintenance of normal spermatogenesis (Simoni et al., 1999). In the
human, there is evidence to suggest that FSH may also play a role in the regulation
of the development of the adult Leydig cell population (Baker et al., 2003a; Sharpe,
1993). Sertoli cells are stimulated by FSH via the FSH receptor and FSH has been
shown to regulate the expression of many Sertoli cell products including androgen
binding protein, transferrin and aromatase (Griswold, 1998; Griswold et al., 1988;
Skinner, 1991). Further evidence that FSH and androgens are both required for
efficient Sertoli cell function is provided by studies in knockout animals and the
effects of the lack of FSH and androgens in these models are discussed in section
1.9.
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1.7.1.2. Androgens
From the Leydig cells, testosterone is released into the bloodstream and also travels
to the Sertoli cells where it can be converted to its more active metabolite DHT
(Figure 1.7). Although the affinity of DHT for the androgen receptor is said to be
twice that of testosterone, it is believed that testosterone is the predominant ligand
for the androgen receptor (Wright and Frankel, 1979). The relative abundance of
testosterone in the testis is around five times greater than DHT (Wright and Frankel,
1979).
It has been proposed that FSH and testosterone work together in the regulation of
spermatogenesis and may share a common post receptor pathway (Russell and
Griswold, 1993). Huang et al. proposed the idea that FSH played a role in
transporting and localising testosterone within the Sertoli cells in association with
ABP (Huang et al., 1991). The importance of testosterone for normal
spermatogenesis has been endorsed by studies showing its withdrawal results in the
degeneration of spermatogenic cells (McLachlan et al., 1996). Following treatment
with ethane dimethane sulphonate (EDS) which is a Leydig cell cytotoxin, pyknotic
nuclei and cytoplasmic vacuoles, both signs of cellular degradation were observed
within cells, particularly in the spermatocytes and spermatids (Kerr et al., 1993).
The studies discussed above involving testosterone were performed on rodent models
and it was hoped that by elucidating the role of testosterone, advances would be
made in the human eventually leading to the use of androgens, especially
testosterone as a male contraceptive. The basis behind this is that high levels of
testosterone decreases LH and FSH secretion leading to a reduction in testicular
testosterone by negative feedback and the cessation of spermatogenesis which in turn
results in a decrease in fertility (Amory and Bremner, 2003). Clinical trials using
exogenously administered testosterone to suppress FSH and LH levels as a hormonal
male contraceptive have induced spermatogenic suppression in a majority of men. A
recent report in which subjects were given weekly injections of the testosterone ester
testosterone enanthate, azoospermia was achieved in only two-thirds of Caucasian
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men (Amory and Bremner, 2003; Kamischke and Nieschlag, 2004). However
oligozoospermia is achieved in a majority of cases and the failure rate in these cases
is low (3.5%). One of the main advantages to hormonal contraception in the male is
that it is reversible and sperm counts are found to return to normal after cessation of
testosterone treatment. Progress is also being made using testosterone in combination
with different progestins or gonadotrophin-releasing-hormone antagonists. Of these,
testosterone administered in combination with either depot medroxyprogesterone
acetate, norethisterone enanthate, desogestrel or etonogestrel have shown promising
efficacy (Kamischke and Nieschlag, 2004).
1.7.1.3. Oestrogens
The importance of oestrogens in the male was first demonstrated when
malformations in the male reproductive tract were observed following exposure to
potent oestrogens (Arai et al., 1983). This was followed by the discovery of the
aromatase complex in the testis and problems with fertility in mice with targeted
deletions in the ERa and aromatase P450 (cypl9) genes (Lubahn et al., 1993;
Robertson et al., 1999). The production rate of oestradiol in the adult human male
has been estimated to be 35-45 p,g per day and 15-20% of this is produced by the
testes (Baird et al., 1969). In the testis, both the immature Sertoli cells and the
Leydig cells synthesise oestrogens and it has been shown that the germ cells ofmany
species including rodents, humans and primates are also a source of oestrogens
(Carreau et al., 1999; Nitta et al., 1993; Turner et al., 2002).
Oestrogens play a major role in many metabolic processes in the male outside the
testis including the cardiovascular system and in bone homeostasis. Patients with
oestrogen insensitivity or aromatase deficiency show decreased bone mineral density
(de Ronde et al., 2003; Morishima et al., 1995; Smith et al., 1994). A report by
Carlsen and co-workers in 2000 suggests that male osteoporosis is associated with
low peripheral oestradiol levels (Carlsen et al., 2000). In another study in young
patients with unexplained osteoporosis but normal oestrogen levels, a reduction in
the level of expression of ERa protein in osteoblasts and osteocytes was seen and it
was suggested this could explain the bone loss (Braidman et al., 2000). Oestrogen
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receptors are also expressed throughout the cardiovascular system (Gray et al.,
2001). In addition, both the aromatase knockout mice and human patients with a
mutation in the CYP19 gene show obesity, hypercholesterolemia and
hypertriglyceridaemia (Fisher et al., 1998). These phenotypes add evidence to the
suggestion that oestrogens play a role in the cardiovascular system.
1.8. Steroid hormone receptors
The gonads and adrenal glands produce five major groups of steroid hormones,
oestrogens, androgens, progestin's, glucocorticoids and mineralocorticoids. In
mammals, the actions of oestrogens and androgens are mediated through members of
the steroid hormone receptor super family (Parker, 1991) expressed in target cells.
Classical steroid hormones receptors are transcription factors that are activated by
ligand binding (Parker, 1990), ligand binding promotes receptor dimerisation and
high affinity binding to chromatin organised DNA sequences termed hormone
response elements (Beato and Klug, 2000; Mangelsdorf et al., 1995). The HRE-
receptor complexes are then able to modulate transcription of target genes. Members
of the steroid hormone receptor family share significant sequence homology and are
characterised by a similar domain structure (Figure 1.10). Briefly, the receptors all
contain a DNA binding domain (DBD), which contains two zinc finger domains,
which are important in targeting the receptor to the HRE. The ligand binding domain
(LBD) is situated at the c-terminal end of the receptor and it is this region that binds
specific hormonal and non-hormonal ligands (Olefsky, 2001). Ligand binding also
activates two different activation functions, the first, termed activation function 1
(AF-1) is located in the A/B region in the N terminal domain and the second,
activation function 2 (AF-2), which is a ligand-inducible activation function close to
the LBD. The two AF's act to connect the receptor to transcriptional apparatus via
transcription factors, co-activators and co-repressors (Beato and Klug, 2000).
Oestrogen receptors were first characterised by Jensen and DeSombre in the 1970's
(Jensen and DeSombre, 1973) and this led to the cloning of the receptors in the
1980's. The first oestrogen receptor, now known as ERa was discovered in 1958 and
cloned in 1986 from a human breast cancer cell line (Green et al., 1986). For several
years it was believed to be the only form that existed. However, in 1996, a second
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form was cloned by degenerative PCR from rat prostate and named ER(3 (Kuiper et
al., 1996).
The androgen receptor is also expressed throughout the male reproductive tract. AR
functions as a ligand-dependent transcription factor, regulating expression of an
array of target genes that are important in male development and fertility (Collins et
al., 2003). Regulation of androgen production via the hypothalamic-pituitary-gonadal
axis is necessary for development of the male phenotype, as well as for initiation and
maintenance of spermatogenesis. AR activity is regulated by the steroid ligand
testosterone and its derivative dihydrotestosterone (DHT), the binding of which
initiates nuclear translocation and the transcriptional regulatory function of AR
(Lindzey et al., 1994), and this can mediate a wide range of physiological responses
and developmental processes. The ligand bound AR can then form homodimers and
bind specific DNA elements referred to as androgen response elements (ARE) in
target gene promoters. After ligand binding, the AR can also interact with various
factors (e.g. co-activators or co-repressors) to modulate transcription of androgen
target genes via specific DNA sequences (Lee and Chang, 2003). AR plays an
important role in the feedback regulation of Testosterone levels. This regulation
occurs through autocrine feedback on the Leydig cells, via effects on GnRH
production, and through inhibition of LH secretion by the pituitary (Amory and
Bremner, 2001). The androgen receptor was cloned in 1988. It was localised to the
X-chromosome and has a similar domain structure to other members of the nuclear
receptor superfamily, shown in Figure 1.10 (Lubahn et al., 1988).
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Figure 1.10 Domain structure of a steroid hormone nuclear receptor.
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1.8.1. Expression of steroid hormone receptors within the testis
Cellular localisation of both the androgen and the oestrogen receptors within the
male has led to a better understanding of their involvement in normal physiology
(Couse and Korach, 1999). Both ERa and ERfl bind oestradiol and bind an oestrogen
response element (ERE), 5'-GGTCAnnnTGACC-3', with high affinity (Klinge,
2001). It has been shown that ERa and ER(3 bind ligands with different affinities and
are distinct in their transcriptional activities (Katzenellenbogen and
Katzenellenbogen, 2000; Kuiper and Gustafsson, 1997; Paech et al., 1997). The
difference in the way that the two receptors are activated suggests further that both
receptors play different roles in gene regulation (Paech et al., 1997).
1.8.1.1. Oestrogen receptor alpha (ERa)
ERa is expressed in many tissues in the mouse including the ovary, uterus, oviduct
and mammary gland in the female and in the testis, prostate and epididymis of the
male (Couse and Korach, 1999; Zhou et al., 2002). ERa is also expressed in non-
reproductive organs including the heart, liver, kidney and lung (Brandenberger et al.,
1998; Couse et al., 1997; Kuiper et al., 1997). In the murine testis, ERa has been
localised to the Leydig cells and the peritubular myoid cells. No expression has been
detected in Sertoli cells or germ cells (Zhou et al., 2002). High levels of expression
have been detected in the efferent ductules (Cooke et al., 1991).
In the rat, ERa is again highly expressed in the efferent ductules. Adult Leydig cells
are also immunopositive for ERa, but ERa is not expressed in Sertoli cells,
peritubular myoid cells, blood vessels or germ cells at any time (Fisher et al., 1997).
In dogs and cats, no expression of ERa has been detected in Sertoli cells or germ
cells. Cats also showed no expression in the peritubular cells and the only expression
of ERa was in the interstitial cells while dogs showed both interstitial cell and
peritubular myoid cells expression of ERa protein (Nie et al., 2002).
In the human, ERa expression was localised to the efferent ducts in fetal and adult
testes but no expression was seen in the Leydig cells, Sertoli cells, peritubular myoid
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cells or the germ cells (Gaskell et al., 2003; Saunders et al., 2001). A comparison of
the expression of ERa in the testes from the human, the macaque and marmoset
monkey showed that the expression of ERa in both primates was identical to that in
the human with the protein shown to be localised to the efferent ducts but not in any
of the cells of the testis (Saunders et al., 2001). In the case of the marmoset, this
differs from the study by Fisher where immunopositive Leydig cells were observed
(Fisher et al., 1997). From all these reports and others published, it is clear that the
efferent ducts are a major site for oestrogen action as the expression of ERa is seen
across numerous species (Hess, 2003). Further evidence for this has been revealed by
studies in ERa knockout mice (section 1.9.1.1).
1.8.1.2. Oestrogen receptor beta (ERp)
ER|3 has been cloned from various species including mouse, human, primate, fish
and eel (Enmark et al., 1997; Mosselman et al., 1996; Todo et al., 1996; Tremblay et
al., 1997). Analysis of the tissue distribution of ERp has revealed differences in
expression between species.
In the female, the expression of ER(3 is seen throughout the reproductive tract in
various species. In the rat, the study by Saunders et al. (1997) localised ER|3 protein
to the granulosa cells and the corpora lutea of the ovary and throughout the oviduct
epithelium. In the rat uterus, ER(3 was seen in the epithelium and in the stroma
(Saunders et al., 1997). In the human, ER(3 is expressed in the granulosa cells of
ovary and ER|3 has been localised to the uterus at all stages of the menstrual cycle
(Critchley et al., 2001; Saunders and Critchley, 2002). ERp is also expressed
throughout the marmoset ovary (Saunders et al., 2000).
In the male, ERp is expressed in multiple cell types within the testis of various
species as well as in the prostate and the epididymis (Couse and Korach, 1999;
Couse et al., 1997; Enmark et al., 1997; Kuiper et al., 1997). ERp was localised to
the testis of the mouse by immunohistochemistry and was seen to be expressed in the
Sertoli, Leydig, peritubular myoid and the germ cells (Zhou et al., 2002). In the male
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rat, ER|3 was expressed in the Sertoli cells, Leydig cells and some germ cells
including spermatocytes and spermatogonia (Saunders et al., 1998) and this was
confirmed in the study by Saunders et al. in 2001 where the expression of ER|3 was
compared between humans, macaque and marmoset testes and was found to be
present in all three cell types of the testis. Expression of ER(3 was greater in the
Sertoli cells than in the germ cells in the marmoset, rat and the human (Saunders et
al., 2001).
The expression of ER|3 has also been described in the male reproductive tract of dogs
and cats. In the dog, ER|3 is expressed the germ cells and the peritubular myoid cells
but no expression is seen in the Sertoli cells or the interstitial cells. In the cat, the
expression is again seen in the germ cells and in the peritubular cells but not in
Sertoli cells (Nie et al., 2002).
1.8.1.3. Androgen receptor
In the adult mouse, AR is expressed in the Leydig, Sertoli and peritubular myoid
cells of the testis as well as throughout the epididymis, vas deferens and the efferent
ducts. AR is not expressed in the germ cells. Similarly, in the adult rat testis, AR
expression occurs in a stage specific pattern in the Sertoli cells and in the Leydig and
peritubular myoid cells but not in the germ cells, AR staining in rat Sertoli cells
appears to be dependant on the cycle of the seminiferous epithelium (Bremner et al.,
1994). In humans, AR is expressed in the somatic cells of the testis but is absent
from the germ cells. Sertoli cell expression of AR is again stage specific in the
human (Suarez-Quian et al., 1999). In humans, mutations in the AR cause a diverse
range of clinical conditions, including motor neuron disease (Kennedy's disease) and
testicular feminization mutation (Tfm) syndrome (Choong and Wilson, 1998;
Quigley et al., 1995).
1.9. Mouse knockout models
Mouse models with targeted disruption of the genes encoding both ER's, AR and the
aromatase enzyme have been described (Dupont et al., 2000; Eddy et al., 1996;
Krege et al., 1998; Lubahn et al., 1993; Yeh et al., 2002). The knockout mouse
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models also show that oestrogens and androgens are essential for fertility but not for
survival after birth or for the formation of the reproductive tract.
1.9.1. Oestrogen receptor knockout mice
1.9.1.1. Oestrogen receptor a knockout mice (ERKO)
The role of the ERa in the reproductive tract was investigated by the generation of a
loss of function mouse model. ERKO mice were generated by targeted insertion of a
1.8kb fragment into exon 2 of the ERa gene, disrupting the DNA binding domain of
the gene (Lubahn et al., 1993). A second line of ERKO mice has been generated by
Dupont et al. (2000). Female mice ERKO were found to be infertile. Elistological
analysis of the reproductive tract showed abnormal uteri and cystic ovaries with few
granulosa cells and no corpora lutea (Dupont et al., 2000; Lubahn et al., 1993).
At birth, male ERKO mice appear normal, however adult males are infertile,
consistent with an essential role for ERa-mediated processes in the regulation of
male reproduction. Adult ERKO male mice have significantly fewer epididymal
sperm than heterozygous or wild-type males, the motility of the sperm is reduced
(Couse and Korach, 1999; Eddy et al., 1996) and the testes begin to degenerate and
become atrophic (Hess et al., 1997). Spermatogenesis can be observed in some
seminiferous tubules but most tubules have dilated lumens and a disorganized
seminiferous epithelium. This disruption of spermatogenesis and degeneration of the
seminiferous tubules becomes apparent after 10 weeks of age. The sperm also have
reduced motility and are unable to fertilize eggs in vitro (Eddy et al., 1996; Mahato
et al., 2001). The ERKO mice created by Dupont et al. (2000) showed a similar
phenotype. The mice were also infertile showing a loss of germ cells and dilated
tubules (Dupont et al., 2000).
The efferent ducts appear swollen in ERKO males and the lumen of the duct is
severely dilated (Hess et al., 1997). As previously discussed in this chapter, the
efferent ducts express the highest levels of ERa in the male reproductive tract in
various species. The ducts are involved in sperm transport from the tubule to the
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epididymis and play a role in fluid reabsorbtion with the ducts reabsorbing
approximately 90% of the fluid from the rete testis (Hess, 2000; Hess et al., 1997).
This reabsorbtion acts to concentrate the spermatozoa as they enter the epididymis
resulting in maximum spermatozoa number being released per ejaculation (Ilio and
Hess, 1994). In the efferent ducts of the ERKO mice, the height of the microvillus
border in the epithelial cells is reduced and this affects fluid resorption (Hess et al.,
2001). This knowledge along with the finding that the efferent ducts are swollen due
to accumulation of luminal fluid has led to the suggestion that one of the main roles
played by ERa in the male is in mediating fluid reabsorbtion and that disruption of
this process was the cause of infertility in the ERKO male mice (Hess et al., 1997).
1.9.1.2. Oestrogen receptor (J knockout mice (pERKO)
The first male mice with targeted disruption of ER(3 were produced by targeted
insertion of a 1.8kb fragment into exon 3 of ER|3 (Krege et al., 1998). Dupont et al.
(2000) used a similar targeting strategy to generate a second (3ERKO line (Dupont et
al., 2000). Both male and female mice develop normally and young animals are
grossly normal. Adult female (3ERKO mice have reduced fertility compared to wild-
type littermates producing fewer and smaller litters. This reduction in fertility is due
to a reduction in ovarian function with more atretic follicles and less corpora lutea
being found in the |3ERKO animals. Sexual behaviour was normal in the knockouts
and mammary gland development and function was normal (Krege et al., 1998).
Male (3ERKO mice are fertile and show no gross abnormalities in the reproductive
tract (Couse and Korach, 1999; Krege et al., 1998). However, data exists showing
cellular changes in the prostate with ER|3 knockout mice developing severe epithelial
hyperplasia in some ducts of ventral prostate as the mice age (Weihua et al., 2001;
Weihua et al., 2002) but this has been disputed by other studies (Dupont et al., 2000)
and the role of ER(3 in the prostate is unclear.
ER(3 is expressed in bone, suggesting oestrogen action on the skeleton is important in
both men and women (Braidman et al., 2001). It has been shown that men lacking
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aromatase suffer from osteopenia (Morishima et al., 1995) and bone loss in ageing
men is associated with a reduction in the levels of oestrogens (Turner et al., 1994). In
postmenopausal women, a reduction in the levels of oestrogens is also associated
with bone loss and increased risk of osteoporosis.
No patients have yet been described lacking the ER|3 gene but patients have been
described that show polymorphisms within the gene resulting in menstrual disorders
(Ogawa et al., 2000a; Sundarrajan et al., 2001). This information combined with the
results from the ERa knockout mice (section 1.9.1.1) and the double knockout
ERa^KO mice suggest that the primary role of ER|3 is to modulate gene regulation
via ERa.
1.9.1.3. a / p ERKO mice
ERa and ER|3 have both differential and overlapping distribution throughout the
male reproductive tracts (Couse et al., 1999) and differences also exist in the
transcriptional activities between the two receptors (Paech et al., 1997). Mice lacking
functional ERa and ERf> receptors have been generated by crossbreeding the ERKO
and (3ERKO mice (Couse et al., 1999; Dupont et al., 2000). ERaflKO male mice
possess a grossly normal reproductive tract, but are infertile. The testes of adult
ERapKO males had some residual spermatogenesis but the number and the motility
of sperm were reduced. Adult males showed a loss of germ cells and the rete testis
appeared dilated (Dupont et al., 2000). This phenotype is similar to that of the ERKO
male and is characteristic of a loss of the ERa gene.
ERa(3KO females exhibit normal differentiation of the uterus, cervix, and upper
vagina. Uterine hypoplasia is seen in ERa(3KO adult females, which resembles that
in the ERKO mice but this does not occur in ER|3KO females. This suggests
differentiation of the female reproductive tract during fetal life can occur in the
absence of a functional ERa and ER|3. Ovaries of adult ER|3KO females exhibited
primordial and growing follicles but no corpora lutea were observed. The ovaries of
adult ERa(3KO mice contained structures that resembled the seminiferous tubules of
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the testis and lacked granulosa cells. In some, a degenerating oocyte was present,
whereas others showed no evidence of germ cells. (Couse et al., 1999; Dupont et al.,
2000).
1.9.2. Androgen receptor knockout mice
The testicular feminisation mouse (Tfm) has a single basepair deletion in the AR
gene which results in a frameshift mutation and translation of a truncated protein
which lacks both the DNA binding and ligand binding domains (Charest et al.,
1991). Tfm mice are totally insensitive to androgens and hence have been used to
study the role of the androgen receptor in normal development (Murphy and
O'Shaughnessy, 1991). AR function is essential for masculinisation during fetal
development. Tfm mice have a grossly abnormal male reproductive tract with the
testes failing to descend at the normal time (25 days) and are completely sterile
(Murphy et al., 1994). Adult Tfm testes have normal Leydig cell numbers but the
levels of androgens produced is severely reduced due to a loss of the enzyme 17a-
hydroxylase (Murphy and O'Shaughnessy, 1991).
Gene targeting via the use of the cre-lox system (Holt and May, 1993) has been used
to perform specific deletion of the AR (Yeh et al., 2002). AR knockout (ARKO)
male mice exhibit the same phenotype as the Tfm mice with a feminised appearance
and small cryptorchid testes. The mice also exhibit signs of micropenis and
hypospadias. Immunohistochemical evaluation of the testis showed that no AR
staining was present in 8-week-old mice. Histological analysis of the testes revealed
that spermatogenesis was incomplete with only a few germ cells being found in the
tubules. No round or elongated spermatids or sperm was seen in the tubules. Sertoli
cells and Leydig cells showed signs of degeneration and hypertrophy and the number
of Leydig cells was reduced, suggesting that androgens exert their actions on
spermatogenesis via Sertoli cells (Yeh et al., 2002).
The Tfm/ARKO mice phenotypes may be partly due caused or compounded by the
cryptorchidism shown by these mice. A way to overcome this has become available
with the recent generation of Sertoli cell selective androgen receptor knockouts using
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cre-lox strategies (Chang et al., 2004; De Gendt et al., 2004; Holdcraft and Braun,
2004). In the study by De Gendt et al. (2004), the authors created a ubiquitous AR
knockout mouse as well as a selective knockout with AR absent from the Sertoli
cells only (SCARKO) to further define the role of the Sertoli cell as a target for
androgens. (De Gendt et al., 2004). The ARKO mice created showed a similar
phenotype to other ARKO mice described above, displaying complete androgen
insensitivity syndrome. The testes were smaller and positioned incorrectly within the
abdominal or inguinal region in males. In the female mice, no uterus or fallopian
tubes were observed (De Gendt et al., 2004).
Sertoli cell selective deletion of AR was achieved by cross breeding mice with a
floxed AR gene with mice expressing cre-recombinase under the control of the AMH
promoter. To date, three lines of SCARKO mice have been generated and in all cases
exhibit normal external sexual development with the testes being correctly positioned
in the males overcoming the issue of a compounded phenotype due to
cryptorchidism. A difference was observed in testis size however with the SCARKO
mice showing a 28.4% reduction in testis size compared to the wild type mice.
Epididymis weight was also reduced by 30% but the mice showed normal
development of the rest of the male reproductive tract including the prostate, seminal
vesicles and epididymis. Upon histological analysis, spermatogenesis was
incomplete. The number of germ cells was reduced with a loss of pachytene and
primary spermatocytes. Few secondary spermatocytes and round spermatids were
observed but no elongate spermatids were seen in the tubules. These observations
were confirmed by quantitative PCR analysis showing a lack of protamine 1 and 2
expression in the SCARKO testes. Immunohistochemistry looking for AR expression
in the SCARKO testes showed the Leydig cells and peritubular cells were positive
for AR but no AR protein expression was seen in any Sertoli cell (De Gendt et al.,
2004).
The Sertoli cell specific AR knockout mouse model described by Chang et al. (2004)
also showed a reduction in testicular size. In their knockout, termed S-AR-/y,
spermatogenic arrest was also observed, determined by flow cytometric scanning of
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propidium iodide-labelled cells from the S-AR-/y testis and results from this
suggested that the spermatogenic arrest occurred in S-AR-/y mice before the first
meiosis (Chang et al., 2004). Conclusions drawn from the investigation of another
Sertoli cell selective knockout generated by Holdcraft and Braun (2004) were that
Sertoli cell AR expression is not required for the completion of meiosis or the
differentiation of round spermatids prior to elongation and the primary role of AR
function is in the final stages of spermiation and is required for the terminal
differentiation of sperm and the release ofmature sperm into the lumen of the tubule
(Holdcraft and Braun, 2004). This model however exhibits a hypermorphic allele and
exhibits a slightly different phenotype from the other two models.
These mouse models along with the earlier evidence from the ARKO mice have
determined that a functional AR is a requirement for the maintenance of normal
spermatogenesis and is essential for the germ cells to be able to successfully
complete meiosis (Chang et al., 2004; De Gendt et al., 2004; Holdcraft and Braun,
2004).
1.9.3. Aromatase knockout mice (ArKO)
Cytochrome P450 aromatase is the product of the CYP19 gene. Fisher et al. (1998)
have generated mice lacking a functional aromatase enzyme (ArKO) by targeted
disruption of exon 10 in the cypl9 gene. By disrupting aromatase activity, oestrogen
biosynthesis is blocked and oestrogens are therefore not available to interact with
ERa and ER(3. Knockout mice with a disrupted aromatase gene (ArKO) are born
phenotypically normal. At sexual maturity, female ArKO mice begin to masculinise.
Male ArKO mice appear to be fertile when young and the gross morphology of the
testes in the younger males appear normal. Fertility was compromised as the mice
aged, and litter sizes are reduced. By 18 weeks, one out of five males show disrupted
spermatogenesis with degeneration of the round spermatids and a lack of elongated
spermatids. (Fisher et al., 1998; Murata et al., 2002; Robertson et al., 1999). Male
ArKO mice had elevated testosterone and LH levels but FSH levels were normal.
Another ArKO mouse model reported that only 14% of males were fertile (Toda et
al., 2001) and a further line generated by Honda et al. (1998) reported total infertility
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in the knockouts as well as showing a behavioural phenotype, with reduced
aggressiveness in the males and impaired sexual behaviour (Honda et al., 1998). The
ArKO mice exhibit some similarities to the ERa(3KO mice described in section
1.9.1.3 with the females of both knockout lines exhibiting seminiferous tubule like
structures within the ovaries however, there is no similarity seen in the male
phenotype as the ArKO mice do not show any dilation of the efferent ductules or any
loss of germ cell numbers (Couse et al., 1999; Dupont et al., 2000; Fisher et al.,
1998).
P450 aromatase is encoded for by the CYP19 gene and in man, patients with defects
in the CYP19 gene exist (Simpson et al., 1997) resulting in problems in bone
formation highlighting an important role in bone metabolism in men. This phenotype
in the bone can be alleviated by administration of oestrogens (Simpson et al., 1997).
Consistent with the reports that oestrogens play a role in bone cell function
(Braidman et al., 2000; de Ronde et al., 2003), and in the cardiovascular system
(Gray et al., 2001), the ArKO mice exhibit a decrease in bone volume and thickness
and increased bone resorption (Miyaura et al., 2001; Oz et al., 2000) and an
accumulation of adipose tissue associated with hypercholesterolemia and insulin
resistance (Jones et al., 2000).
1.9.4. Oestrogen sulfotransferase knockout mice
Oestrogen sulfotransferase (EST) is a cytosolic enzyme that catalyses the sulfation
and inactivation of oestrogens (Strott, 1996; Tong et al., 2004). It is known that
although oestrogens are synthesised in the testis, as shown by the presence of the
aromatase complex, uncontrolled oestrogen activity in the testis leads to inhibition of
steroidogenesis and spermatogenesis in mice (O'Donnell et al., 2001; Tong and
Song, 2002). EST is highly expressed in the Leydig cells and in the middle to distal
regions of the epididymis of male mice (Tong and Song, 2002). EST knockout mice
were indistinguishable from wild type littermates at 2 months. However, as the
animals aged, the knockout mice began to show abnormalities in the testis compared
to the control animals. By age 12 months, the Leydig cells of the knockouts were
hyperplastic and damage to the seminiferous tubules was observed with the tubules
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being filled with large vacuoles and the seminiferous epithelium disrupted. A
significant decrease in testis weight and a reduction in sperm motility of up to 80%
was also seen in the knockout animals (Qian et al., 2001). EST is not expressed in
the fetal and immature testis and as the fetal development and sexual determination
is normal in the knockouts, it is thought that the damaging effect of a lack of EST in
the testis is a progressive and age dependant result of altered paracrine stimulation
due to unmetabolised oestrogen (Qian et al., 2001).
1.9.5. Follicle stimulating hormone knockout mice
FSH acting via its receptor which is expressed in Sertoli cells (Sairam and
Krishnamurthy, 2001) is thought to play a major role in the regulation of
spermatogenesis. Further evidence of the role(s) played by FSH have been obtained
from mouse models involving targeted deletion of FSH and the FSH receptor (Abel
et al., 2000; Dierich et al., 1998; Kumar et al., 1997).
1.9.5.1. FSHpKO mice
Removal of the (3 subunit of FSH results in female mice that are infertile due to a
block in folliculogenesis. FSH|3KO males are fertile but have reduced testis sizes and
a reduction in sperm motility (Kumar et al., 1997; Sairam and Krishnamurthy, 2001).
Circulating testosterone levels were reported to be normal in the adult FSHJ3KO mice
and Leydig cell number and function were normal in the knockouts. In a study using
stereological analysis, Wreford et al. (2001) claimed that the defects seen in the
FSH(3KO knockout mice are related to diminished FSH action resulting in a
reduction in Sertoli cell proliferation and the capacity of Sertoli cells to nurture germ
cells (Wreford et al., 2001).
1.9.5.2. FSHRKO mice
The FSH receptor (FSH-R) is a G-protein-coupled, seven transmembrane receptor
and is expressed in the Sertoli cells of the male and the granulosa cells of the female.
Generation of mice carrying a null mutation of the FSH-R resulted in females that
were infertile. In two separate lines of mice, ovary size was significantly reduced and
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folliculogenesis was arrested at the pre-antral stage (Abel et al., 2000; Dierich et ah,
1998).
However, the two different lines of FSH-R knockout mice described exhibit
differences in the phenotypes of the males. The FSHRKO generated by Dierich et ah
(1998) resulted in male mice with small testes, partial spermatogenic failure, and
reduced fertility. Testosterone levels were reduced in by 50% but this was still
enough to maintain partial spermatogenesis (Dierich et ah, 1998). This was a more
severe phenotype than the one described for the FSHRKO mice generated by Abel et
ah (2000), where the male mice were fully fertile although they did show a reduction
in testicular weight and the gonadotrophin feedback mechanisms were disturbed
resulting in altered hormonal levels (Abel et ah, 2000). Although differences in the
two knockouts exist, it is clear that FSH signalling is not essential for initiating
spermatogenesis, but it is thought to be involved in the maintenance of viability and
motility of sperm.
A recent study investigating the effect of the absence of the FSH-R on Sertoli cell
function reported a reduction in ABP expression and analysis by electron microscopy
showed large spaces within the Sertoli cells that are believed to be an accumulation
of fluid in the Sertoli cell cytoplasm (Grover et ah, 2004). Jegou et ah (1982)
proposed that FSH is involved in fluid absorption and/or secretion and it is known
that Sertoli cells are involved in fluid transport from the interstitial space into the
lumen of the seminiferous tubule to aid in sperm movement from the testis to the
epididymis so it is not surprising that this phenotype exists in the FSHRKO mice
(Jegou et ah, 1982).
Mice lacking the FSH-R also appear to have altered Leydig cell function. Baker et ah
(2003) reported that the lack of FSH-R resulted in a reduction in the number of
Leydig cells in adult animals (Baker et ah, 2003b). This reduction in the number of
Leydig cells could account for the drop in testosterone levels observed by Dierich
(1998) but this does not seem to occur in the FSH|3KO males (Abel et ah, 2000).
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1.9.6. Luteinising hormone receptor knockout mice (LuRKO)
The LH receptor is expressed in interstitial Leydig cells. Mice that lack the LH
receptor appear normal at birth with both testicular size and location similar to that of
wild-type littermates (Zhang et al., 2001). This is consistent with gonadotrophin-
independent production of testosterone by the fetal Leydig cells. Testosterone
production in the adult testis is regulated by LH. In the fetal testis, the regulation of
testosterone production is unclear and it is has been suggested that the onset of
androgen production in the fetal testis takes place in an LH-independent way (Majdic
et ah, 1998). By age 30-35 days, knockout males exhibit an undeveloped scrotum
and micropenis. By 7 weeks of age, the males have very small testis compared to
wild types and show signs of abnormal spermatogenesis. The seminiferous tubules
are poorly developed and spermatogenesis is arrested at the round spermatid stage.
Female mice show a similar pattern of events, they are born phenotypically normal
but by age 7 weeks, ovarian size was decreased and follicles only progressed to the
early antral stage. The main role of LH is to simulate testosterone synthesis by the
Leydig cells (Cooke and Saunders, 2002), in the LuRKO mice, Leydig cell size and
number was dramatically decreased were poorly differentiated due to their inability
to respond to LH. The male testicular phenotype is reminiscent of that seen in the
SCARKO males (De Gendt et ah, 2004) and would be consistent with inadequate
production of testosterone by the Leydig cell population.
1.10. RNA interference
Many scientific advances have been achieved by the use of transgenic and knockout
animals, however, these animals are costly and time consuming to create. The advent
of a new technology, termed RNA interference (Fire et ah, 1998), has the potential to
overcome some of the problems associated with the generation of knockout mice,
allowing knockdown of specific genes in mammalian systems.
1.10.1 .Overview of the method
RNA interference is the process of sequence specific post transcriptional gene
silencing initiated by double stranded RNA (dsRNA) (Elbashir et ah, 2001). The
process has been observed in a variety of organisms including plants, fungi, insects,
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protozoans and mammals (Bernstein et al., 2001; Elbashir et al., 2001; Harborth et
al., 2001; Moss, 2001). Since its discovery in C. elegans (Fire et al., 1998), RNAi
has been developed as an important tool in the study of gene expression. The uptake
of dsRNA had been shown to be effective in silencing specific genes in insects and
plants but this method initially proved unsuccessful in mammals. When long double
stranded RNA's, typically >200 nucleotides are introduced into cells, they get
processed into 20-25 nucleotide small interfering RNA's (siRNA's) by an enzyme
complex called Dicer. Dicer, discovered in Drosophila (Bernstein et al., 2001)
contains domains for dsRNA binding, RNA unwinding and ribonuclease activity
(Denli and Hannon, 2003). The siRNA's then assemble into endoribonuclease-
containing complexes known as RNA-Induced Silencing Complexes (RISC). The
siRNA guides the RISCs to the complementary RNA where they cleave the RNA
Figure 1.11 shows the mechanism of the RNAi process.














Figure 1.11 The mechanism ofRNA interference, adapted from Ambion (ww.Ambion.com).
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1.10.2.Mammalian siRNA
Introduction of dsRNA into the cytoplasm ofmammalian cells triggered a number of
pathways that mediated suppression of gene expression some of which were non¬
specific and included global inhibition of protein synthesis and non-sequence
specific degradation of mRNA. Furthermore, dsRNA acted as a potent inducer of
type 1 interferon synthesis and activated two classes of IFN induced enzymes: PKR,
which is a dsRNA dependent protein kinase and 2',5' oligoadenylate synthetases
(Sledz et al., 2003). Because the 2'5 oligoadenylate synthase activates RNasel,
which leads to mRNA cleavage, and PKR phosphorylates the translation initiation
factor eI2a, which leads to inhibition of mRNA translation, activation of the
interferon system had the effect of shutting down protein synthesis. In 2001, Elbashir
et al. showed for the first time that chemically synthesised 21 nucleotide small
interfering RNA's (siRNA's) could mediate knockdown of specific mRNAs in
Hek293 and HeLa cells. (Elbashir et al., 2001) and that the interferon response was
not initiated. It is thought that the short size of the siRNA's mimic's the products of
the Dicer enzyme and avoids the PKR response (Paddison et al., 2002). After
transfection with siRNA's, a reduction in specific mRNA can be detected within 24
hours and the effect can last for several days depending on the turnover rate of the
RNA or protein.
1.10.3.Vector delivery systems
Although heralded as the scientific breakthrough of the year in 2002, RNAi is not
without problems. Working with RNA can be problematic and degradation of
siRNA's is common. Also, the knockdown effect of the siRNA is transient so long
term effects of gene silencing cannot be observed. The advent of RNAi vectors,
especially short hairpin RNA's (shRNAs) in 2002, (Brummelkamp et al., 2002) was
an important technical advance and allowed more stable expression of the siRNA
whilst working with a DNA based vector. Most short hairpin vectors contain the
RNA polymerase III HI promoter, resulting in a small RNA transcript with a well-
defined transcription start site and a 5-thymidine RNA termination site. Other vectors
have been successfully used containing the Pol III U6 promoter. In these vectors, the
target gene specific insert contains the siRNA 19nt followed by a short (9nt) spacer
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sequence then the reverse complementary 19nt siRNA which folds into a hairpin
loop structure (Brummelkamp et al., 2002). This is shown in Figure 1.12. When the
vector is expressed in mammalian cells, the hairpin loop containing the siRNA
sequence is recognised by Dicer and is cleaved to form a functional siRNA
(Brummelkamp et ah, 2002).
H1/U6 Promoter 19 nt coding sequence 9 nt spacer
i




Figure 1.12 siRNA synthesised from a DNA template.
Viral vectors containing siRNA's have also been developed which should allow an
increase in the range of cells that can be transfected e.g. primary cells and these are
also suitable for use in vivo. For example, Tiscornia et ah have designed a lentiviral
vector capable of expressing siRNA in mammalian systems (Tiscornia et ah, 2003).
The siRNA construct with a HI promoter was cloned into the 3' LTR of the
lentivirus. Knockdown of GFP was achieved in 293T cells and successful
transduction of preimplantation mouse embryos was shown. This decrease in GFP
expression was also shown in the progeny derived from these embryos meaning that
generation of "knockdown" mice through viral transgenesis was now achievable
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1.11. Aims of the project
The aims of this study were to investigate the role of steroid hormones, in particular
oestrogens in murine spermatogenesis. A major focus of these investigations was the
role played by ER|3 in the modulation of germ cell and somatic cell function. Initial
studies focussed on the spermatogonial stem cells, which were successfully isolated
and characterised. The impact of steroids on Sertoli cell function made use of a
transformed murine cell line, which had maintained a differentiated Sertoli cell
phenotype. Steroid receptor status, steroid responsiveness and the impact of targeted
deletion of receptors using RNAi were all assessed.
Chapter 2
General Materials and Methods
2.1. Animal experimentation
Animal experimentation was carried out in accordance with the UK Home Office
Animal Experimentation (Scientific Procedures) Act 1967 under project licence
PPL60/2923. The appropriate ethics committee also approved all experiments. Wild
type mice from heterozygote mating of the transgenic strain Dazl Tmlhgu/mlhgu (Ruggiu
et al., 1997) were used for these studies and the mice were housed under standard
conditions and fed ad libitum.
2.1.1. Tissue collection and fixation
Animals were killed by cervical dislocation or other approved Schedule 1 method.
Tissues were removed from both immature (day 0 to day 21 animals) and adult mice.
Tissues were fixed or snap frozen in liquid nitrogen for subsequent RNA extraction
(section 2.5).
Fixation was carried out for 6 hours using Bouins solution (BIOS), which forms
cross-links between proteins and aldehydes, resulting in a stable structure without
loss or damage to antigenic sites. Samples were then transferred into 70% ethanol
and processed into paraffin wax (section 2.2.1).
2.2. Immunohistochemistry
Immunohistochemistry is a technique which allows specific localisation of proteins
within tissue sections and cultured cells using antibody-antigen interactions. The
antigen is recognised within a cell using a specific antibody raised to an epitope of
the protein in question.
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2.2.1. Tissue processing and sectioning
Tissues were embedded in paraffin wax blocks by the histology support service,
MRC Human Reproductive Sciences Unit. Wax blocks were cut into 5p.m sections
on a hand-operated microtome RM 2135 (Leica). The sections were floated onto ice
cold followed by warm (42°C) distilled water and placed onto charged slides
(Superfrost® Plus, BDH) and dried overnight at 50°C. The slides were de-waxed in
xylene for 5 minutes then rehydrated through a series of graded alcohols
(100%—>90%—>80%—*70%) for 20 seconds in each alcohol and finally rinsed in
water.
2.2.2. Antigen retrieval
Antigen retrieval was performed to reduce cross-linking of proteins formed during
the fixation process, allowing the antibody to bind to the antigen (Shi et al., 1993).
This was carried out by pressure-cooking. Slides were heated in 0.01M citrate buffer
pH6 in a Tefal Clipso pressure cooker (Tefal). Briefly, the slides were placed in 2L
of boiling citrate buffer; the lid was sealed and set to pressure setting 2. The slides
were heated until full pressure was reached and left for 5 minutes. After this time, the
pressure was released, the pressure cooker removed from the heat and the slides left
in the hot buffer for 20 minutes before cooling with H2O and transferring to TBS
(section 2.13.1).
2.2.3. Methanol / peroxide block
Slides were incubated in 3% hydrogen peroxide (BDH) in methanol for 30 minutes
to decrease endogenous peroxidase activity in an attempt to eliminate background
staining. After blocking, slides were rinsed in tap water and washed three times in
TBS, 5 minutes each wash.
2.2.4. Avidin-biotin block
The Avidin-Biotin blocking kit (Vector SP-2001) was used to block endogenous
biotin, which can lead to non-specific staining. Four drops of avidin/ml of 1 part
blocking serum (Diagnostics Scotland) / 4 parts TBS / 5% BSA (Sigma) were added
to the slides and incubated for 30 minutes at room temperature. The slides were
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washed in TBS three times for 5 minutes before biotin was added (4 drops per ml of
TBS), incubated at room temperature for 15 minutes followed by 3 x 5 minute
washes in TBS.
2.2.5. Primary antibodies
The appropriate primary antibody (Table 2.1) was diluted as required in blocking






ER|3 1:1500 Citrate Sheep Raised in house,
(Saunders et al., 2000)
c-kit 1:30 Not required Rabbit Santa Cruz
RBM 1:500 Citrate Rabbit Raised in house
AR 1:200 Not required Rabbit Santa Cruz
Oct-4 1:75 Citrate Goat Santa Cruz
GATA-1 1:100 Not required Goat Santa Cruz
Table 2.1 Details ofprimary antibodies.
2.2.6. Secondary antibodies
After incubation with the primary antibody, the slides were washed in TBS three
times for 5 minutes. The appropriate secondary antibody (Table 2.2) was diluted in
blocking serum, added to the slides and incubated for 1 hour at room temperature
and washed offwith TBS as before.
Antibody Dilution Source
Rabbit anti mouse biotinylated 1:500 DAKO
Swine anti rabbit biotinylated 1:500 DAKO
Rabbit anti sheep biotinylated 1:500 Vector
Rabbit anti goat biotinylated 1:500 Vector
Table 2.2 Details of Secondary antibodies.
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2.2.7. Horse-radish peroxidase
The ABC-HRP detection system (DAKO) was used to amplify the signal obtained
from the secondary antibody. Avidin is composed of four subunits, which form a
tertiary structure possessing four biotin-binding pockets. The ABC-HRP complex
works because 3 of the biotin binding sites on the avidin molecule are occupied with
biotin molecules complexed to HRP whilst one site remains empty and can bind to
the biotinylated secondary antibody (Figure 2.1).
HRP
Figure 2.1 ABC-HRP reaction.
ABC-HRP was prepared by adding 1-drop solution A (DAKO) and 1-drop solution
B (DAKO) to 5 ml of Tris-HCl. This was made up 20 minutes prior to use. ABC-
HRP was added to the slides for 30 minutes at room temperature followed by 3 x 5
minute washes in TBS.
2.2.8. Developing, counterstaining and mounting
The slides were developed using diaminobenzidene (DAB); 1 drop/ml in DAB buffer
(DAKO). After DAB staining, the slides were counterstained with haematoxylin,
differentiated in acid-alcohol and the blue nuclei developed in Scott's tap water. The
slides were dehydrated in increasing concentrations of alcohol and cleared in
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histoclear and xylene for 5 minutes each before being mounted under a glass
coverslip using Pertex mounting medium (CellPath).
2.2.9. Immunohistochemistry on cultured cells
Cells plated out on 2 well or 8 well glass chamber well slides (Nunc) at the
appropriate density (Table 2.4) to be stained were fixed in 100% ice cold methanol
or modified Davidson's (Section 2.13.1) fixative (for fluorescent
immunohistochemistry) for 10 minutes. The fixative was removed and the cells were
washed in PBS. The cells were permeablised with the addition of 0.2% NP40
(Sigma), 1% BSA (Sigma) 10% appropriate blocking serum (Diagnostics Scotland)
in TBS for 20 minutes at room temperature. The cells were washed twice in TBS and
the procedure for immunohistochemistry for tissue sections from the avidin-biotin
blocking step (section 2.2.4) was followed.
2.2.10. Fluorescent immunohistochemistry
Fluorescent immunohistochemistry was carried out on cultured cells. Cells were
fixed in modified Davidson's fixative (Section 2.13.1) for 10 minutes at room
temperature followed by 2 washes in PBS for 5 minutes each wash. Non specific
staining was blocked by addition of 1 part blocking serum (Diagnostics Scotland)/ 4
parts PBS / 5% BSA (Sigma) for 30 minutes at room temperature then washed twice
in PBS for 5 minutes each wash. Primary antibody (Table 2.3) was added and the
cells were incubated overnight at 4°C. The following day, the cells were washed
twice for 5 minutes each wash in PBS before addition of the appropriate
fluorescently labelled secondary antibody (Table 2.3) and incubated for 1 hour at
room temperature. The cells were washed twice in PBS and then counterstained with
either To-Pro-3 or propidium iodide to visualise the nuclei. To-Pro-3 (Molecular
Probes) was added at a 1:2000 dilution for 2 minutes before a final PBS wash.
Propidium iodide (Sigma) was added at a concentration of 1:2000 for 2 minutes
before a final PBS wash. The slides were mounted under a glass coverslip using
Permafluor mounting medium (Immunotech) and observed using the confocal
microscope (section 2.11.4).
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Primary antibody Dilution Species raised in Supplier
Tyrosine a- tubulin 1:2000 Mouse Sigma
(3-tubulin 1:1500 Mouse Sigma
Lamin A/C 1:500 Mouse Santa-Cruz





Goat anti-mouse Cy-5 1:60 Goat Molecular
probes
Table 2.3 Details of primary and fluorescently labelled secondary antibodies used on
cultured cells.
2.2.11. Imaging
Slides were examined using an Olympus Provis microscope (Olympus Optical Co.)
and images captured using a Kodak DCS330 camera (Eastman Kodak Co.). Captured
images were compiled using Photoshop CS (Adobe).
2.3. Cell culture
Cell culture experiments were performed in a class II cabinet and the cells
maintained in a humidified incubator either at 33°C, 37°C or 39°C with 5% CO2.
2.3.1. Cell lines
SKI 1 cells were a gift from Drs Walther and Ivell, Hamburg; (Walther et al. 1996).
The cell line was derived from Sertoli cells from a 10 day old H-2kb -tsA58
transgenic mouse (Jat et al. 1991) and immortalised using the SV40 large T antigen.
The cells remain mitotically active at 33°C where they exhibit characteristics of
immature Sertoli cells but when cultured at the non-permissive temperature of 39°C,
they differentiate and stop dividing.
GC-1 and GC-2 cells were obtained from ATCC. GC-1 cells (Hofmann 1992) are a
germ cell line derived from testes of a 10-day-old BALB/c mouse were immortalised
using the SV40 large T antigen. GC-2 cells (Hofmann and Millan, 1995) are derived
from spermatocytes isolated from a 6-week-old BALB/c mouse transformed with the
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SV40 large T antigen and also contain a temperature sensitive mutant of the p53
tumour suppressor gene (LTRp53cG9).
STO cells were purchased from ECACC. They are a mouse embryo fibroblast cell
line that has been selected for 6-thioguanine and ouabain resistance. The cells were
mitotically inactivated by treatment with Mitomycin C and used as a feeder layer for
the culture of spermatogonial stem cells (Chapter 4, section 4.2.8.1).
2.3.2. Passaging of cells
Media was removed from the cells and discarded; cells were rinsed with 5 ml PBS
(Sigma) to remove any traces of media. The PBS was removed and 1.5 ml 1 x
Trypsin /EDTA (Gibco) added per T75 flask. The cells were incubated at 37°C for 3-
5 minutes until they had detached from the surface of the flask; thereafter 8.5 ml
"complete medium" (section 2.17.2) was added containing 10% FCS which halts any
further action of the trypsin. If required, a cell count was performed using a
haemocytometer before the cells were diluted and plated out in new flasks.
2.3.3. Transient transfection of cells
Cells to be transfected were trypsinised and plated out at the appropriate density for
the culture vessel used (Table 2.4) the day before transfection. If required, the cells
were also changed into Phenol-red-free media (section 2.13.2). Three different
transfection reagents were routinely used for transient transfections: JetPEI,
(Qbiogene, section 2.3.3.1) for luciferase reporter transfections; oligofectamine
(Invitrogen) for siRNA transfections (section 2.11.3.1) and JetSI (Poly Transfection)
(Chapter 3, section 3.2.8.3) for fluorescently labelled siRNA transfections. All
transfections were performed in duplicate and carried out at least 3 times. At the time
of transfection, cells were 70% confluent to increase transfection efficiency.
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Culture vessel Number of cells plated
8 well glass slides 1 x 104 cells / well
2 well glass slides 1 x 105 cells / well
12 well plate 1 x 105 cells / well
6 well plate 4 x 105 cells / well
3.5 cm glass bottomed dish 2 x 105 cells / dish
Table 2.4 Details of cell number plated onto various culture vessels.
One hour prior to transfection, the media on the cells was removed and replaced with
an appropriate volume of serum free transfection media (section 2.13.2), which
contained no antibiotics.
2.3.3.1. JetPEI
JetPEI (QBiogene) was used for luciferase transfections and volumes stated below
are for transfections carried out in 12 well plates; for other plate sizes the volumes
were scaled up or down accordingly. A total of 2pg DNA was diluted into 50pl
150mM NaCl, vortexed gently and centrifuged briefly. In a separate tube, 4pl JetPEI
reagent was diluted in 50ql 150mM NaCl, vortexed and spun down. The JetPEI
solution was immediately added to the DNA containing solution and the mixture
vortexed then briefly centrifuged. The complex was incubated for 30 minutes at
room temperature before being gently added to the cells in each well, which already
contained 500ql serum free media. After 4 hours, incubation at 37°C, 5% CO2, 500pl
complete media with ligand (if required) was added and the cells were incubated for
a further 24-48 hours.
2.3.4. Ligands
Various ligands were added during transfection to stimulate the cells: 17|3-Oestradiol
(E2, Sigma), 5 alpha-androstane-3-beta, 17 beta-diol (3(3Adiol, Sigma) both natural
oestrogenic ligands, and diethylstilbestrol (DES, Sigma), a synthetic oestrogen were
all reconstituted in 100% ethanol and serial dilutions (10 3M to 10"nM in ethanol)
were made. Genistein (Sigma) which is classed as a phytoestrogen was reconstituted
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in DMSO and serially diluted (10"3M to 10"nM in DMSO). Two receptor selective
synthetic ligands, DPN™ and PPT™ were also used; 2,3-bis(4-Hydroxyphenyl)-
propionitrile (DPN™, Tocris Cookson) is an ER|3 agonist while 4,4',4"- (4-propyl-
[lH]-pyrazole-l,3,5-triyl)trisphenol (PPT™, Tocris Cookson) is a highly potent ERa
agonist. Both of these ligands were reconstituted in 100% ethanol and serially diluted
in ethanol as before. Testosterone (Sigma) was reconstituted in 100% ethanol and
serial dilutions (10~3M to 10"UM in ethanol) were made.
2.4. Dual-Luciferase® Reporter gene assay
Reporter systems are used to study gene expression. Dual reporters are commonly
used to improve experimental accuracy by measuring two individual reporter
enzymes within a single system. The Promega Dual-Luciferase® reporter assay
system measures the activity of firefly (Photinus pyralis) and Renilla (Renilia
reniformis, also known as sea pansy) luciferases. In this study, both 3x ERE
luciferase and pem-Luc reporter constructs were used. The 3x ERE-TK-Luc reporter
construct was a gift from S.C. Nagel and D.P. McDonnell (Nagel et al., 2001). The
pem-Luc construct was a gift from Professor G. Verhoeven and contains a functional
ARE (Barbulescu et al., 2001). The pRL-CMV vector (Promega) contains the CMV
enhancer and early promoter elements, which provide a high level expression of
Renilla luciferase, which was used as the internal control. Because of their distinct
evolutionary origins, both luciferases have dissimilar enzyme structures and substrate
requirements. The experimental reporter is correlated with the effect of specific
experimental conditions, while the activity of the co-transfected control reporter
provides an internal control. Normalising the activity of the experimental reporter to
the activity of the internal control minimises experimental variability caused by
differences in cell viability, transfection efficiency and pipetting errors. The results
are presented as a fold increase in activity over the control.
2.4.1. Cell lysis
The media was removed from the cells and 250ql lx Passive Lysis Buffer (Promega)
added per well of the 12 well plate. The plate was incubated at room temperature for
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15 minutes on a rocking platform. The cell lysate was transferred to a 1.5 ml
microcentrifuge tube and centrifiiged at 14,000 rpm at 4°C for 30 seconds.
2.4.2. Reporter assay
All reagents used in the reporter assay were obtained from Promega.
Luciferase Assay Reagent II (LAR II) was prepared by resuspending the lyophilised
Luciferase Assay Substrate in 10 ml of Luciferase Assay Buffer II. One volume of
50X Stop & Glo® Reagent was added to 50 volumes of Stop & Glo® Buffer and
vortexed for 10 seconds.
The reporter assay was performed on a microplate luminometer (Berthold
Laboratories). The luminometer was primed with LAR II. Cell lysates (20p,l each)
were pipetted in duplicate into a white 96 well plate (Nunc), the luminometer was
programmed to dispense 30pl of LAR II reagent into each well and perform a 10
second measurement. Once the entire plate was read, the firefly luciferase
measurements were saved and the luminometer washed with water and then primed
with Stop & Glo® reagent. The plate was read again, this time for Renilla activity
and the data saved for subsequent analysis.
2.4.3. Data analysis of luciferase reporter assay
Each sample was transfected in duplicate and the reporter assay performed in
duplicate. The mean of the luciferase counts of the transfected duplicates was taken
and the same was performed for the Renilla counts. The following calculation was
then used to obtain a normalised value:
Mean Luciferase count
Mean Renilla count/1000
The mean of the normalised duplicates performed in the reporter assay was then
calculated. To calculate the fold increase, the control sample in each experiment was
given a value of 1 and the sample to be analysed was divided by the control value.
Chapter 2 General Materials and Methods 62
2.5. RNA extraction from cells and tissues
RNA was extracted from cell lines and frozen tissue samples using Tri Reagent
(Sigma). TRI reagent is an improved version of the single-step total RNA isolation
reagent developed by Chomczynski (Chomczynski and Sacchi, 1987). All tubes and
instruments used were RNase free. From cell lines, the cells were trypsinised (section
2.3.2), counted, 107 cells resuspended in 1 ml of media and centrifuged at 1000 rpm
for 10 minutes at 4°C. The supernatant was discarded and the pellet resuspended in
lml Tri Reagent. Frozen tissue was ground up using a mortar and pestle under liquid
nitrogen, thereafter lOOmg powdered tissue was transferred to a fresh RNase free
tube and lml Tri reagent added. For fresh tissue, lml of TRI reagent was added to
lOOmg tissue.
Samples were homogenised using a mini pellet pestle for 30 seconds, 200pl
chloroform (ICN) added and the samples incubated at room temperature for 10
minutes before centrifuging at 13,000 rpm for 15 minutes at 4°C. The upper aqueous
layer was removed to a fresh RNase free tube and 500pl isopropanol added. The
samples were incubated at room temperature for 10 minutes then centrifuged for 15
minutes at 13,000rpm at 4°C. The supernatant was removed and the RNA pellet
resuspended in lml 100% ethanol and centrifuged at 7,500 rpm at 4°C. The pellet
was washed in 500pl 70% ethanol and allowed to air-dry before being resuspended
in 50pl RNA storage buffer (Ambion) or nuclease free water (Promega). RNA
concentrations were measured on the GeneQuant spectrophotometer (section 2.10.1).
2.6. Oligo (dT) primed reverse transcription PCR (RT-PCR)
Expression of messenger RNAs in cells and tissues used in this study was
determined by RT-PCR using cDNA pools synthesised by oligo (dT) priming of total
RNA.
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2.6.1. cDNA synthesis
Approximately lpg of total RNA extracted from cells or tissues (section 2.5) was
used in each reaction. This cDNA was then used as a template for the PCR reaction.
The RNA was combined with oligo dT as follows:
Samples were incubated at 70°C for 5 minutes then chilled on ice before addition of:
Samples were incubated at 42°C for 1 hour and then at 72°C for 10 minutes to
inactivate the enzyme. The concentration of the cDNA samples were measured on
the GeneQuant (section 2.10.1).
2.6.2. Polymerase Chain Reaction
2.6.2.1. Primer design and oligonucleotide synthesis
Oligonucleotides were obtained from published papers or designed using primer
design packages (Genejockeyll, primer3). All primers were synthesised by MWG
(MWG-Biotech). For the PCR reaction, primers were used at 50pM. Table 2.5 shows
sequences and product sizes of the primer pairs used.
RNA(lqg) + H20
Oligo dT (50pM) (MWG-Biotech)
llql
lpl
RNasin (20 units/ql, Promega)
lOmM dNTP mix (Promega)
5 x RT Buffer (Bioline)
H20
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Table 2.5 RT-PCR primer sequences
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2.6.2.2. PCR reaction
Two different Taq polymerases were used during the course of the studies.
BioTaq (Bioline)
1Ox PCR buffer (Bioline) 2.5pl
lOmM dNTP mix (Promega) 0.5pl
50mM MgCl2 (Bioline) 0.75pl
Forward Primer 0.5pl
Reverse Primer 0.5pl
BioTaq DNA Polymerase (Bioline) 0.25pl




1 Ox PCR buffer (Sigma) 2.5pl
lOmM dNTP mix (Promega) 0.5pl
Forward Primer 0.5pl
Reverse Primer 0.5pl
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In general, 35 cycles of amplification were carried out as detailed below:
Initial denaturation 94°C 2 minutes
Denaturation 94°C 30 seconds
35
Specific primer annealing temperature X°C 30 seconds cycles
Final extension
Extension 72°C 1 minute / kb of product
72°C 10 minutes
Products were analysed on a 1% agarose gel (section 2.7).
2.7. Agarose gel electrophoresis
Agarose gel electrophoresis was used to analyse double stranded DNA's after PCR
amplification or restriction endonuclease digestion. All gels were prepared and run
using IX TAE buffer (section 2.13.4). For DNA sizes below lkb, a gel prepared with
2% (w/v) agarose (Bioline) was used, for pieces ofDNA above lkb a gel containing
1% w/v agarose was used. Ethidium bromide (Sigma) was added to the gel at a
concentration of 0.5pg/pl, ethidium bromide intercalates between DNA bases and
fluoresces under UV light and allows visualisation of DNA bands within gels. In
order to monitor the migration of DNA during electrophoresis, samples (10-20pl)
were mixed with 3pi of Orange G loading dye (section 2.13.4). DNA sizes were
detected by loading 5pi ofDNA ladder (Hyperladder IV (Bioline) for fragment sizes
below lkb and Hyperladder I (Bioline) for fragments larger than lkb) into one or
more wells within the gel. Gels were run at lOV/cm in a Bio-Rad electrophoresis
tank. Following electrophoresis DNA was visualised on a UV transilluminator (GRI
Syngene) and photographed using a BioRad camera and integration control unit.
2.8. Cloning
Partial and complete cDNA's generated by PCR or cut and purified from plasmid
vectors were cloned into variety of vectors prior to transient transfection.
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2.8.1. Cloning of RT-PCR products
PCR products were cloned into TOPO-pCRII vector (Invitrogen) according to
manufacturer's instructions. Briefly, lOOng of PCR product was mixed with lpl salt
solution (Invitrogen), lpl TOPO vector and 2pl sterile H2O. The mixture was
incubated at room temperature for 10 minutes before 2ul of the mix was transformed
(section 2.8.5) into 50pl XL-1 Blue cells (Stratagene). The entire transformation
reaction was spread onto LB Agar plates containing ampicillin at a final
concentration of 50pg/ml and incubated inverted overnight at 37°C.
2.8.2. Restriction enzyme digestion of DNA
Restriction enzymes were purchased from New England Biolabs (NEB) or Promega.
In general, lpg of plasmid DNA was mixed with 5pl lOx appropriate enzyme
reaction buffer, 5pi 10X BSA (if required), 2.5pi appropriate enzyme(s) and made
up to 50pl with sterile H2O. The mix was incubated at 37°C for at least 2 hours. A
small aliquot (2-5pl) of the reaction mixture was analysed on an agarose gel to check
for complete digestion. To ensure that re-ligation of linearised plasmid vectors did
not occur they were incubated with 5 units of shrimp alkaline phosphatase (SAP,
Promega) per pg DNA for 15 minutes at 37°C. The sample was then heated to 65°C
for 15 minutes to kill any remaining SAP activity. Incubation with SAP catalyses the
dephosphorylation of 5' phosphates from DNA preventing recircularisation and
religation of the vector.
2.8.3. Extraction of DNA fragments from agarose gels
Following digestion, DNA fragments which were to be cloned into plasmid vectors
were separated from vector DNA by gel electrophoresis. The DNA band containing
the correctly sized fragment was cut out of the gel using a scalpel and purified using
the Qiagen Gel extraction kit. The gel was weighed and 3 volumes of Buffer QG
(Qiagen) added and the sample incubated at 50°C for 10 minutes until the gel slice
had dissolved. The sample was loaded onto a QIAquick spin column and centrifuged
for 1 minute at 13,000 rpm. The flow-through was discarded, 750pl of Buffer PE
was added and the column left to stand for 3-5 minutes before centrifuging for 1
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minute at 13,000 rpm to wash the column. Again, the flow-through was discarded
and the sample was eluted with the addition of 50p.l lOmM Tris-Cl pH 8.5 to the
centre of the column followed by a final spin at 13,000rpm for 1 minute. The sample
was analysed using the GeneQuant spectrophotometer (section 2.10.1).
2.8.4. Ligation of DNA inserts into plasmid vectors
After preparation and purification, ligation of the insert into the linearised SAP-
treated vector was carried out using T4 DNA ligase (NEB). Generally, the ratio of
insert to vector was 3:1 and was calculated using the following equation:
Xng insert = (Y base pairs of insert)(50ng Vector)
Base pairs of vector
The insert and vector were mixed with lpl of T4 ligase buffer and lp.1 T4 DNA
ligase in a total volume of 10ql and incubated overnight at 16°C; thereafter 2p,l of
this mix was used for transform competent E.coli (section 2.8.5).
2.8.5. Transformation of competent E.coli
Plasmid DNA was propagated in E.coli following transformation. This was carried
out by adding 2pl (approximately lOng DNA) of ligation mix (section 2.8.4) to 50pl
of subcloning grade XL 1-Blue competent cells (Stratagene). The mixture was placed
on ice for 30 minutes. The cells were heat shocked by incubating at 42°C for 45
seconds and then returned to ice for 2 minutes. Following this, 950p,l of SOC
medium (section 2.13.5) was added and the cells incubated at 37°C whilst being
shaken at 225 rpm for 1 hour. The bacterial cells were spread onto LB agar plates
(section 2.13.5) containing the correct antibiotic using aseptic technique and the
plates were incubated inverted overnight at 37°C. Bacterial colonies were isolated
and propagated as below (section 2.8.6).
2.8.6. Small scale preparation of plasmid DNA
Single bacterial colonies were picked from LB-agar plates, inoculated to lOmls LB-
broth containing antibiotics and incubated overnight in a rotary shaker at 37°C, 225
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rpm. The next day, mini-preps were performed using the Promega Wizard ® Plus SV
Minipreps DNA Purification System according to the manufacturer's instructions. In
brief, 2ml of the overnight culture was centrifuged at 13,000 rpm for 2 minutes. The
medium was removed and the pellet resuspended in 250ql cell resuspension solution
(50mM Tris-HCL pH 7.5, lOmM EDTA and lOOqg/ml RNase); thereafter cells were
lysed and denatured by the addition of 250pl cell lysis solution (0.2M NaOH, 1%
SDS) and the samples were mixed by inverting 4 times. Alkaline protease solution
(lOql) was added to the mixture and the samples inverted a further 4 times before
they were left to incubate at room temperature for exactly 5 minutes. The reaction
was neutralised with 350ql neutralisation solution (1.32M KOAc, 6.4% glacial acetic
acid pH 4.8). Samples were mixed by inverting and centrifuged at 13,000 rpm for 10
minutes in order to pellet cell debris, genomic DNA and proteins. The cleared lysate,
which contained the plasmid DNA, was loaded into a spin column and centrifuged
for 1 min. The column was washed using 500ql column wash solution (200mM
NaCl, 20mM Tris-HCL pH 7.5, EDTA and 47.5% v/v ethanol), centrifuged at 13,000
rpm and the flow-through discarded. This step was repeated using 250ql column
wash solution. The column was transferred to a sterile 1.5ml tube, 30pl nuclease free
water (Promega) was added and the samples were centrifuged for 2 minutes at
13,000 rpm to elute the plasmid DNA. The concentration and purity of the DNA was
measured using the Gene Quant (section 2.10.1). Restriction enzyme digestion
(section 2.8.2) followed by agarose gel electrophoresis (section 2.7) was carried out
to check that the plasmid contained the insert of the correct size.
2.9. Sequence analysis
Sequence analysis of cloned DNA products was carried out to ensure that the inserts
cloned into vectors had no errors in the sequence and that they had been introduced
in the correct orientation. Primers used for sequencing are shown in Table 2.6.
Primers were diluted to 20qM and 7ql was used for each sequencing reaction. At
least lOOng DNA, either plasmid or PCR product was required for sequence analysis.
Samples were sequenced by the MRC Human Genetics Unit Automated DNA
Sequencing Service using a ABI 377 sequencer. Sequences were analysed using 2
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programmes, GeneJockeyll and Vector NTI, and compared to sequences lodged in
GenBank using Blast searches.







Table 2.6. Sequencing primers
2.9.1. Glycerol stocks
Following plasmid preparation, analysis by restriction digestion and sequencing
glycerol stocks were prepared so more plasmid could be grown up at a later date.
Briefly, 500pl of the bacterial culture was added to 500pd of glycerol (Sigma),
vortexed thoroughly and stored at -80°C.
2.10. Caesium chloride preparation of plasmid DNA
For successful transfection, DNA needs to be of high purity therefore large-scale
purification of plasmid preparations based on the method established by Ish-
Horowicz and Burke, (Ish-Horowicz and Burke, 1981) followed by banding on a
CsCl gradient was undertaken as follows: 500ml terrific broth (Mo Bio Laboratories)
containing the appropriate antibiotic was inoculated with Iml mini-prep culture or
inoculated from a frozen glycerol stock (see section 2.9.1) and grown up overnight at
37°C (225 rpm). The next day, the culture was split between two 250ml plastic
centrifuge tubes (Nalgene) and centrifuged in a J2-21 Beckman centrifuge using a
JA-14 rotor at 6000 rpm for 10 minutes at 4°C to pellet the bacteria. The supernatant
was carefully resuspended by gentle shaking in 36ml solution PI (section 2.13.4)
followed by 36mls of solution P2 (section 2.13.4) and gently mixed. The solution
was incubated for exactly 5 minutes at room temperature because if the cells are left
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any longer, they will lyse and release genomic DNA. After this, 36ml chilled
solution P3 (section 2.13.4) was added and the contents incubated on ice for 15
minutes; this step precipitated the proteins and high molecular weight DNA. The
samples were then centrifuged at 7000 rpm for 10 minutes at 4°C. The supernatant
was filtered through miracloth (Calbiochem) to remove any precipitate into clean
centrifuge tubes to which 0.7 volumes of isopropanol (ICN) was added and gently
mixed. The tubes were centrifuged at 7000 rpm for 10 minutes at 4°C. The
supernatant was discarded and the pellet resuspended in 4ml TE buffer. The sample
was extracted with phenohchloroform (1:1) by vigorous inversion following the
addition of 2mls Tris saturated phenol (Sigma) and 2mls chloroform (ICN) and
centrifuged at 2500 rpm for 5 minutes. The aqueous layer was removed to a fresh
tube, 4 ml chloroform added, the sample again inverted vigorously and the
centrifugation step repeated.
The resulting aqueous phase was transferred to a clean tube and the DNA
precipitated by addition of 1/10 volume of 3M NaOAc pH 5 and 2 volumes of 100%
ethanol, mixed gently and left at -20°C for at least 15 minutes. The sample was
centrifuged for 5 minutes at 8000 rpm at 4°C, ethanol removed and the pellet washed
with 1ml 70% ethanol and centrifuged again. The supernatant was removed and the
pellet allowed to air-dry before being resuspended in 5.6ml TE buffer.
To purify the plasmid DNA, banding on a caesium chloride gradient was performed.
The gradient was prepared by adding 1.77g CsCl (Roche) to 1,4ml of the sample plus
40ql ethidium bromide solution (lOmg/ml, Sigma). The mixture was heated at 37°C
for 5 minutes to dissolve the CsCl before centrifugation at 13,000 rpm for 5 minutes
to pellet any debris.
The mixture was added to 2ml polyallomer "Re-Seal Ultra" centrifugation tubes
(Kendro Laboratory Products) avoiding any air bubbles, before sealing with a plug
and crown (Kendro Laboratory Products). Samples were centrifuged in the Sorvall
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Microultracentrifuge using the S150-AT rotor, total centrifugation time was 2.5
hours and the following speeds were used:
After ultracentrifugation, two DNA bands were visible; the lower band corresponds
to plasmid DNA whilst the upper band represents contaminating genomic DNA;
RNA is found in the pellet at the bottom of the tube. The plasmid DNA bands were
recovered by holding the tube in a retort stand and carefully inserting an 18-gauge
needle and syringe. DNA was drawn out into the syringe and transferred into a fresh
15ml tube (Costar).
To remove the ethidium bromide from the plasmid DNA, an equal volume of CsCl
saturated with isopropanol was added and the samples mixed by shaking. When the
mixture settled, two phases were visible; the upper aqueous phase, coloured pink,
contained the ethidium bromide, and this was removed using a Pasteur pipette. This
process was repeated until both phases appeared clear. Subsequently, DNA was
precipitated from the lower phase by the addition of 1/10 volume 3M NaAc (Sigma)
and 3X volume 70% ethanol, after gentle mixing samples were stored at -20°C for at
least 1 hour to allow the DNA to precipitate. Tubes were warmed to room
temperature and centrifuged at 7000 rpm for 10 minutes, the supernatant discarded,
the pellet washed using 70% ethanol and centrifuged again at 13,000 rpm for 10
minutes. The supernatant was discarded and the pellet allowed to air-dry before
DNA was resuspended in 500pl TE buffer.
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Any contaminating RNA was removed by RNase treatment: 2pl RNase A (Sigma)
was added to the samples and incubated at 37°C for 15 minutes. A final
phenohchloroform extraction was then carried out by addition of 250p,l Tris-
saturated phenol and 250pl chloroform to the samples, which were then mixed by
shaking. Samples were centrifuged at 13,000 rpm for 5 minutes, the upper aqueous
layer removed to a fresh tube and 250pl chloroform added, centrifuged again and the
aqueous layer removed to a new tube. To this, 1/10 volume 3M NaAc (Sigma) and
3X volume 100% ethanol was added and incubated at -20°C for at least 30 minutes
to precipitate the DNA. The sample was then centrifuged for 5 minutes at 13,000
rpm, ethanol removed and the pellet washed with 200pl 70% ethanol and centrifuged
again. The ethanol was removed and the pellet allowed to air-dry before being
resuspended in 250pl TE buffer. The sample was quantified using the GeneQuant
(section 2.10.1) and stored at -80°c.
2.10.1. GeneQuant analysis
Concentration and purity of nucleic acid samples was performed using the
GeneQuant spectrophotometer (Pharmacia Biotech). When measuring optical density
at 260nM, a reading of 1 is equivalent to 50pg/ml dsDNA or 40pg/ml ssDNA or
RNA. The machine was blanked using nuclease free water then lOpl of the sample
was placed in the cuvette and analysed. The 260nM:280nM ratio gives an indication
of the purity of the sample. A ratio of 1.7 for DNA and 2.0 for RNA is considered to
represent a sample free of any degradation or protein contamination.
2.11. RNA interference
2.11.1. Design of siRNAs
Mammalian RNA interference as first described by Elbashir et al (2001), was used in
this thesis to enable sequence specific knockdown of target genes. For siRNA studies
in mammalian cells, most reports have used a 21mer RNA sequence corresponding
to the cDNA of interest (see Chapter 1, section 1.10.1 for details). Many companies
offer web-based design tools to aid in siRNA design as well as list of sequences that
have been shown to achieve good levels of knockdown. For this study, three web
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based design tools were used, Ambion, www.ambion.com. Dharmacon,
www.dharmacon.com and Clontech, www.clontech.com. These companies apply
certain algorithms to choose a siRNA, which should give good silencing efficiency.
These methods are not guaranteed to work so all 3 different design tools were used
and a sequence that was chosen by all three was selected, hopefully increasing the
chance of obtaining a sequence that will give good silencing efficiency. The siRNAs
for ER(3 and GFP shown in Table 2.8 were chosen in this manner with the GAPDH
sequence either provided as a control sequence, and the others published on the
Dharmacon website (www.dharmacon.com).
Targeted Gene siRNA target sequence
GFP AAGCTGACCCTGAAGTTCATC





Table 2.7 siRNA target sequences
2.11.2. In vitro transcription of siRNAs
An alternative to using chemically synthesised siRNAs is to construct the siRNA
using in vitro translation with T7 polymerase. This is a cheaper but just as effective
method to produce siRNAs. An overview of the procedure is shown in Figure 2.2.
The Silencer ™ siRNA construction kit (Ambion) was used in this study, according
to the manufacturer's instructions. This method was used to construct a GFP siRNA
(Table 2.8) and a GAPDH siRNA (control sequence, provided by Ambion).
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Figure 2.2 In vitro transcription of siRNAs using the Silencer siRNA Construction kit
(Ambion).
Two 29-mer DNA oligonucleotides were designed with 2lnt encoding the desired
siRNA (see section 2.11.1 on designing siRNA) and a 8nt "leader sequence" which
is complementary to the T7 promoter primer. Oligonucleotides were synthesised by
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MWG. These 2 oligonucleotides were hybridised to a T7 promoter primer in separate
reactions. All reagents were obtained from Ambion.
T7 promoter primer 2pl
DNA hybridisation buffer 6pl
Sense or antisense siRNA oligonucleotide template 2pl
The mixture was heated to 70°C for 5 minutes and then incubated at room
temperature for 5 minutes. The 3' ends of the hybridised oligos were extended by the
Klenow fragment to create double stranded siRNA transcription templates. The
following was added to the hybridised oligonucleotides:
lOx Klenow reaction buffer 2pl
lOx dNTP mix 2pi
Nuclease free water 4pl
Exo-Klenow 2pi
The mixture was gently mixed by pipetting and incubated at 37°C for 30 minutes.
The sense and the antisense templates are separately transcribed by T7 RNA
polymerase and then the transcripts are hybridised together to create dsRNA which
consists of the 5' leader sequence, the 19nt target specific siRNA and a 3' UU.
Transcribing the templates separately reduces potential competition between the
templates for the transcription reagents, which could limit the synthesis of one of the
strands of the siRNA duplex. For each of the templates, the following transcription
reactions were set up:
Sense or antisense siRNA hybridised and Klenowed template 2pl
Nuclease free water 4pl
2xNTPmix lOpl
1Ox T7 reaction buffer • 2pi
T7 enzyme mix 2pl
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The transcription reactions were incubated for 2 hours at 37°C. The sense and the
antisense transcription reactions were combined into a single tube and the incubation
was continued overnight.
The dsRNA that was made still contained the single stranded 5' leader sequences
that required to be removed. This was done by digesting the dsRNA with RNase and
the DNA template was removed by treatment with DNase.
Transcribed dsRNA 20pl
Digestion buffer 6pl
Nuclease free water 48.5pl
RNase 3pi
DNase 2.5pl
The mixture was then incubated for 2 hours at 37°C. The siRNA was purified using
the glass fibre filter cartridges provided with the kit. siRNA binding buffer (400pl)
was added to the nuclease digestion reaction and incubated for 2-5 minutes at room
temperature. siRNA wash buffer (lOOpl) was added to a filter cartridge and then the
siRNA containing the siRNA binding buffer was loaded onto the filter cartridge. The
sample was centrifuged at 10,000 rpm for 1 minute and the flow through was
discarded. The cartridge was washed with 500pl of siRNA wash buffer and
centrifuged at 10,000 rpm for 1 minute, the flow through was discarded and this
procedure repeated. The filter cartridge was transferred into a fresh tube and lOOpl of
nuclease free water that was pre-heated to 75 °C was added and incubated for 2
minutes at room temperature. The filter cartridge was spun at 12,000 rpm for 2
minutes and the eluted product was then ready for transfection into cells.
2.11.3. Transfection of siRNAs
2.11.3.1. Oligofectamine
Transfections were carried out according to the manufacturer's instructions. Volumes
are given for transfection of a 3.5cm glass bottomed dish, for other culture vessels
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the volumes were scaled up or down as appropriate. Cells were plated out 24 hours
prior to transfection (section 2.3.3). Serum free transfection medium (section 2.13.2)
was used to dilute 3pl oligofectamine reagent to a final volume of 15ul in a sterile
microcentrifuge tube. In a separate tube, 200nM siRNA or 200nM siRNA plus 2pg
plasmid DNA were diluted in serum free medium to a final volume of 175ptl. Both
tubes were incubated for 10 minutes at room temperature. After incubation, the
diluted oligofectamine reagent was added to the siRNA/DNA, mixed gently and
incubated together for 20 minutes at room temperature. The
oligofectamine/siRNA/DNA complex was added to the cells, which were already
bathed in 800[fi of serum free media and returned to the incubator. Four hours post-
transfection, 1ml complete media containing 3x normal serum was added and the
cells were replaced in the incubator. The cells were assayed for gene activity 24-48
hours post-transfection either by luciferase assay (section 2.4), confocal analysis
(section 2.11.4), Q-RT-PCR (section 2.12) or immunohistochemistry (section 2.2.9
/2.2.10).
2.11.4. Analysis of transfected cells by confocal microscopy
Cells transfected with a fluorescent protein (section 2.15.4) or immunostained using
fluorescent antibodies (section 2.2.10) were observed on a LSM 510 Laser Scanning
confocal microscope (Zeiss) using the Argon 488nm laser to visualise green
fluorescence, the HeNel 543nm laser to visualise red fluorescence and the HeNe2
633nm laser to visualise blue fluorescence. The cells were transfected on glass slides
or in 3.5cm glass bottomed dishes as optimum imaging of cells is achieved using
glass. The media was removed and replaced with 1ml PBS containing 25mM HEPES
(Sigma) and observed on a warm (37°C) stage.
2.11.5. Preparation of plasmid vectors containing shRNA's
The pSilencer 3.0-H1 vector (Ambion) was used to express siRNAs to ER|3 and Oct-
4. This plasmid encodes a small hairpin RNA (shRNA) under the control of an RNA
Polymerase III HI promoter (Figure 2.3). The HI promoter provides a high level of
constitutive expression across a variety of cell types; shRNA-containing vectors
provide longer-term reduction in target gene expression and are easier to work with,
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as they are DNA, rather than RNA. The vector was linearised with BamHl and





Figure 2.3 pSilencer 3.0 HI vector (Ambion)
2.11.5.1. Hairpin siRNA Oligonucleotide design
Oligonucleotides (55-60mer) with 3' single stranded overhangs were designed to
contain a 19mer hairpin sequence specific to the mRNA target, a loop sequence
separating the two complementary domains and a transcription termination sequence.
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BamHl siER|3 sense sequence Loop sequence siERp antisense sequence Terminator
I I I I I I I I
5'GATCC AAGAAGATAATGGTCAAGCTT CTCAAGAGA AAGCTTGACCATTATCTTCTT TTTT GGAAA 3'
Sense oligonucleotide
Hindlll Terminator siERp sense sequence Loop sequence siERb antisense sequence
I I I I I I I I I I
5'AGCTTTTCC AAAA AAGAAGATAATGGTCAAGCTT TCTCTTGAG AAGCTTGACCATTATCTT CG 3'
Antisense oligonucleotide
AAG AAG ATA ATG GTC AAG CTT






Figure 2.4 ER|3 DNA oligonucleotide sequences for hairpin insert and resulting hairpin
structure
The oligonucleotides were prepared as a lpg/pl solution and annealed using the
following method:
Sense hairpin siRNA oligo 2pl
Antisense hairpin siRNA oligo 2pl
1 X DNA annealing solution (Ambion) 46pl
The mixture was heated to 90°C for 3 minutes, cooled to 37°C and incubated for 1
hour.
Chapter 2 General Materials and Methods
2.11.5.2. Ligation of hairpin siRNA inserts into pSilencer vector
The hairpin siRNA (5pi) was added to 45pi nuclease free water (Ambion) to give a
final concentration of lOng/pl and a ligation reaction was set up as follows:
The ligation reaction was incubated overnight at 16°C, a negative control (no insert)
reaction was prepared in parallel.
2.11.5.3. Transformation and identification of hairpin siRNA containing
clones
The ligation mixture (lOpl) was transformed into XL-1 Blue competent cells
(Stratagene) as in section 2.8.5 and propagated onto LB-agar-ampicillin plates at
37°C overnight. Colonies were picked, grown up in medium and plasmid minipreps
prepared (section 2.8.6). The plasmids were sequenced (section 2.9) to confirm the
presence of the correct siRNA insert. Large-scale plasmid preparations were
prepared and purified using CsCl banding (section 2.10) before they were used for
cell transfections.
2.12. Quantitative RT-PCR
Quantitative RT-PCR was carried out using the TaqMan analysis system devised by
Applied Biosystems. Primers and probes were designed to each DNA target using the
Primer Express software package (2.12.2) and where available Assay On Demand™
Gene Expression-Assays (Applied Biosystems) (section 2.12.4) containing pre-
validated primer probe sets were used in the study.
Diluted annealed siRNA insert
Nuclease free water (Ambion)
pSilencer vector (0.5pg/ql)
10 x T4 DNA ligase buffer (NEB)
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2.12.1. Principles of the TaqMan reaction
Sequence specific probes located between the forward and reverse primers were
chosen for each sequence. Probes have a reporter dye and quencher attached to the 5'
and 3' ends respectively. In this study, the 5' end of the probe was 6-
carboxyfluorescein, (FAM) dye labelled, which is the reporter dye and the 3' end is
labelled with a 6-carboxy-tetramethyl-rhodamine (TAMRA) quencher dye. Whilst
intact, the close proximity of the reporter to the quencher suppresses fluorescence of
the reporter (Figure 2.5).







£ Taq Polymerase Reverse Primer
Figure 2.5 Reporter-quencher proximity results in suppression of fluorescence
If the target sequence is present in the sample being amplified, the probe anneals to
the target gene cDNA between the forward and reverse primers. The TaqMan probe
has a melting temperature 10°C higher than that of the primers and the sequence of
either strand can be complementary to the probe. Taq polymerase has nuclease
activity in the 5' to 3' direction, cleaving the probe releasing the FAM dye so it is no
longer quenched by the TAMRA dye (Figure 2.6). This only takes place if the probe
has hybridised to the target sequence of cDNA. The fluorescent activity increases
with an increase in the amount of probe cleavage, which in turn is proportional to the
amount of PCR product formed. The accumulation of PCR product is measured
quantitatively by the sequence detection system.
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Figure 2.6 Cleavage of the reporter from the quencher
2.12.2. Taqman primers and probes
Table 2.9 shows the sequences of the primer pairs and probes used in this study.




















Table 2.8 Taqman primer/probe sequences
2.12.3. Optimisation of primers and probe concentration
For efficient amplification, the optimal concentration for the primer pair and the
probe needs to be determined.
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2.12.3.1. Primer optimisation
The combinations of forward and reverse primers shown in Table 2.10 were set up in



















Table 2.9 Primer Optimisation Matrix
The average ACt values for ER(3 and AR were evaluated by subtracting the internal
control (18S) Ct value from the experimental sample Ct value (section 2.12.7). The
best primer pair combination is the one that gives the minimum ACt with the lowest
concentration. In the case of ER|3 and AR, this was found to be 300 nM forward and
300nM reverse and this was used throughout.
2.12.3.2. Probe optimisation
The amount of probe used also must be optimised to prevent probe-limiting
fluorescence. A reaction was carried out using the optimised primer pair combination
of 300nM forward primer/300nM reverse primer with increasing probe concentration
from 50nM to 200nM. The sample analysed was mouse ovary RNA in the case of
ER|3 (shown in Figure 2.7) and mouse testis RNA in the case ofAR. The lowest ER|3
- 18S Ct value without using excess probe was chosen. In the case of both ER|3 and
AR, this was found to be lOOnM.
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25
50nm lOOnM 125nM 150nM 200nM
Probe Concentration
Figure 2.7 ER(5 probe optimisation
2.12.4. Assay-On-Demand™
The Assay-On-DemandrM Gene Expression system (Applied Biosystems) are
optimised, validated ready-to-use primer/probe assays for use with the TaqMan
system. In this study, Assay-On Demand systems were used for c-kit (Cat no.
Mm00445241_ml) and Oct-4 (Cat no. Mm00658129_gH).
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2.12.5. Preparation of cDNA pools for TaqMan analysis
Using Applied Biosystems' TaqMan Reverse Transcription Reagents kit, cDNA was
synthesised using random hexamers according to the following reaction








The reagents were added together in a sterile 0.2ml thin walled PCR tube (CLP) and
placed in a thermocycler programmed with the following cycle times:




Primers were diluted to 5pM and probes to 5pM in TE buffer (lOmM Tris; ImM
EDTA). Samples to be tested were run in triplicate on a 96 well MicroAmp optical
reaction plate (Applied Biosystems). For each sample, a tube containing 37.5pl 2x
universal PCR master mix (Applied Biosystems), 1.65pi each primer, 1.5pi probe,
1.125pl 18S primer/probe mix, and 24.075pl H2O was prepared and 7.5pl of cDNA
(section 2.12.5) added to give a final volume of 75pl; 25pl of this mixture was added
to each of three wells in the plate. Appropriate positive and negative controls were
included on each plate.
Chapter 2 General Materials and Methods
For the Assay on Demand samples, 37.5pl 2x PCR master mix (Applied
Biosystems), 3.75pl Assay on Demand primer/probe mix, 1.125pl 18S primer/probe
mix and 25.125pl H2O were combined together, 7.5p,l cDNA added and 25ql of the
mixture added per well. The plate was sealed with an ABI prism optical adhesive
optical cover (Applied Biosystems) and loaded onto the ABI 7900 sequence
detection system.
2.12.7. Analysis of results - comparative Ct method
Taqman PCR results are shown as an amplification plot. This plot gives the amounts
of the reporter dye generated during amplification and is directly related to the
formation of PCR products. An example of an amplification plot is shown in Figure
2.8. The FAM Ct value obtained corresponds to the cycle number at which the
fluorescence due to amplification of the PCR product reaches a significant level
above the background fluorescence (threshold level). The threshold level is
determined as the point when an increase in signal is associated with an exponential
increase of PCR product.





Detector:lunknown template ^1 Piot:|&Rn vs. Cycle Threshold: 0.1 0580797
Figure 2.8 Example of an amplification plot after a successful Taqman RT-PCR reaction.
The Ct value is directly related to the amount of PCR product and therefore is related
to the original amount of target mRNA present in the reaction. A change in Ct value
of one equates to a two-fold difference in initial template concentration, for example,
if the Ct value decreases by one compared to the control sample, this is due to a
doubling of the initial template concentration. The 18S ribosomal RNA control is a
measure of the mRNA content of the sample and is used as an internal control for
mRNA variation between samples. To analyse the results, the ACt value was
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calculated where ACt is the difference between the FAM Ct and the 18S Ct value and
enables the amplified signal to be normalised against the total mRNA content. The
mean ACt between triplicates on the plate was calculated. This was used to calculate
the AACt, which is the difference between the ACt of a treated sample compared to
the control sample in that experiment. Within each experiment the ACt is related to
its own control. The amount of amplified target is given the value of 2"AACt. This
function is based on the mathematical equation that describes the exponential
amplification of the PCR reaction Xn = Xq x (1+ Ex)n where Xn is the number of
target molecules at the threshold at cycle n, X0 is the initial number of target
molecules, (1+ Ex) being the efficiency of the target gene amplification and n
equalling the number of cycles. Assuming that the efficiencies of the target and
internal control reactions are equal (section 2.12.8), the 2~AACt value is a measure of
relative quantification and in this study is used to show the fold increase or decrease
in mRNA expression of the samples relative to the control with each control always
having a 2"AACt value of 1.
2.12.8. Validation
To analyse the results using the comparative Ct method, a validation experiment
must be carried out to demonstrate the efficiencies of target and endogenous control
amplifications are approximately equal. Mouse ovary cDNA was diluted from lng
down to 0.0lng and a reaction performed. The average ACt value was calculated
(section 2.12.7) and was plotted against the log amount of input RNA. The absolute
value of the slope of log input RNA versus ACt should be <0.1. Relative efficiency
of ER(3 target and 18S reference is shown in Figure 2.9. The slope in this case is
0.0741, which passes the test. The advantage of using the comparative Ct method is
that the need for a standard curve to be run on each plate is eliminated.
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ER0/18S relative efficiency
y = -0.0741X + 9.8063
Log ng total RNA
Figure 2.9 Plot of log input RNA amount versus ACt
2.13. Statistical analysis
Where required, data was analysed for statistical significance using the GraphPad
Prism software package. Statistical significance was determined by either using a
paired students t-test or by one-way analysis of variance (ANOVA). Results were
deemed significant when P < 0.05.
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2.14. Commonly used solutions
2.14.1. Immunohistochemistry
Modified Davidson's 37-40% formaldehyde (Sigma) 30% final
Fixative Ethanol (Haymans) 15% final
Glacial acetic Acid (BDF1) 5% final
Water 50% final
TBS Tris (Sigma) 60.5g
NaCl (Sigma) 87.6g
HC1 (BDH) 300ml
Adjust pH to 7.4 using concentrated HC1
2.14.2. Tissue culture
Complete medium Dulbecco's Modified Eagles Medium (DMEM,
Sigma), supplemented with:
10% Charcoal stripped foetal calf serum (FCS, Gibco)
1% Non-essential amino acids (Sigma)
1% D-(+)-Glucose (45% solution, Sigma)
1% 2mM L-Glutamine (Sigma)
1% Penicillin-streptomycin (Gibco)
1% Fungizone (Gibco)
For studies involving the investigation of steroid hormone receptors, the cells were
changed to complete medium made with DMEM containing no phenol-red (Sigma).
Transfection medium Phenol red free DMEM (Sigma), supplemented with:
1% Non-essential amino acids (Sigma)
1% D-(+)-Glucose (45% solution, Sigma)
1% 2mM L-Glutamine (Sigma)
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Freezing Medium 40% complete medium (Section 2.13.2)
50% FCS (GIBCO)
10% DMSO (Sigma)
Filter sterilised before use
2.14.3. Stem cell isolation and sorting
Supplemented EBSS lOOmls Earle's Balanced Salt Solution (Gibco)
500pl lOOmM sodium pyruvate (Sigma)
112pil sodium lactate (60% w/w) (Sigma)
lml 200nM glutamine (Gibco)
2.14.4. Molecular biology
0.5M EDTA Dissolve 186.lg of EDTA (Sigma) in 800ml of dH20
Adjust to pFl 8.0 with NaOH (Sigma)
Make up to 1 litre with dH20
1 x TE 5ml 1M Tris (Sigma)
lml 0.5M EDTA (Sigma)
Make up to 500ml with dH20
3M Sodium Acetate Dissolve 408.lg NaAc3H20 (Sigma) in 800ml dFl20
Adjust to pF15.2 with acetic acid (BDH)
Make up to 1 litre with dFl20
50 x TAE 242g Tris (Sigma)
100ml 0.5M EDTA (Sigma)
57.1ml acetic acid (BDH)
Make up to 1 litre with dH20, use at I x.
Orange G loading dye 50% lx TAE
20% Glycerol (Sigma)
0.25% Orange G (Sigma)
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Solution PI 50mM Glucose (Sigma)
25mM Tris HC1 pH 8 (Sigma)
lOmM EDTA (Sigma)





3M KAc pH 4.8 (ICN)
Dissolve 25 pellets of LB-Broth (Q-Biogene) in
1 litre of dPLO and autoclave.
LB Agar Dissolve 31 pellets of LB-Agar (Q-Biogene) in
1 litre of dH20 and autoclave.
SOC media 20g bacto-trypytone
5g bacto-yeast extract
0.5g NaCl (Sigma)
10ml fdter sterilised 2M glucose (Sigma)
Make up to 1 litre with H2O
Ampicillin stock solution 50mg/ml ampicillin (Sigma) in dtLO
Working concentration 50pg/ml.
Kanamycin stock solution 30mg/ml kanamycin (Sigma) in dfLO
Working concentration 30pg /ml
Chapter 3
Steroid receptor expression and modulation in Sertoli cells
3.1. Introduction
The testis has two major functions, the synthesis of steroid hormones and the
production of spermatozoa. The adult testis contains three main somatic cell types,
namely Sertoli cells, Leydig cells and peritubular myoid cells as well as germ cells at
all stages of maturation. Interactions between these cells, some of which involve
steroid hormones are responsible for the maintenance of spermatogenesis and
fertility.
3.1.1. Sertoli cell development and function
The Sertoli cell is the only somatic cell in direct contact with the germ cells in the
seminiferous epithelium. They are the first cells to differentiate within the male fetal
gonad and they prevent the germ cells from premature entry into meiosis (Mackay,
2000). The Sertoli cells are the only type which express Sry and they therefore play a
role in sex determination and influence the determination of other cell types in the
testis (Swain et al., 1998). Sertoli cells first appear in the human fetal testis at
approximately 8 weeks of age and by birth, the human testis contains approximately
10% of the adult complement of 4000 million cells (Pelliniemi et al., 1993). In mice,
Sertoli cells are thought to be present in the gonad by embryonic day 11.5, the
evidence for this comes from the fact that anti mullerian hormone (AMH), which is a
Sertoli cell specific gene product during fetal life is first detected in the gonad at this
time (Byskov, 1986; Karl and Capel, 1998).
3.1.1.1. Sertoli cell maturation
At puberty, the role of the Sertoli cell alters and the cells become essential for
supporting the process of spermatogenesis by interactions with other cells via cell-to-
cell contact or by paracrine and endocrine signals (Sharpe, 1994). Sertoli cell
differentiation is marked by the development of a tripartite nucleus with a prominent
nucleolus (Sharpe et al., 2003). As only immature Sertoli cells can proliferate, the
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total Sertoli cell number is determined prior to adulthood. In rodents and in humans,
proliferation of Sertoli cells begins during fetal life. In rats and mice, this
proliferation declines steadily after birth. Puberty in the male rat is usually
recognised to be between 25 and 30 days of age and Sertoli cell proliferation ceases
around day 15 (Sharpe, 1994). In the mouse, the proliferative activity decreases after
birth and by day 11 the Sertoli cells show their typical adult appearance. The murine
Sertoli cell population reaches the level of approximately 18 x 105 cells per testis by
around day 17 (Vergouwen et al., 1991). Similar findings were reported by Kluin et
al. (1984) who found that Sertoli cell proliferation ceased at day 12 (Kluin et al.,
1984). In humans and primates Sertoli cell proliferation also occurs in the neonatal
period, with in some cases a further phase at puberty (Sharpe, 1994). For example, in
the marmoset, it has been shown that adult numbers of Sertoli cells are reached by
the end of the neonatal period whereas the rhesus monkey shows the greatest rate of
proliferation in the peripubertal period (Plant et al., 1978; Sharpe, 1994; Sharpe et
al., 2003).
3.1.1.2. Regulation of Sertoli cell function
Sertoli cell function is regulated by hormones, growth factors and other paracrine
factors (Sharpe et al., 2003). Androgens are synthesised from cholesterol in the
Leydig cells of the testis resulting in the production of androstenediol and
testosterone. Testosterone produced from this conversion can pass into the Sertoli
cells where it can be further converted into its more active metabolite
dihydrotestosterone (DHT) by the enzyme 5a reductase (Miller, 1988). Oestrogens
are synthesised from androgens by the cytochrome P450 aromatase complex
(Carreau et al., 1999; Carreau et al., 2003; Hess, 2003; Hess et al., 2001). P450
aromatase converts androstenedione to oestrone and testosterone to 17|3-oestradiol
(Murata et al., 2002). In rats, aromatase is expressed in fetal and neonatal Sertoli
cells but its expression is downregulated during Sertoli cell maturation (Palmero et
al., 1995). Aromatase is also highly expressed in the Leydig cells of the testis as well
as in some germ cells in mice, rats and the marmoset monkey (Nitta et al., 1993;
Rommerts et al., 1982; Turner et al., 2002). Humans express the aromatase enzyme
in germ cells and in spermatozoa (Carreau et al., 2003).
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FSH is one of the most important regulatory signals involved in the regulation of
Sertoli cell function. The first evidence came from experiments where FSH was
administered to hypophysectomised rats; this resulted in the maintenance of
spermatogenesis in these animals (Greep and Fevold, 1937). FSH has been shown to
control the proliferation of Sertoli cells during fetal and early postnatal life and their
final differentiation during puberty (Griswold, 1993). The presence of the FSH
receptor on Sertoli cells is critical for the hormonal response of the testis to FSH
(Heckert and Griswold, 1991). The importance of FSH to Sertoli cell function was
further demonstrated by the generation of knockout mice for FSH and the FSH
receptor, both of these mice show reduced Sertoli cell numbers in adulthood. In the
FSH receptor KO mouse, Sertoli cell numbers are normal at birth but are
significantly decreased by day 20 (Abel et al., 2000; Dierich et al., 1998; Kumar et
al., 1997). These knockouts are described in more detail in chapter one, section 1.9.5.
The ability of FSH to regulate Sertoli cell number can also be shown by experiments
in which high levels of oestrogens administered neonatally suppressed FSH resulting
in a reduction of Sertoli cell numbers, indicating an indirect impact on testicular
function resulting in abnormal spermatogenesis (Arai et al., 1983; Atanassova et al.,
1999; Sharpe et al., 1998).
In addition to FSH, androgens are involved in the regulation of spermatogenesis. The
study by Johnson et al. (2004), investigated the role ofFSH and androgens in relation
to Sertoli cell maturation and function in the FSHKO and Tfm mice. They concluded
that in the knockouts studied, both FSH and androgens were required to produce the
normal number of Sertoli cells in the adult mouse testis but it is androgens that are
essential during the neonatal period for normal Sertoli cell function (Johnston et al.,
2004). Androgens have also been shown to affect Sertoli cells in culture (Sar et al.,
1993).
3.1.2. Steroid hormone receptors
Steroids act on target tissues via specific receptors, which are members of a
superfamily of ligand activated transcription factors. Receptors for androgens and
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oestrogens are expressed in the male reproductive tract of many species including
mouse (Zhou et al., 2002), rat, (Bremner et al., 1994; Fisher et al., 1997; Hess et al.,
1997; Sar et al., 1990; Saunders et al., 1998), rabbit (Danzo and Eller, 1979),
monkey (Fisher et al., 1997; McKinnell et al., 2001; Saunders et al., 2001), cats and
dogs (Nie et al., 2002) and humans (Saunders et al., 2001; Saunders et al., 2002;
Suarez-Quian et al., 1999). In the mouse, immunohistochemistry has shown that AR
and ER(3 are present in Sertoli cells but ERa is absent (Atanassova et al., 2000;
Walther et al., 1996; Zhou et al., 2002). The distribution ofAR, ERa and ER|3 is not
uniform throughout different species.
In the adult mouse testis, ERa immunoexpression has been detected in the Leydig
cells and the peritubular myoid cells but not in the Sertoli and germ cells (Zhou et al.,
2002). Species differences have been reported, for example, Saunders et al. (2001)
did not detect ERa immunoexpression in any cell type of the testes in humans,
marmosets or macaques (Saunders et al., 2001) although, Fisher et al. (1997)
detected ERa in occasional Leydig cells in the marmoset (Fisher et al., 1997). ERa
has also been detected in the Leydig cells of cats and dogs (Nie et al., 2002). In
comparison, ER|3 is found in multiple cell types within the mouse and rat (Saunders
et al., 1998; Saunders et al., 2001; Zhou et al., 2002). In the human, ER|3 has been
immunolocalised to Sertoli cell nuclei and in some, but not all germ cells as well as
in Leydig cells and peritubular myoid cells (Saunders et al., 2001). In primate
models, ER(3 was found in all the cell types of the testis (Saunders et al., 2001).
In rodents and humans, Sertoli cell expression of AR is switched on postnatally. In
adults, Sertoli cell expression of AR is stage dependent (Bremner et al., 1994;
Suarez-Quian et al., 1999). As well as the Sertoli cells, AR is also found in the other
somatic cells of the testis, the Leydig and peritubular myoid cells. AR activity is
regulated by the steroid hormone testosterone and its derivative DHT. The androgen
receptor plays a role in the feedback regulation of testosterone levels through
autocrine feedback on the Leydig cells (Holdcraft and Braun, 2004). AR is not
detected in the germ cells of the mouse and rat testis (Bremner et al., 1994; Zhou et
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al., 2002) suggesting that the actions of androgens on the germ cells are mediated by
the Sertoli cells. A few reports however, claim to have found AR positive germ cells
in other species including the rat (Kimura et al., 1993; Vornberger et al., 1994).
3.1.3. Sertoli cells in vitro
The culture of Sertoli cells in vitro is an important tool for the study of Sertoli cell
function. As Sertoli cells are only a small proportion of the adult testis, isolated
Sertoli cells are commonly used for functional studies. However most primary
cultures of Sertoli cells are established using cells from prepubertal rodents and in
most cases, these cells dedifferentiate and fail to proliferate (Karl and Griswold,
1990). Primary Sertoli cell cultures are known to lose their characteristic
morphology after enzymatic digestion and become rounded (Bellve et al., 1977). In
addition to this, primary Sertoli cells, lose receptor expression and consequently
become unresponsive to hormones after 6 to 10 days in culture (Karl and Griswold,
1990).
Several attempts have been made to establish long-term cultures of Sertoli cells.
Examples of these include the TM4 (Mather, 1980) and MSC-1 (Peschon et al.,
1992) cell lines. However, the TM4 cell line have become dedifferentiated and the
MSC-1 cell line has lost FSH receptor expression (Mather, 1980; Peschon et al.,
1992). As well as these, two cell lines have been immortalised using SV40 large T
antigen. The Sertoli cell line chosen for use in this study was the SK11 cell line
(Walther et al., 1996). This line was derived from Sertoli cells of a 10 day old H-
2Kb-tsA58 transgenic mouse (Jat et al., 1991). The mice carry the temperature
inducible SV40 large-T antigen which is a conditional immortalising gene under the
control of the mouse major histocompatibility complex-1 promoter H-2kb which is
active at various levels throughout various tissues. The tsA58 TAg gene product is
functional at the permissive temperature of 33°C but is degraded at the non-
permissive temperature of 39°C. The presence of the TAg gene results in the
generation of continuously proliferating cells, capable of differentiation following
culture at the non-permissive temperature. SKI 1 cells were established using this
method. Primary Sertoli cells were isolated from these mice and cultured in the
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presence of interferon-y, which induces the expression of the SV40 large T antigen,
stimulating permanent growth. The cells were continuously passaged until a
homogeneous population was obtained. Upon transfer to the non-permissive
temperature of 39°C, the temperature sensitive SV40 antigen is inactivated, resulting
in differentiation of the cells and a significant reduction in growth (Walther et al.,
1996; Walther et al., 1997). After two days of culture at 39°C the cells stopped
growing and began to show a morphological change and become flattened. SKI 1
cells were reported to express mRNAs for AR and FSHR, as well as other Sertoli cell
products including a-inhibin, GATA-1, SGP-2, SCF and SF-1 (Walther et al., 1996).
Recently, another cell line has been described which conditionally immortalised
freshly isolated Sertoli cells again using the SV40 Large T antigen under the control
of an ecdysone inducible promoter. These cells expressed SCF, GATA-1 and SGP-2
and were shown to be able to support the survival of germ cells in culture (Flofmann
et al., 2003).
3.1.4. RNA interference
As described in Chapter One, RNA interference is a technique which results in
sequence specific gene silencing (Elbashir et al., 2001). The development of vector-
based delivery systems has allowed more stable expression of siRNAs. When placed
in a vector, siRNAs are expressed as fold-back hairpin-loop structures that give rise
to siRNAs after intracellular processing (Tuschl, 2002). Transfection of plasmid
DNA, rather than synthetic siRNAs, is advantageous in many ways, overcoming
problems with RNase contamination and the costs of chemically synthesized siRNAs
or siRNA transcription kits. By using a vector based delivery system, longer-term
knockdown can also be achieved.
3.1.5. Aims
The studies described in this chapter were designed to determine the impact of
steroid hormones (oestradiol and testosterone) on Sertoli cell function and to attempt
to knockdown the expression of ER|3 using siRNA. All studies utilised the
immortalised Sertoli cell line SKI 1. A cell line was chosen to perform the studies in
this chapter due to the drawbacks of using freshly isolated Sertoli cells, which
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include morphological changes and the loss of receptor expression. The advantage of
using this cell line is that it can be maintained in both an undifferentiated and
differentiated state. Initial studies characterised the pattern of gene expression in the
SKI 1 cells and the expression of steroid hormone receptors. Steroid responsiveness
was then investigated using transient transfection studies.
The knockdown of ER(3 was attempted in the SKI 1 cell line by the use of RNA
interference technology. siRNA methodologies were optimised using the SKI 1 cells
and the expression of ER(3 was knocked down in these cells with the use of a short-
hairpin siRNA.
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3.2. Materials and methods
3.2.1. SK11 cell culture
The SK11 cell line was maintained at 33°C in 5% (v/v) CO2 in complete media
(sections 2.3.1 and 2.13.2). Passaging of the cells was performed every 3-4 days by
trypsinisation (section 2.3.2). The cells were induced to differentiate by incubation at
39°C for at least 48 hours before any experimental procedure was carried out.
3.2.2. Immunohistochemistry
Immunohistochemistry was carried out on SKI 1 cells and on sections prepared from
the testis of 10 day old and adult mice using standard methods as detailed in chapter
2, section 2.2.9. The SKI 1 cells were grown on 2 well or 8 well chamber-well slides
(Nalgene Nunc) and immunohistochemistry carried out when the cells reached 60-
70% confluency. Antibodies used for immunohistochemistry are shown in Table
3.1.
Antigen Dilution Species raised in Source
ER|3 1:1500 Sheep Raised in house,
(Saunders et al., 2000).
ERa 1:20 Mouse Novocastra
AR 1:200 Rabbit Santa Cruz
GATA-1 1:100 Goat Santa Cruz
Table 3.1 Antibodies used for immunohistochemistry of cultured SK11 cells and testis tissue
sections
3.2.2.1. Fluorescent immunohistochemistry
SKI 1 cells (differentiated and undifferentiated) were plated onto glass 2-well
chamberwell slides and left to attach overnight. Immunohistochemistry was
performed as in section 2.2.10 using primary and secondary antibodies shown in
Table 3.2. The cells were counterstained using To-Pro3 (Molecular Probes) as
described in section 2.2.10 and observed using the confocal microscope (section
2.11.4).
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Antigen Dilution Species raised in Source Dilution
Primary
Antibody








Table 3.2 Primary and secondary antibodies used for fluorescent immunohistochemistry
3.2.3. RT-PCR
Total RNA was extracted from the SKI 1 cells and from mouse testes (adult and 10
day old) as described in section 2.5. Oligo dT primed cDNA was synthesised, using
standard conditions (section 2.6) and a standard PCR reaction was carried out with
30 cycles of amplification (section 2.6.2.2) and a reaction mix containing BioTaq
(Bioline). Primer pairs designed to amplify mouse ERa, ER|3 and selected Sertoli
cell products are given in Table 3.3.
Gene
Name




















































Table 3.3 Primer sequences and product sizes
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3.2.4. Steroid treatment of SK11 cells
Steroid treatment ofSKI 1 cells at 33°C and 39°C was carried out by incubation with
lOnM and lOOnM oestradiol (Sigma) or testosterone (Sigma) for a period of 48
hours. Total RNA was isolated from the cells (section 2.5) and random primed
cDNA pools were prepared for Q-RT-PCR (section 2.12.5).
3.2.5. Q-RT-PCR
The relative levels of expression of ER(3 and AR in SK11 cells (control/steroid
ligand treated and siRNA/shRNA transfected) were determined using quantitative
RT-PCR (Taqman) using random primed cDNA (section 3.2.4) as detailed in section
2.12. Results were analysed as in section 2.12.7.
3.2.6. Transient transfections
In order to assess the impact of oestrogenic ligands on the SKI 1 cells, transient
transfections were performed using a reporter construct containing a 3X vitellogenin
ERE-linked to TK-luciferase or the androgen-responsive promoter-reporter construct
pem-Luc. ERE-Luc was a gift from S.C. Nagel and D.P. McDonnell (Hall and
McDonnell, 1999), this vector contains three tandem copies of the vitellogenin ERE
sequence (Figure 3.1) ligated into the TK-Luciferase vector (Ligand
Pharmaceuticals). Pem-Luc was a gift from Professor G. Verhoeven (Leuven,
Belgium). The pern promoter is selectively stimulated by androgens and contains
two functional AREs. Both ARE's differ in sequence from the classical steroid
response element but exhibited characteristics of direct repeats of the TGTTCT half-
site and are preferentially stimulated by androgens (Barbulescu et al., 2001). The
sequence of the ARE 1 and 2 from the pem-Luc construct are shown in Figure 3.2.
TAGGTCAcaqTGACCTGCGGATCCGCAGGTC
ActqTGACCTAGATCCGCAGGTCActaTGACCT
Figure 3.1 Sequence of the 3x ERE. The 3 repeats of the ERE sequence are underlined
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ARE-1 AGATCTcattcTGTTCC
ARE-2 AGCACAtcgTGCTCA
Figure 3.2 Sequence of the ARE-1 and ARE-2 from the pem-Luc reporter construct. The
consensus sequence of each is underlined and the SRE half site variations are shown in blue.
A control vector (pCMV, Promega) was co-transfected in all cases and used to
measure Renilla luciferase as an internal control (section 2.4). Transient transfections
were carried out and results analysed as in section 2.4.3. All transfections were
carried out using serum free media made with DMEM that did not contain phenol red
(section 2.13.2)
3.2.6.1. Steroid treatment of SK11 cells following transient
transfection
The response of the cells treated with various steroid ligands was investigated. The
ligands used were 17(3oestradiol, testosterone, the potent oestrogen diethylstilbestrol
(DES), the ERp agonist 3|3Adiol (a metabolite of DHT) and the phytoestrogen
genistein. The response of two receptor selective ligands was also investigated;
PPT™ which is reported to be ERa specific and DPN™ which is reported to be ER(3
specific (both of these ligands were supplied by Tocris).
Four hours following transfection with the reporter constructs, complete medium
(section 2.13.2) containing either 17(3oestradiol, testosterone, 3|3Adiol, DES,
genistein, DPN™ or PPT™ was added to the cells. Dose response studies were
performed by adding the ligands at 5 different concentrations, 10 nM, 10"9M, 10"SM,
1 ft
10" M and 10" M to evaluate the concentration required for maximal ER activation.
A control sample was set up in each case, which contained no ligand, only ethanol or
DMSO as appropriate. The ligand containing media was replaced again 24 hours
following transfection and the cells were harvested 48 hours following transfection
for analysis using a luciferase assay (section 2.4) and the results were analysed as in
section 2.4.3.
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3.2.7. Cloning of ERp- fluorescent protein construct
In order to visualise the expression of ERp in the SK11 cells after transient
transfection, the full-length murine ERp cDNA (a gift from Professor M Parker) was
amplified and inserted into the dsRed-C2 vector (Clontech).
3.2.7.1. PCR amplification of murine ERp cDNA
Primers were designed to amplify the coding region of the mouse ERp cDNA and
add a Bgl II restriction enzyme site on the 5' end and a Sac II site on the 3' end
(Table 3.4). PCR was carried out using Hot Star Taq polymerase (Qiagen),
conditions were as follows:
lOx Hot Star Buffer 5pl
20mM dNTPs lql
ERp Sense primer 2ql
ERP Antisense primer 2ql
Hot Star Taq 0.4[xl
H20 37.6ql
40 cycles of amplification were carried out with an initial annealing temperature of
50°C for 5 cycles followed by 35 cycles at 55°C. The PCR product was run on a
0.8% agarose gel (section 2.7) and the 1.5kb fragment excised using a clean scalpel
blade. Gel extraction and PCR product purification was carried out using the Qiagen
gel extraction kit according to the manufacturer's instructions as in section 2.8.3.
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Sense ERp cloning primer
5'-»3'






Table 3.4 Sequence of primers used to amplify murine ERp cDNA with restriction enzyme
sites at the 5' and 3' ends to allow directional cloning into the dsRed vector. Bgl II site is
shown in red, Sac II site is shown in blue. The start (ATG) and stop (TCA) sites of the ERp
cDNA are underlined in bold.
3.2.7.2. Topo-TA cloning of ERp PCR product
The gel extracted and purified ERP PCR product was cloned into the TOPO-pCRII
vector (Invitrogen) according to manufacturer's instructions to facilitate sequencing
of the PCR product. Briefly, lOOng of PCR product was mixed with lpl salt solution
(Invitrogen), lpl TOPO vector and 2pl sterile H2O. The mixture was incubated at
room temperature for 10 minutes before 2pl of the mix was transformed (section
2.8.5) into 50pl XL-1 Blue cells (Stratagene). The entire transformation reaction was
spread onto LB Agar plates containing ampicillin at a final concentration of 50pg/ml
and incubated inverted overnight at 37°C. Individual colonies were picked the
following day and used to inoculate lOmls of LB-broth containing ampicillin which
were incubated overnight in a rotary shaker at 37°C, 225 rpm. The next day, mini-
preps were performed using the Promega Wizard® Plus SV Minipreps DNA
Purification System according to the manufacturer's instructions (section 2.8.6).
Restriction enzyme digestion (section 2.8.2) followed by agarose gel electrophoresis
(section 2.7) was carried out to check that the plasmid contained the insert of the
correct size. Sequencing (section 2.9) was performed to ensure no errors had been
introduced into the sequence before glycerol stocks (section 2.9.1) and large-scale
CsCl preparations were made (section 2.10).
3.2.7.3. Ligation into dsRed vector
The ERp cloned into the TA cloning vector was digested with Bgl II and SacII in
order to release the ERp fragment from the vector. The dsRed vector was digested
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with the same enzymes to allow ligation. Digests were set up as in section 2.8.2 and
the vector dephosphorylated to ensure no re-ligation occurred using SAP (Promega,
section 2.8.2). Ligation of the ER|3 insert into the dsRed vector was carried out as in
section 2.8.4 using T4 DNA ligase (NEB), incubated overnight at 16°C.
Transformation of XL-1 blue competent cells with the ligation product was carried
out as in section 2.8.5 and the resulting colonies were picked, grown up and
miniprepped as in section 2.8.6. Sequence analysis was performed to check the
vector contained the correct insert before glycerol stocks and a large scale CsCl
preparation was prepared (sections 2.9.1 and 2.10).
3.2.8. RNA interference
3.2.8.1. Design and construction of siRNA's
Linear siRNA's were designed as described in section 2.11.1. Table 3.5 shows the
sequences of the siRNA's used in this chapter. A control siRNA to GAPDH provided
by Ambion and a siRNA to GFP were both synthesised using the Silencer™ siRNA
construction kit (Ambion) as described in section 2.11.2. Control siRNA sequences
for a-tubulin, (3-tubulin and lamin A/C, which have been reported to produce high
levels of knockdown in mammalian cells, were selected from a database of
sequences published on the Dharmacon website (www.dharmacon.com). Sequences
for GFP and murine ER(3 were chosen using the design guidelines provided on the
Ambion website (www.ambion.com) and the ER|3 siRNA was synthesised by MWG.






GAPDH No sequence supplied
Table 3.5 Sequence of siRNA's
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3.2.8.2. Fluorescent labelling of siRNAs
Fluorescently labelled siRNAs were synthesised and used to check whether they
were being successfully transfected into the cells. By labelling the siRNA duplex
with fluorescein, the route of the siRNA into the cell can be tracked by using
confocal microscopy. The Silencer ™ siRNA labelling kit from Ambion was used
according to the manufacturer's instructions. The labelling reaction was prepared as
follows:
Nuclease free water 18.3pl
lOx labelling buffer 5.0pl
2 lmer siRNA duplex at 20pM 19.2pl
FAM labelling reaction 7.5pl
The samples were incubated in the dark at 37°C for 1 hour then precipitated using
ethanol; 5pi 5M NaCl and 125pi 100% cold ethanol was added to the labelling
reaction and mixed well. The mixture was placed at -20°C for 1 hour to precipitate
the labelled RNA. The RNA was centrifuged at 13,000 rpm for 20 minutes to pellet
the RNA, and a green coloured pellet was formed. The supernatant was removed and
175pi cold 70% ethanol was added to the pellet and the sample centrifuged for 5
minutes at 13,000 rpm. The ethanol was removed and the pellet air-dried for 5-10
minutes before being resuspended in 19.2 pi of nuclease free water. This resulted in
the same nucleic acid concentration as at the beginning of the reaction. The RNA
was quantified using the GeneQuant spectrophotometer (section 2.10.1) before being
used for transfection.
3.2.8.3. Transfection of siRNA's using a fluorescently labelled reagent
JetSI-FluoR (Polytransfection) is a rhodamine-conjugated transfection reagent that
facilitates the measurement of transfection efficiency and the tracking of siRNA
complexes. Optimisation of the transfections showed that the best transfection
efficiency was seen using lOOnM siRNA.
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The following calculation was used to determine the appropriate volume of jetSI-
FluoR:
Amount of siRNA (ng) x 0.003 = Xpl jetSI FluoR
For transfection of a 3.5cm glass bottomed dish using lOOnM siRNA, 20pl of siRNA
was added to 80pl of serum-free medium in a sterile 1.5ml tube. In a separate tube,
8.4pl jetSI-FluoR was added to 91.6 pi serum-free medium. The tubes were vortexed
vigorously and incubated at room temperature for 10 minutes. The jetSI FluoR mix
was then added to the siRNA mix, vortexed for 10 seconds and incubated for 30
minutes in the dark. The JetSI/siRNA mixture was added to the wells, which already
contained 1ml of serum free transfection medium and the cells incubated for 4 hours.
After 4 hours, 1ml of complete medium was added to the cells and they were
returned to the incubator. Cells were observed on the confocal microscope after 24
and 48 hours.
3.2.8.4. Transfection of siRNA's into SK11 cells
Routine transfection of siRNA's was performed using oligofectamine as described in
section 2.11.3.1. Ligand addition, if required, was performed 4 hours after
transfection and gene activity was measured 24-48 hours after transfection by
luciferase assay (section 2.4), confocal analysis (section 2.11.4), Q-RT-PCR (section
2.12), or immunohistochemistry (section 3.2.8.5)
3.2.8.5. Immunohistochemistry of siRNA transfected cells
Cells were grown on 2 well glass chamber-well slides or 3.5cm glass bottomed
dishes and transfected with siRNA's (section 3.2.8.4). Cells were fixed using ice-
cold methanol or modified Davidson's fixative (section 2.13.1) before
immunohistochemistry was performed as described in section 2.2.10. Cells were
visualised using a LSM 510 confocal microscope as described in section 2.11.4.
Table 3.6 gives details of the antibodies used.
Chapter 3 Steroid receptor expression and modulation in Sertoli cells 110
Primary antibody Dilution Species raised in Supplier
Tyrosine a- tubulin 1:2000 Mouse Sigma
P-tubulin 1:1500 Mouse Sigma
Lamin A/C 1:500 Mouse Santa-Cruz





Goat anti-mouse Cy-5 1:60 Goat Molecular
probes
Table 3.6 Antibodies used in fluorescent immunohistochemistry
3.2.9. Preparation of plasmid vectors containing shRNA's
Section 2.11.5 describes in detail the design and construction of shRNA containing
plasmid vectors. The siRNA specific for ER|3 is shown in Table 3.5. Table 3.7 shows
the sequence of the DNA sense and antisense oligonucleotides used in the
construction of the shER(3 which was inserted into pSilencer.
Sense oligonucleotide 5'-» 3' Antisense oligonucleotide 5'-» 3'
GATCCAAGAAGATAATGGTCA AGCTTTTCCAAAAAAGAAGATAA
AGCTTCTCAAGAGAAAGCTTG TGGTCAAGCTTTCTCTTGAGAAG
CCATTATCTTC1 1 1 1 1 1GGAAA CTTGACCATTATCTTCG
Table 3.7 ER(3 shRNA oligonucleotide sequence. The 19mer ER(3 sequence specific siRNA
sequence (sense and antisense) is underlined and shown in red with the loop sequence shown
in blue.
Transfection of the shER(3 pSilencer vector was performed as in section 3.2.8.4 and
subsequent analysis of knockdown by confocal microscopy, luciferase assay and
Taqman quantitative RT-PCR was performed as described in sections 2.11.4, 2.4 and
2.12 respectively.
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3.3. Results
3.3.1. Immunolocalisation of ERa, ER0 and AR in the immature and
adult mouse testis
ERa was immunolocalised to the Leydig cells of the immature and adult mouse
testis. No immunoexpression was detected in the Sertoli cells or the germ cells
(Figure 3.3, panels A and B).
ER(3 protein was localised to the nuclei of the germ cells of both the immature and
adult testes. The Sertoli cells and the Leydig cells also stained positive for ER(3
(Figure 3.3, panels C and D).
AR protein was localised to the nuclei of the Sertoli cells, the Leydig cells and the
peritubular myoid cells of the immature and adult testis (Figure 3.3, panels E and F).
The Sertoli cell expression is weaker in the 10-day-old section than in the adult
section; in the adult, expression was stage dependent. No AR positive germ cells
were observed in the immature or the adult testis.
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Figure 3.3 Immunohistochemical analysis of ERa, ER|3 and AR protein expression in the
mouse testis. Sections taken from a 10-day-old mouse were stained for ERa (A), ER(3 (C)
and AR (E). Adult testis sections were stained for ERa (B), ER(3 (D) and AR (F). Arrows
represent Sertoli cells, arrowheads represent Leydig cells and asterisks represent germ cells.
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3.3.2. Characterisation of the SK11 cell line
The SKI 1 cell line was first characterised in 1995 and therefore before embarking on
a large series of experiments, the pattern of gene expression was checked to confirm
that it had maintained its phenotype. It has been reported that freshly isolated Sertoli
cells lose their expression steroid receptors and Sertoli cell products (Karl and
Griswold, 1990)
3.3.2.1. Differentiation of the SK11 cell line
Differentiated (39°C) and undifferentiated (33°C) cells stained with |3-actin are
shown in Figure 3.4. Undifferentiated cells are shown in panels A and B. The cells
are large with an even distribution of P-Actin. After differentiation, the cells became
more rounded and flattened in shape and showed an accumulation of P-actin around
their nuclei (Figure 3.4, panels C and D). The apparent increase in P-actin observed
in the differentiated cells was mirrored by an increase in mRNA levels as detected by
semi-quantitative RT-PCR (Figure 3.5, lanes 3 and 4). RT-PCR was performed on
the same samples using primers for GAPDH, a housekeeping gene, the levels of
which should remain constant throughout, acting as a control.
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Figure 3.4 Confocal image of the SKI 1 Sertoli cell line growing at 33°C (A and B) and after
culture at 39°C for 48 hours (C and D) after immunostaining for P-Actin (red) to show
changes in morphology after differentiation. Cells are counterstained using To-Pro3 (blue).
Figure 3.5 Panel A shows |3-actin mRNA expression in dlO testis (lane 1), adult testis (lane
2), undifferentiated SKI 1 cells (lane 3) and differentiated SKI 1 cells (lane 4). Panel B shows
GAPDH expression in the same samples M represents DNA hyperladder.
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3.3.2.2. Expression of Sertoli cell product mRNA's in SK11 cells
Expression of mRNA's previously identified as Sertoli cell specific products was
investigated in SKI 1 cells by RT-PCR using specific primers designed for GATA-1,
SGP-1, SGP-2, testatin and DAX-1 (Figure 3.6 and 3.7). cDNA's prepared from d8
and adult testes were used as controls.
As expected, mRNA's for SGP-1 and SGP-2 (Figure 3.6) were both detected in the
adult mouse testis. Both mRNA's were expressed in the SK11 cells; SGP-l was
expressed in higher amounts in the differentiated sample. No change was observed in
SGP-2 mRNA expression in the differentiated compared to the undifferentiated cells.
Messenger RNA for GATA-1 appeared lower in the SK11 cells than in the intact
testis but no difference was observed between undifferentiated and differentiated
cells. Testatin and Dax-l mRNA's were expressed in similar amounts in both
undifferentiated and differentiated cell types (Figure 3.7).
3.3.2.3. Expression of Sertoli cell specific proteins in undifferentiated
and differentiated SK11 cells
Immunohistochemistry of undifferentiated and differentiated SKI 1 cells was carried
out to confirm that the SKI 1 cells had actively translated the mRNA's detected by
RT-PCR (Figure 3.8). Fligher levels of SGP-1 expression was seen in the
differentiated SKI 1 cells compared to the undifferentiated cells. GATA-1 protein
expression was similar in both cell types.
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GATA-1 SGP-1 SGP-2
Figure 3.6 Expression of GATA-1 (362bp) SGP-1 (484 bp) and SGP-2 (460bp) in testis and
SKI 1 cells. Lanes 1, 6 and 11 are adult whole testis cDNA samples. Lanes 2, 7 and 12 are
dlO mouse testis cDNA samples. Lanes 3, 8 and 13 are undifferentiated SKI 1 cells cultured
at 33°C. Lanes 4,9 and 14 are differentiated SK11 cells cultured at 39°C. Lanes 5,10 and 13
are -ve control samples and M represents Hyperladder 1 DNA marker.
500bp
Figure 3.7 Expression of Testatin (488bp) and Dax-1 (418bp) in mouse testis and SKI I
cells. Lanes 1 and 6 are adult whole testis cDNA samples. Lanes 2 and 7 are dlO mouse
testis cDNA samples. Lanes 3 and 8 are undifferentiated SKI 1 cells cultured at 33°C. Lanes
4 and 9 are differentiated SK11 cells cultured at 39°C. Lanes 5 and 10 are -ve control
samples and M represents Hyperladder 1 DNA marker.








Figure 3.8 Immunohistochemical analysis of SGP-1 and GATA-1 protein expression in
undifferentiated and differentiated SK11 cells. SK11 cells cultured at 33°C were stained for
SGP-1 (A) and GATA-1 (C). SK11 cells cultured at 39°C stained for SGP-1 (B) and GATA-
1 (D). E and F show SKI 1 cells stained with the respective secondary antibody only, as a
negative control.
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3.3.3. Expression of steroid hormone receptors in SK11 cells
As the results from the previous sections showed that the SKI 1 cells were behaving
in a similar way to Sertoli cells in vivo, with respect to their expression pattern, the
following experiments were performed in order to investigate the expression of
steroid hormone receptor mRNA's and protein within the cells.
3.3.3.1. Steroid hormone receptor mRNA expression
Following PCR, DNA products corresponding to ERa (290bp), ER|3 (339bp) and
AR (266bp) were amplified from cDNA's prepared from adult mouse testis (Figure
3.9). cDNA's prepared from SK11 cells (both differentiated and undifferentiated)
were positive for ER(3 (Figure 3.9) but no ERa expression was detected (Figure 3.9).
Levels of expression of ER(3 mRNA's were similar in differentiated and
undifferentiated cells. AR specific mRNA's were detected in SK11 cells; levels of
AR mRNA appear higher in differentiated cells compared to the undifferentiated
cells (Figure 3.9).
300bp
Figure 3.9 RT-PCR using primers specific for ERa (290 bp), ER|3 (339bp) and AR (286bp).
Lanes 1.6 and 11 are 8d testis samples, lanes 2,7 and 12 are adult testis samples, lanes 3,8
and 13 are undifferentiated SK11 cells, lanes 4,9 and 14 are differentiated SK11 cells and
lanes 5,10 and 15 are H20 -ve control samples. M represents Hyperladder 1 DNA marker.
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3.3.3.2. Steroid hormone receptor protein expression
Immunohistochemistry performed on the cell monolayers resulted in the detection of
ER|3 and AR protein but not ERa in the SKI 1 cells (Figure 3.10). ER|3 (Figure 3.10,
panels C and D) and AR (Figure 3.10, panels E and F) was observed within the
nuclei of the cells. More intense AR staining was immunolocalised in the
differentiated cells cultured at 39°C compared to the undifferentiated cells. No
difference was observed in the intensity of ER(3 immunostaining in differentiated and
undifferentiated SKI 1 cells. Expression of ERa protein was not observed in the cells
either in the differentiated or undifferentiated states (Figure 3.10, panels A and B).














Figure 3.10 Immunohistochemical analysis of ERa, ERp and AR protein expression in
undifferentiated and differentiated SKI 1 cells. SKI 1 cells cultured at 33°C were stained for
ERa (A), ERp (C) and AR (E). SKI 1 cells cultured at 39°C stained for ERa (B) and ER(3
(D) and AR (F). Small inset image in A shows MCF-7 cells immunostained using the same
antibody against ERa, as a positive control. G, FI and I show SK11 cells immunostained
using only the secondary antibodies, acting as a negative control.
Chapter 3 Steroid receptor expression and modulation in Sertoli cells 121
3.3.4. Steroid responsiveness of SK11 cells
As the cells were shown to express both ER|3 and AR (section 3.3.3.1 and 3.3.3.2),
the following experiments were designed and carried out to investigate whether the
cells were able to respond to treatment with oestrogens and androgens.
3.3.4.1. Impact of steroid hormones on expression of steroid hormone
receptor mRNA's
Expression of ER[3 and AR mRNA's in undifferentiated SK11 cells were analysed
by TaqMan after treatment with either lOnM and lOOnM 17(3 oestradiol or
testosterone (Figure 3.11 A and B). Compared to a control sample, which was treated
with vehicle alone (ethanol), addition of oestradiol resulted in a significant increase
in ER|3 mRNA expression (P < 0.001). A 19-fold increase of ER(3 mRNA expression
occurred after exposure to lOnM oestradiol. When cells were exposed to
testosterone, no increase in expression of ER|3 was observed at either concentration
used.
Addition of oestradiol had no effect on AR expression in the cells but treatment with
testosterone at both concentrations resulted in a 4-fold and 14-fold increase in AR
mRNA levels at lOnM and lOOnM testosterone respectively.
The same experiment was repeated this time using cells that have been differentiated
by culture at 39°C (Figure 3.11 C and D). Significantly increased ER|3 mRNA
expression was observed upon addition of oestradiol however, the maximum
response was seen at lOOnM E and the fold increase was not as great (13.8 fold) as
was seen in the undifferentiated cells. Addition of testosterone had no effect on ER|3
levels in the SKI 1 cells. Androgen receptor expression increased with addition of
testosterone at both concentrations with a 14-fold increase at lOnM T and a 33-fold
increase at lOOnM T being seen. This was higher than that observed in the
undifferentiated cells. A slight effect was observed on androgen receptor expression
upon addition of oestradiol with a 3-fold increase being observed but this increase
was not shown to be statistically significant.
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Figure 3.11 Steroid responsiveness in the SK11 cell line, both undifferentiated cells cultured
at 33°C (A and B) and differentiated cells cultured at 39°C (C and D). A and C show ER(3
relative amounts, C and D show AR relative amounts determined by Taqman Q-RT-PCR
after culture with oestradiol (purple bars) and testosterone (yellow bars) at a concentration of
either lOnM or lOOnM. Results are shown as relative expression compared to a vehicle
treated control (blue bars). Statistical significance was calculated using one-way ANOVA,
n=2. * P < 0.05; ** P < 0.01; *** P < 0.001.
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3.3.4.2. Activation of an oestrogen response element reporter in SK11
cells
In order to investigate whether the ER|3 protein detected in the SK11 cells was
functional, cells were co-transfected with an ERE-luciferase reporter plasmid and the
Renilla luciferase internal control plasmid. Oestrogenic ligands (natural and
synthetic) were added to the cells 4 hours post transfection to obtain a dose response.
The results were normalised and expressed as a fold increase compared to a no
ligand control. One-way ANOVA was performed on the data to test for statistical
significance.
3.3.4.2.1. Natural oestrogenic ligands
E2 and 3|3Adiol are both natural ligands synthesised within the testis. A dose
response curve was observed when E2 was added in increasing concentrations (lOpM
to lpM) to the SK11 cells transiently transfected with the 3x ERE-Luc reporter
construct (Figure 3.12A). The maximum response was seen with addition of lOOnM
E2. A dose dependant response was also observed after ERE transfection when
3f3Adiol was added in increasing concentrations (lOpM to lpM) with the maximum
response was seen with addition of lpM 3(3Adiol (Figure 3.12A).
3.3.4.2.2. Phytoestrogens
Genestein is a phytoestrogen, which is reported to activate ER|3. SK11 cells
transfected with ERE-Luciferase and stimulated with genistein resulted in a dose
dependant increase of ERE activity with maximum response at lp,M genistein
(Figure 3.13).
3.3.4.2.3. Synthetic ligands
Three synthetic oestrogenic ligands were used to stimulate the cells after transient
transfection. DES which is reported to activate both ERa and ER|3, DPN which is an
ER|3 selective ligand and PPT which is reported to be ERa selective. When
transiently transfected SK11 cells were treated with increasing concentrations of
DES (Figure 3.15), the response was slight at low concentrations (lOpM-lOnM). At
higher concentrations, (lOOnM and lpM) the ERE is activated to a greater extent
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with a 5.8 and 6.5 fold increase being observed at lOOnM and lp,M DES
respectively.
The ERE was activated in a dose dependant manner when DPN™ was added in
increasing concentrations (lOpM to lpM). The maximum response was seen with
addition of lOOnM DPN™ (Figure 3.14A).
No activation of the ERE was observed after addition of PPT™ in increasing
concentrations (lOpM to lpM) after transient transfection (Figure 3.14B).




































Figure 3.12 Dose response in SKI 1 cells after ligand treatment. SKI 1 cells were transiently
transfected with the 3x ERE-Luc reporter and the pRL-CMV Renilla internal control. Cells
were treated with a vehicle, or increasing concentrations of (A) 17(3 oestradiol (lOpM to
lp,M) or (B) 3(3 Adiol (lOpM to lpM). Results are expressed as ± SEM (n=3). Statistical
analysis was performed using one-way ANOVA, * P < 0.05; ** P < 0.01; *** P < 0.001.
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Figure 3.13 Dose response in SK11 cells after genistein treatment. SKI I cells were
transiently transfected with the 3x ERE-Luc reporter and the pRL-CMV Renilla internal
control. Cells were treated with a vehicle, or increasing concentrations of genistein (lOpM to
1 pM). Results are expressed as ± SEM (n=3). Statistical analysis was performed using one¬
way ANOVA, * P < 0.05; ** P < 0.01; *** P < 0.001.
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Figure 3.14 Dose response in SK11 cells after ligand treatment. SK11 cells were transiently
transfected with the 3x ERE-Luc reporter and the pRL-CMV Renilla internal control. Cells
were treated with a vehicle, or increasing concentrations of (A) DPNrM (1OpM to 1 pM) or
(B) PPT™ (lOpM to lpM). Results are expressed as ± SEM (n=3). Statistical analysis was
performed using one-way ANOVA, * P < 0.05; ** P < 0.01; *** P < 0.001.
Chapter 3 Steroid receptor expression and modulation in Sertoli cells 128
** **
Control lOpM InM lOnM
DES concentration
lOOnM luM
Figure 3.15 Dose response in SK11 cells after DES treatment. SK11 cells were transiently
transfected with the 3x ERE-Luc reporter and the pRL-CMV Renilla internal control. Cells
were treated with a vehicle, or increasing concentrations of DES (lOpM to lpM). Results are
expressed as ± SEM (n=3). Statistical analysis was performed using one-way ANOVA, * P
< 0.05; ** P < 0.01; *** P < 0.001.
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3.3.4.3. Activation of an androgen response element in SK11 cells
As the cells were able to activate an oestrogen response element, a similar study was
carried out using the pem-Luc androgen responsive promoter-reporter construct to
investigate androgen responsiveness in the SKI 1 cells. Cells were co-transfected
with pem-Luc and the internal control Renilla plasmid then stimulated with either
testosterone or 17(3 oestradiol 4 hours after transfection to obtain a dose response. A
luciferase assay was performed and the results were normalised and expressed as a
fold increase compared to a no ligand control. A dose response curve was observed
when the cells were stimulated with increasing concentrations of testosterone (lOpM
to lp,M) with maximum response of 2.5 fold being seen with lOnM (Figure 3.16A).
The addition of E2 did not result in activation of the androgen response element at
any concentration of E2 added (Figure 3.16B).
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Figure 3.16 Androgen response in SK11 cells after ligand treatment. SK11 cells were
transiently transfected with a pem-Luc reporter and the pRL-CMV Renilla internal control.
Cells were treated with a vehicle, or increasing concentrations of (A) testosterone (lOpM to
lpM) or (B) 17(3 oestradiol (lOpM to lpM). Results are expressed as ± SEM (n=3).
Statistical analysis was performed using one-way ANOVA, * P < 0.05; ** P < 0.01; *** P <
0.001.
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3.3.5. Sequence specific knockdown using RNAi
The ability to knockdown the expression of ER|3 in the Sertoli cell is an exciting
prospect, and this is one of the main aims of this chapter. RNA interference presents
an opportunity to perform this but before it was carried out, the technique was
optimised by experiments designed to knockdown various control genes to check
that the use of this technique was a viable option.
3.3.5.1. Construction and transfection of control siRNA's
Control siRNA's for GFP, lamin, (3-tubulin and (3-actin were used to optimise
conditions for siRNA transfection. An siRNA to GFP was constructed using the
Silencer™ siRNA construction kit as detailed in section 2.12.2. Lamin A/C, a-
tubulin and (3-tubulin siRNA's were selected from the commercially available
control siRNA sequences published by Dharmacon. These sequences have been
shown to achieve high levels of knockdown in mammalian cells.
3.3.5.1.1. GFP
SK11 cells were transfected with a GFP expressing vector (pEGFP-Cl, Clontech).
Figure 3.18, panel A shows confocal images of the cells 48 hours after transfection
with the GFP vector. Using an in-vitro transcribed siRNA to GFP, GFP expression in
the cells was knocked down (Figure 3.17, panel B), shown by the absence of any
green cells. Another siRNA, specific for the GAPDH gene was transfected along
with GFP to show that non-specific knockdown was not occurring (Figure 3.17,
panel C). Expression ofGFP in these cells was unchanged showing that the reduction
in GFP levels observed in the test samples was due sequence specific knockdown.
3.3.5.1.2. Lamin A/C
SKll cells were transfected using a control siRNA for Lamin A/C supplied by
Dharmacon. 48 hours after transfection, the cells were fixed and immunostained
using an anti-lamin A/C antibody and observed using the confocal microscope
(Figure 3.18, panel B). The cells were counterstained with propidium iodide. No
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knockdown in lamin A/C expression in the SK11 cells was seen compared to
untransfected cells (Figure 3.18, panel A).
3.3.5.1.3. a-tubulin
SKI 1 cells were transfected using a control siRNA for a-tubulin provided by
Dharmacon. 48 hours after transfection, the cells were fixed and immunostained
using an anti-a-tubulin antibody and observed using the confocal microscope (Figure
3.19, panel B). The cells were counterstained with To-Pro3. A reduction in the
intensity of the a-tubulin staining in the SK11 cells was observed compared to
untransfected cells (Figure 3.19, panel A).
3.3.5.1.4. p-tubulin
SKll cells were transfected using a control siRNA for P-tubulin provided by
Dharmacon. The cells were fixed and immunostained 48 hours after transfection
using an anti-P-tubulin antibody and observed using the confocal microscope (Figure
3.20, panel B). The cells were counterstained with To-Pro3. High levels of
knockdown in P-tubulin protein expression in the SKI 1 cells was seen compared to
untransfected cells, shown in Figure 3.20, panel A.
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Figure 3.17 Knockdown of GFP expression in SKI 1 cells. Panel A shows cells transfected
with a GFP vector. Panel B shows a reduction in the expression of GFP after co-transfection
ofGFP and siGFP. Panel C shows calls transfected with GFP and an siRNA to Gapdh.
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Figure 3.18 Panel A shows SK11 cells immunostained using an anti-lamin A/C antibody
(blue) and counterstained with propidium iodide (red). Panel B shows SKI 1 cells transfected
with a siRNA to lamin A/C prior to immunostaining with an anti-lamin A/C antibody (blue)
and counterstained with propidium iodide (red).
Chapter 3 Steroid receptor expression and modulation in Sertoli cells 135
Figure 3.19 Panel A shows SK11 cells immunostained using an anti-a-tubulin antibody
(red) and counterstained with To-Pro3 (blue). Panel B shows SK11 cells transfected with a
siRNA to a-tubulin prior to immunostaining with an anti-a-tubulin antibody (red) and
counterstained with To-Pro3 (blue)
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Figure 3.20 Panel A shows SK11 cells immunostained using an anti-P-tubulin antibody (red)
and counterstained with To-Pro3 (blue). Panel B shows SKI 1 cells transfected with a siRNA
to p-tubulin prior to immunostaining with an anti-P-tubulin antibody (red) and
counterstained with To-Pro3 (blue)
Chapter 3 Steroid receptor expression and modulation in Sertoli cells 137
3.3.6. siRNA labelling
In order to ascertain whether the siRNA's were able to enter the cells and to track the
movement of the siRNA, two approaches were undertaken, the first involved
labelling the siRNA with a fluorescent marker, this enabled visualisation of the
siRNA after transfection. The second approach was to use a fluorescently labelled
transfection reagent in order to track the movement of the siRNA into the cells.
3.3.6.1. Visualisation of the entry of fluorescently labelled siRNA's
entry into SK11 cells
To check that the siRNA's were entering the cells, FAM labelled siRNAs for
GAPDH (control sequence) and ER(3 were transfected into cells and observed using
a confocal microscope 24 and 48 hours after transfection. It was seen that after 24
hours, the siRNAs accumulated in the cytoplasm near the nucleus (Figure 3.21 A and
C). By 48 hours post transfection the siRNAs appear in bright "spots" localized in
the cytoplasm in close proximity to the nuclear membrane (Figure 3.21, B and D).
3.3.6.2. Visualisation of the movement of siRNA into SK11 cells using
a fluorescently labelled transfection reagent.
Using a rhodamine labelled transfection reagent (Jet FluoR), siER|3 was introduced
into the SK11 cells. Figure 3.22A shows an accumulation of labelled transfection
reagent carrying the siRNA around the nucleus of the SK11 cells 24 hours post
transfection. Figure 3.22B shows cells transfected with the transfection reagent
alone. No accumulation of fluorescent label is shown around the cells, which were
counterstained with the nuclear stain To-Pro3.
Figure 3.21 Panels A and B show SKI 1 cells transfected with FAM labelled siER(3. C and D
show SK11 cells transfected with a control siGAPDH siRNA. Images were taken using a
LSM 510 confocal microscope 24 (A and C) and 48 hours (B and D) after transfection.
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Figure 3.22 Panel A shows SK11 cells transfected with siER(3 (red) using a rhodamine
labelled transfection reagent and counterstained using to-pro 3 (blue). 48 hours after
transfection, the siRNA has moved to the nuclear membrane of the cells. SiRNA. Panel B
shows cell transfected with the transfection reagent only (no siRNA) and counterstained with
To-Pro3 (blue).
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3.3.7. Targeted knockdown of ERp in SK11 cells
Once the technique had been shown to work effectively in the knockdown of control
genes in the SKI 1 cells, it was decided to attempt to knock down the expression of
ERp within the SKI 1 cells.
A linear siRNA was chosen from the murine ERp sequence as described in section
3.2.8.1. SKI 1 cells were transfected with ER(3-dsRed (section 3.2.7) and the siRNA
to ERp (section 3.2.8.4). 48 hours after transfection, the cells were visualised using
the confocal microscope and the expression of ERp protein was monitored using the
expression of dsRed in the cells (Figure 3.23B). Cells transfected with ERp-dsRed
alone were used as a control (Figure 3.23A). The cells were counter-stained with To-
Pro3 in order to visualise the nuclei of the cells. There was a reduction in the number
of cells expressing dsRed in the cells transfected with ERp-dsRed and siERp
compared to the cells transfected with ERp-dsRed alone. Any cells treated with
siERp that were fluorescing under the confocal microscope showed a reduction in
intensity of red fluorescence. Figure 3.23C shows cells transfected with ERp-dsRed
and sip-tubulin. No reduction in the expression of ERp-dsRed is seen in these cells
showing that the knockdown observed in the cells is sequence specific.
Following the observation that the linear siRNA was effective at knocking down
ERp expression in the SKI 1 cells, a short hairpin RNAi (shRNA) was designed
based on the linear siRNA sequence specific for ERp and constructed in the
pSilencer vector as described in section 2.12.6. Sequencing was performed to
confirm the presence of the siERp and the hairpin sequence and is shown in Figure
3.24A and B. The siERp sequence is underlined and shown in red. The hairpin
sequence is shown in blue and the Bam Hl/FIind III sites shown in green with a
portion of the pSilencer vector sequence surrounding the insert shown in black.
To test the efficiency of the shERp SKI 1 cells were transfected with ERp-dsRed and
shERp. Cells transfected with ERp-dsRed alone were used as a control and all cells
were counterstained with To-Pro3 to visualise cell nuclei. The cells were observed
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on a confocal microscope 48 hours after transfection. In the cells transfected with
shERp (Figure 3.25B), no red cells were observed showing that knockdown of ER|3
had been achieved in these cells using the hairpin vector. Figure 3.25, panel A shows
cells transfected with ER(3-dsRed alone showing expression of dsRed in these cells.




Figure 3.23 Confocal images showing knockdown of ER(3 protein using a siRNA to ER(3.
Panel A shows cells transfected with ERfl-dsRed. 48 hours after transfection. Panel B shows
cells transfected with ER(3-dsRed and siERp. Panel C shows SK11 cells transfected with
ER(3-dsRed and a non-specific siRNA to ^-tubulin. All cells were counterstained with To-
Pro3 nuclear stain (blue).
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Figure 3.24 A shows the sequence of the shERp hairpin containing pSilencer vector. The
siERp sense and antisense sequence are underlined and shown in red. The hairpin loop
sequence is shown in blue with the BamHl/EIindlll sites used to clone the hairpin insert
shown in green. A portion of the pSilencer sequence at either side of the insert is shown in
black. B shows how the hairpin folds up with the loop sequence shown in blue and the siERp
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Figure 3.25 Knockdown of ER|3 using a shRNA to ERfh Panel A shows cells transfected
with ER(3-dsRed. Panel B shows cells transfected with ERfl-dsRed (red) and shER(3. Images
taken 48 hours after transfection using a LSM 510 confocal microscope. Cells were
counterstained with To-Pro3 (blue).
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3.3.7.1. Knockdown of ERE response using RNAi in SK11 cells
3.3.7.1.1. Linear siERfi
It has previously been shown in this chapter that the addition of 17(3 oestradiol can
activate an ERE in the Sertoli cells after transient transfection (section 3.3.4.2). The
ability of siRNA to knock down this response was investigated by co-transfection of
a 3x ERE-luc construct (section 3.2.6) and the linear siRNA to ER(3 followed by
stimulation of the cells with increasing concentrations of 17(3 oestradiol (lOpM to
1 pM), luciferase activity was measured and fold increase in ERE response over
control (no ligand added) was determined. Figure 3.26 (blue bars) shows SKI 1 cells
transfected with ERE-Luc alone. A dose dependant increase in ERE activity is
observed upon addition of E2 with maximum response being seen at lOOnM E2. After
transfection of siER(3 alongside the ERE-Luc, no response to E2 is observed at any
concentration.
ER|3 mRNA levels were investigated after transfection with ERE-Luc and siER(3 by
TaqMan quantitative RT-PCR. Figure 3.27 shows SK11 cells transfected with ERE
alone (blue bars) with a dose dependant increase of ER(3 mRNA expression after
addition of E2 at increasing concentrations (lOpM to lpM). Transfection of the cells
with ERE-Luc and siER|3 resulted in the knockdown of ER(3 mRNA expression
(Figure 3.27, pink bars).
3.3.7.1.2. shERp
To establish whether the hairpin shER|3 is as effective in knocking down ER(3
expression in SK11 cells as the linear siRNA, the experiments were repeated using
the shER(3 vector. Activation of the 3x ERE-Luc construct with E2 was shown to
have been knocked down with the use of the shER|3 vector (Figure 3.28). Luciferase
activity was measured and fold increase in ERE response over control was
determined. Blue bars show the response of the cells to 17(3 oestradiol (lOpM to
1 pM) after transfection with the 3x ERE-Luc, which gives a maximum response with
Chapter 3 Steroid receptor expression and modulation in Sertoli cells 146
lOOnM E2. This response is knocked down after transfection with the shER|3 vector
as shown by the pink bars. No response to E2 is observed at any concentration.
Relative ER|3 expression after transfection with the ERE-Luc construct and shER|3
was measured by TaqMan RT-PCR and is shown in Figure 3.29 In agreement with
the luciferase assay results, ER(3 mRNA was reduced in the cells transfected with
ERE-Luc and shER(3 prior to stimulation with increasing concentrations of (lOpM to
1 p,M) E2 (pink bars) as compared to cells transfected with ERE-Luc followed by E2
stimulation with no shER(3 added (blue bars).
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Figure 3.26 Knockdown of ERE response in SK11 cells after transfection with siER|3. The
blue bars show the response of the SK11 cells transfected with a 3x ERE-Luc construct after
stimulation with increasing concentration of 170 oestradiol (E2). The pink bars show the
response of the SKI 1 cells transfected with a 3x ERE-Luc construct and a siRNA to ER|3
after stimulation with increasing concentration of 17(3 oestradiol. Results are ± SEM n=3.
Statistical analysis to compare differences between samples treated with siRNA and those
untreated was performed by the use of one-way ANOVA, ** p < 0.01; *** P < 0.001.
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Figure 3.27 Effect on ERp mRNA expression after transfection with a 3xERE-Luc reporter
construct and siERfi. Blue bars show an increase in ERp mRNA expression after stimulation
with increasing concentrations of E2. The pink bars show a reduction in ERp mRNA levels
after transfection of ERE-Luc and siERP followed by stimulation with increasing
concentrations of E2. Results are ± SEM n=3. Statistical analysis to compare differences
between samples treated with siRNA and those untreated was performed by the use of one¬
way ANOVA, *** P < 0.001.
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Figure 3.28 Knockdown of ERE response in SK11 cells after transfection with shER|3. The
blue bars show the response of the SKI 1 cells transfected with a 3x ERE-Luc construct after
treatment with increasing concentrations of E2. The pink bars show the response of the SKI 1
cells transfected with a 3x ERE-Luc construct and an shRNA to ERfl after stimulation with
increasing concentration of E2. Results are ± SEM n=3. Statistical analysis to compare
differences between samples treated with siRNA and those untreated was performed by the
use of one-way ANOVA, *** P < 0.001.


















Figure 3.29 Knockdown of ERE response to E2 in SK11 cells. Relative ERp mRNA
expression in reduced (pink bars) when SK11 cells are transfected with a 3x ERE-Luc
construct and shERfl then stimulated with increasing concentrations of E2 compared to cells
transfected with ERE alone prior to stimulation with E2 (blue bars). Results are ± SEM, n=3.
Statistical analysis to compare differences between samples treated with siRNA and those
untreated was performed by the use of one-way ANOVA, * P < 0.05; ** P < 0.01.
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3.3.7.2. Knockdown of ER|3 mRNA in SK11 cells using RNAi
The previous section (3.3.7.1) has shown that the cells response to oestrogenic
stimulation after transfection with an ERE-reporter construct can be blunted with the
use of RNA interference. The following experiments were performed to investigate
whether endogenous ER|3 levels within the SKI 1 cells could be knocked down using
RNAi, after oestrogenic stimulation.
3.3.7.2.1. siERp
Levels of ER|3 (without transfection of the ERE reported construct) after knockdown
using the linear siRNA to ER|3 were investigated using TaqMan quantitative
RT-PCR. Cells were transfected with siER|3 and stimulated with increasing
concentrations of E2 (lOpM to lpM) 48 hours later, RNA and cDNA was prepared
from the cells for Taqman analysis. ER|3 mRNA levels were compared to cells not
transfected with siER|3. ER|3 mRNA levels after stimulation with E2 is shown in
Figure 3.30 (blue bars). Unstimulated cells were used as a control. A dose dependant
increase of ER(3 mRNA is seen. This response is knocked down after transfection
with siRNA (Figure 3.30, pink bars).
3.3.7.2.2. shERp
Relative ER|3 amounts were determined in SK11 cells after transfection with the
shER|3 vector and stimulation with E2 by Taqman quantitative RT-PCR. Cells, both
transfected and untransfected with the shER|3 vector were stimulated with lOpM to
1 qM E2 for 48 hours. Unstimulated cells were used as a control. Again, a dose
dependant increase of ER|3 mRNA is seen after stimulation with E2 (Figure 3.31,
blue bars) and this response is knocked down after transfection with the shER|3
vector (Figure 3.31, pink bars)
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Figure 3.30 Reduction in ERf? mRNA levels in SK11 cells after transfection with siERfl.
Blue bars show relative ER(3 mRNA expression in cells stimulated for 48 hours with
increasing concentrations of 17p oestradiol (E2). Pink bars show relative ERp mRNA
expression in cells transfected with siERp then stimulated with increasing concentrations of
17(3 oestradiol (E2) for 48 hours. Results are ± SEM n=3. Statistical analysis to compare
differences between samples treated with siRNA and those untreated was performed by the
use of one-way ANOVA, *** P < 0.001.
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Figure 3.31 Reduction in ERp mRNA levels in SK11 cells after transfection with shERp.
Blue bars show relative ERp mRNA expression in cells stimulated for 48 hours with
increasing concentrations of 17p oestradiol (E2). Pink bars show relative ERp mRNA
expression in cells transfected with shERp then stimulated with increasing concentrations of
17p oestradiol (E2) for 48 hours. Results are ± SEM n=3. Statistical analysis to compare
differences between samples treated with siRNA and those untreated was performed by the
use of one-way ANOVA, *** P < 0.001.
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3.4. Discussion
In order to fully understand the role of the Sertoli cell in spermatogenesis, several
attempts have been made to create Sertoli cell lines. The current study has used one
of these, the SKI 1 cell line (Walther et al., 1996). Other cell lines, including the one
described by Hofmann et al have been shown to express various Sertoli cell products
including SCF, SGP-2 and GATA-1 (Hofmann et ah, 2003). However, this cell line
does not express androgen receptor or FSH receptor and as a result, this line is not
suitable for carrying out studies investigating the hormonal control of
spermatogenesis. The cell line TM4 (Mather, 1980) was derived from continued
passaging of testicular cells and is presumed to be of Sertoli cell origin. This cell line
does not show a differentiated phenotype and is therefore not ideal for studying
differentiated Sertoli cell function. Another cell line has been produced by
transfecting in expression vectors containing the FSH receptor in an attempt to get
the cells to express the receptor resulted in cells that were responsive to hormonal
stimulation but they do not proliferate in vitro and the cells do not behave as Sertoli
cells in vivo (Eskola et ah, 1998). Although no cell line will ever recreate the in vivo
situation exactly, looking at this evidence and the many other Sertoli lines described
in the literature, it seems apparent that the SKI 1 cell line shares many features
exhibited by Sertoli cells in vivo and is therefore a valuable tool in the study of
Sertoli cell function.
One of the main features of the SKI 1 cells is that they can be maintained in both an
undifferentiated and differentiated state. After differentiation of the cells, which
occurs after inactivation of the SV40 large-T antigen (Walther et ah, 1996), a
reduction in growth is observed and a morphological change in cell shape is seen.
This change in morphology was demonstrated after immunostaining for (3-actin
protein in the undifferentiated and differentiated cells, a change in the cytoskeletal
architecture was observed with an increased accumulation of [3-actin protein around
the nucleus of the differentiated cells. This is accompanied with an increase in |3-
actin mRNA expression in the differentiated SKI 1 cells.
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This chapter investigated the expression profile of the Sertoli cell line SKI 1 and
compared the expression of various Sertoli cell products in the cell line with Sertoli
cells within the intact mouse testis using RT-PCR and immunohistochemistry.
Sulphated glycoprotein (SGP-1), which is a secretory product of Sertoli cells
(Collard and Griswold, 1987) mRNA and protein was localised to the cytoplasm of
the mouse testis and in the SK11 cells, both differentiated and undifferentiated.
Androgen receptor, another well known Sertoli cell product was localised to the
nuclei of the SK11 cells and to Sertoli cell nuclei of fixed sections of mouse testis
and was shown to be expressed in higher levels in the differentiated cells. Androgen
receptor was also expressed in the Leydig cells and peritubular myoid cells of the
testis but expression was absent from the germ cells. This expression pattern is
consistent with previous studies that report expression of these genes in the Sertoli
cells of the mouse (Walther et al., 1996) and the results obtained in this study show
that the SKI 1 cells exhibit a molecular phenotype similar to that of Sertoli cells in
vivo even after being in culture for a prolonged period of time.
The expression of ER|3 and AR has been demonstrated in the SKI 1 cells in this
chapter. ER(3 is expressed in multiple cell types including Sertoli cells, in the dlO
and adult testis and in undifferentiated and differentiated SK11 cells. As previously
mentioned, AR expression in Sertoli cells is induced postnatally in the mouse. It was
observed in these studies that the differentiated SKI 1 cells expressed higher levels of
AR protein and mRNA compared with those maintained at 33°C (undifferentiated),
which fits with the observation that AR expression in the mouse testis increases after
Sertoli cell differentiation.
The fact that the SK11 cells express steroid hormone receptors suggested that they
would be responsive to oestrogens and androgens. This was demonstrated when the
cells were hormonally stimulated with either 17(3 oestradiol or testosterone. This
stimulation resulted in an increase in relative expression of both receptors as
determined by real time PCR. This was further tested by carrying out transient
transfections using both an oestrogen response element reporter construct and an
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androgen response element containing promoter construct. The results show that
upon addition of oestrogenic ligands, transcriptional activation of the ERE was
achieved. Previous studies using the human ER have indicated that different ligands
cause differing conformational changes in the receptor upon binding to the response
element resulting in varying levels of transcriptional activation (Hall et al., 2002). In
this study, six different oestrogenic ligands were added to the cells after they had
been transfected with an ERE reporter construct to investigate if the endogenous ER
in the SKI 1 cell line was functional. The results obtained showed that treatment with
lOOnM 17(3 oestradiol resulted in receptor-induced activation of transcription. This
effect was also demonstrated when the ligands DES and DPN were used. After
addition of genistein and 3(3 Adiol, an increase in transcription was obtained at a
ligand concentration of lqM. These results are consistent with the expression of ER(3
protein within the Sertoli cells.
Various studies have reported that ERa is not expressed in Sertoli cells in various
species (Saunders et al., 2001; Zhou et al., 2002). This study has shown the SK11
cell line does not express ERa mRNA or protein as demonstrated by RT-PCR and
immunohistochemistry. Further proof of the absence of the receptor was given when
the cells were transfected with the ERE reporter construct and stimulated with
PPT™. The results in this study have shown that this ERa specific ligand did not
activate gene transcription via the ERE upon transient transfection.
Cells were also transfected with an ARE containing reporter construct and stimulated
with testosterone; this induced an increase in expression of the reporter showing that
the cells contained a functional AR. No response was observed when the cells were
transfected and stimulated with E2. The levels of testosterone-induced response seen
after transfection were lower than expected, as these were preliminary results, further
work is required to optimise conditions for transfection. As it has been shown that
levels of androgen receptor increase in differentiated SK11 cells, it would be
interesting to see if higher levels of transcriptional activation after androgen
stimulation could be achieved in the cells after culture at 39°. Future work
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investigating the response of the SK11 cells using the androgen and oestrogen
response elements may help in understanding of the role of the androgen and
oestrogen receptors in the Sertoli cell and this in turn, may reveal information of the
relationship between androgens and oestrogens in the testis.
According to most studies, and the data presented in this chapter, male germ cells are
devoid of the androgen receptor (Bremner et al., 1994; Zhou et al., 2002), it is clear
however from evidence in the literature that androgens acting on Sertoli cells are
essential for efficient spermatogenesis.
Androgens and AR are required for normal spermatogenesis, yet AR is not expressed
in all cell types of the testis. Evidence for roles ofAR in spermatogenesis have been
shown through the study of AR-deficient mice (O'Shaughnessy et al., 2002; Yeh et
al., 2002), AR-deficient mice, both Tfm and ARKO, are infertile and display
feminized internal and external phenotypes but due to the developmental roles of
AR, removal of AR in the whole animal does not allow the study ofAR function in
specific cell types in the testis (de Krester and Kerr, 1994). Recent data involving the
development of a Sertoli cell specific androgen receptor knockout mouse (SCARKO)
gave proof that androgens are likely to be having an effect on spermatogenesis
indirectly via the Sertoli cells as removal of the receptor resulted in infertility
associated with a reduction in the numbers of spermatocytes and spermatids causing
impaired spermatogenesis (De Gendt et al., 2004). Soon after this report, another
conditional Sertoli cell androgen receptor knockout mouse was described, also
exhibiting infertility due to a spermatogenic arrest at the premeiotic diplotene
spermatocyte stage (Chang et al., 2004). These mice models demonstrate that the AR
in Sertoli cells is essential for the maintenance of fertility. As the Sertoli cells
express both AR and ERf3, interactions between the two receptors may be a major
regulatory force in the control of spermatogenesis but the data from the conditional
Sertoli cell knockouts clearly shows that even although ER|3 is co-expressed with AR
in Sertoli cells, it is not able to compensate for the loss of AR in the SCARKO mice
and the role of ER(3 in the Sertoli cell remains unknown.
Chapter 3 Steroid receptor expression and modulation in Sertoli cells 158
The information gained from knockout animals can be very valuable and with the
advent of conditional knockout technologies this has become even more exciting.
However, the production of such animals is time consuming and expensive and it
was with this in mind that studies using RNA interference was carried out in this
thesis. As described in chapter one, RNAi presents an opportunity to knockdown
gene expression in cells and tissues. In this study, the expression of ER|3 and AR was
attempted in the SK11 cells. Initial optimisation of the technique was carried out
using control sequences, which were claimed to give good knockdown in
mammalian cell lines. Using a sequence for GFP, knockdown of a transfected GFP
vector in the SKI 1 cells was seen by confocal microscopy. This was followed by
attempts to knockdown the cytoskeletal proteins a-tubulin, [3 tubulin and lamin A/C.
Out of these three siRNA's, only that directed against (3-tubulin showed a good level
of knockdown. This is an important observation, as it shows how published
sequences supposedly guaranteed to give knockdown do not always work. This could
be due to the cell lines or the method of staining used.
Visualisation of the siRNA moving into the cells using fluorescently labelled
siRNA's and transfection reagents was performed. These techniques allow the
intracellular delivery and trafficking of siRNA's and can be useful in determining if
any lack of knockdown observed is due to the siRNA not entering the cell. In the
case of GFP, GAPDH and ER(3, the movement of the siRNA was observed over a
period of time and the siRNA was seen to enter the cytoplasm and take up position
surrounding the nucleus of the cells. Once the technique was optimised, knockdown
of ER(3 and AR in the SK11 cells was attempted. An siRNA to ER(3 was chosen and
knockdown of ER(3 protein and mRNA was achieved in the SKI 1 cells. Using this
sequence, a short hairpin RNAi was constructed in the pSilencer vector, this was
seen to give slightly better levels of knockdown of ER|3 protein expression as shown
by confocal microscopy using a fluorescently tagged ER|3 transfected into the cells.
The ability of the cells to respond to E2 and induce expression of a 3x ERE reporter
construct after transfection with both the siER|3 and shER(3 constructs was also
investigated and knockdown of E2 induced transcriptional activation was achieved.
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These experiments showed that the induction of reporter gene expression was
blunted consistent with knockdown of endogenous ER(3 protein levels.
Little progress was made in achieving knockdown of androgen receptor mRNA in
SK11 cells. The design of an effective siRNA sequence can be "hit or miss" and in
this case, none of the sequences used showed any effect on the AR levels within the
cells. Further work will be required to design a sequence that is capable knocking
down endogenous AR in Sertoli cells.
One of the advantages of using plasmid delivered siRNA is that longer-term
knockdown can be achieved with the levels ofmRNA and protein remaining reduced
for up to 12 days. This effect would be advantageous if the technique was transferred
to in-vivo studies and used for direct injection of shRNA vectors into the testis. It
has been shown that adenoviruses are preferentially taken up by Sertoli cells (Scobey
et al., 2001). If an shRNA was cloned into an adenoviral vector then introduced into
the testis, the effects of knocking down AR/ER|3 specifically in the Sertoli cells
could be observed and it could be determined whether results are similar to that seen
in the SCARKO animals. These studies are planned.
The studies performed in this chapter have shown that the SK11 cell line is an
excellent system to study the effects of androgens and oestrogens on Sertoli cells and
to try and understand the role of steroid hormone receptors in the seminiferous
epithelium. The optimisation ofRNA interference technology in these cells has been
an important breakthrough in the use of this method for further understanding of the
process of spermatogenesis and further studies using this method should yield very
interesting results.
Chapter 4
Isolation, characterisation and in vitro differentiation of
murine spermatogonia! stem cells
4.1. Introduction
In the adult testis, spermatogonial stem cells are located on the basement membrane
of the seminiferous tubule. These cells divide to populate the testis with germ cells
that are committed either to a differentiation pathway or to maintain the stem cell
population (de Rooij, 2001; de Rooij and Grootegoed, 1998; Kent Hamra et al.,
2004; McLean et al., 2003; Oakberg, 1971). Spermatogonial stem cells and germ cell
development have been extensively studied in mice and a wide range of transgenic
mice exist with defects in spermatogenesis resulting in infertility or subfertility
(Cooke and Saunders, 2002; de Rooij and de Boer, 2003; Matzuk and Lamb, 2002).
These highlight the usefulness of using the mouse as a model for the understanding
of germ cell development.
4.1.1. Development of spermatogonia
Stem cells are the only cells that are capable of sustained self renewal (de Rooij and
Russell, 2000). Spermatogonial stem cells originate from primordial germ cells
(PGCs). By embryonic day 7 of mouse development, about 100 PGCs can be
detected in the extra-embryonic mesoderm, which lies posterior to the primitive
streak (Ginsburg et al., 1990). The PGCs migrate along the hindgut into the genital
ridges. The cells proliferate during migration and by the time they reach the genital
ridges, which is around embryonic day 13 in the mouse, they have increased in
number to about 10,000 cells in each gonad (Tarn and Snow, 1981). The PCGs are
arrested at the G0/G1 stage at around day embryonic day 16.5. Once in the genital
ridges, the PGCs are in close contact with the Sertoli cells and become enclosed in
the seminiferous cords, where they are termed gonocytes (Huckins and Clermont,
1968). Differences exist between PGCs and gonocytes. For example, gonocytes are
only able to survive in the presence of Sertoli cells but PGCs can be successfully
cultured with other cell types suggesting that gonocytes have a restricted
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differentiation potential (Resnick et al., 1992; van Dissel-Emiliani et al., 1993). The
mitotically quiescent gonocytes, re-enter the cell cycle shortly before birth and by
half a day after birth, gonocytes are uniformly round and separated from the
basement membrane (Clermont and Perey, 1957; Huckins and Clermont, 1968;
Vergouwen et al., 1991). The gonocytes then migrate to the basement membrane and
spermatogenesis begins with the differentiation of the cells to type A spermatogonia
(Bellve et al., 1977; Huckins and Clermont, 1968). This movement is thought to be
critical to ensure survival of these cells, as it has been observed that gonocytes
remaining in the centre of testis cords eventually degenerate (Hasthorpe et al., 1999).
It has been suggested by de Rooij (1998) that the gonocytes are a heterogeneous
population in which only some of cells retain stem cell properties while the others
are destined to enter the differentiation pathway during spermatogenesis (de Rooij
and Grootegoed, 1998). Figure 4.1 summarises the pattern of development that leads
to the formation of spermatogonia.
Stem cells exist in a specialized cellular compartment termed a "niche" that promotes
stem cell survival/maintenance and excludes factors that induce differentiation
(Schofield, 1978). The presence of such a niche in the testis was discovered during
the development of the germ cell transplantation technique (Shinohara et al., 2001).
After transplantation, stem cells migrate down into the tubule, passing through
Sertoli cell tight junctions to colonise sites on the basement membrane of the tubule
(Spradling et al., 2001). When a stem cell divides in its niche, only one daughter cell
can remain, the other cell will be committed to differentiate (Schofield, 1978). The
spermatogonial stem cell niche is defined in part by close associations with Sertoli
cells which line the basement membrane of the seminiferous tubules (Orth et al.,
2000; Ryu et al., 2003; Shinohara et al., 2001).
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Time schedule in the mouse
Primordial germ cells
1
Migration to genital ridge Up to E13
1






Arrest in G1/G0 phase From E16 onwards
1




Figure 4.1 Scheme of the development of the spermatogenic lineage from primordial germ
cells to type A spermatogonia in the mouse. Adapted from de Rooij (1998).
In the adult male, once type A spermatogonia are formed, further maturation of germ
cells occurs in three distinct phases, a proliferative phase where spermatogonia
undergo several mitotic divisions culminating in the onset of meiosis and the
differentiation into spermatocytes. After a lengthy meiotic prophase, the final meiotic
division results in the production of haploid spermatids. The final phase, termed
spermiogenesis is where the spermatids undergo structural remodelling. The nuclear
material becomes compacted and the spermatid elongates to form the spermatozoa
Chapter 4 Spermatogonia! stem cells 163
which will be released from the lumen of the tubule (Cooke and Saunders, 2002; de
Rooij, 2001; Sharpe, 1994).
4.1.2. Gene expression in spermatogonia
The testis contains many different types of spermatogonia with a small fraction of
these being stem cells. In recent years, the expression of specific markers has been
shown in the testis and the localisation pattern of such markers has been useful in the
identification of different populations of spermatogonia.
4.1.2.1. Oct-4
Oct-4 (also known as Oct-3) is a transcription factor that belongs to class V of the
POU (Pit, Oct, Unc) homeodomain family of transcriptional regulators (Rosner et al.,
1990; Scholer et ah, 1990). Oct-4 belongs to the sub-group of octamer-binding
proteins, which bind to promoter and enhancer regions of various genes via the POU
domain. Most POU domain transcription factors are developmentally-regulated in
mice (Hansis et ah, 2000). Oct-4 is expressed in murine embryonic cells, germ cells
(Palmieri et ah, 1994) and in cultured embryonic stem cells (Rosner et ah, 1990) but
is absent from trophectoderm cells (Palmieri et ah, 1994). Human OCT-4 orthologs
have been cloned and show high homology to murine Oct-4. Oct-4 is one of the
factors known to play an important role in the establishment and maintenance of the
mammalian totipotent cell population (Hansis et ah, 2000; Nichols et ah, 1998). As
totipotent cells differentiate, Oct-4 is downregulated (Pesce and Scholer, 2000). Oct-
4 expression has been detected in the postnatal mouse testis and it is thought to be
involved in the development of germ cells. A transgenic mouse created by inserting a
construct containing the Oct-4 genomic fragment with a GFP reporter gene was used
to demonstrate the germ-line expression of Oct-4. The pattern of Oct-4 protein
expression was shown to be expressed in the mitotically arrested prospermatogonia
in testes at late gestation and at birth in the mouse (Yoshimizu et ah, 1999). This
expression has also been reported to continue into type A spermatogonia and then be
down-regulated in type B spermatogonia and in spermatocytes in the adult testis
(Pesce et ah, 1998).
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As well as Oct-4, another transcription factor, Stat3 participates in the process of
embryonic stem cell renewal. It was thought that Oct-4/Stat3 were the main
regulatory factors involved in the process of ES cell self renewal but in 2003, studies
described another transcription factor, which was named "Nanog", and suggested
that this factor together with Oct-4 and Stat3 plays a crucial role in the process. In
particular, it was shown that Nanog overexpression reduces the differentiation
potential of mouse embryonic stem cells while Nanog deletion pushes ES cells to
differentiate (Chambers et al., 2003; Mitsui et al., 2003). It has been recently
reported that suppression of Oct-4 using RNA interference can affect the choice of
lineage of mouse embryonic stem cells, pushing the stem cells towards a
differentiated phenotype (Velkey and O'Shea, 2003).
4.1.2.2. c-kit
Studies investigating the role of the tyrosine kinase receptor c-kit and its ligand stem
cell factor (SCF, also known as Kit ligand) have shown the importance of these
factors for the normal development of spermatogonia. The c-kit gene is found on
mouse chromosome 5 and human chromosome 4 (Loveland and Schlatt, 1997).
During development, c-kit mRNA is expressed in PGCs from 7dpc in the mouse
indicating a role for c-kit/SCF in PGC migration (Manova et al., 1993). In mice,
mutations in genes encoding either c-kit or SCF result in infertility due to a loss of
germ cells (Besmer et al., 1993). In the postnatal testis, c-kit mRNA is found in
spermatogonia, spermatocytes and round spermatids as well as in the Leydig cells
(Manova et al., 1993). When c-kit binds to its ligand SCF, the receptor dimerises and
becomes autophosphorylated, initiating a signalling cascade which induces cell
growth and differentiation (Loveland and Schlatt, 1997). Two forms of SCF have
been identified, a soluble and a membrane bound form, both expressed by the Sertoli
cells (Rossi et al., 1991). In the mouse testis at birth, the membrane bound SCF is the
most abundant form found but as development progresses, the soluble form becomes
more prevalent (Manova et al., 1993). SCF is encoded at the SI locus by nine exons
in the mouse, rat and human (Brannan et al., 1992; Martin et al., 1990). It has been
shown that interactions between SCF/c-kit can modulate primordial germ cell
adhesion to somatic cells. It has been suggested that the role played by SCF in the
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promotion of survival, proliferation and migration of these cells in vitro and in vivo,
might depend on the ability of the membrane-bound form of this cytokine to mediate
primordial germ cell adhesion to the Sertoli cells (Pesce et al., 1997).
The importance of c-kit, which is encoded at the white spotting (W) locus (Chabot et
al., 1988; Manova et al., 1990; Matsui et al., 1990), was first discovered when an
anti-c-kit antibody (ACK2) was injected into adult male mice. This caused a
reduction in the number of differentiated spermatogonia (Packer et al., 1995). Using
the vitamin A deficient mouse which only contain A type spermatogonia, (van Pelt et
al., 1996), c-kit mRNA and protein expression in differentiated and undifferentiated
type A spermatogonia was investigated (Schrans-Stassen et al., 1999). It was shown
that As and Apr spermatogonia are c-kit negative while the Aai and Ai spermatogonia
are c-kit positive. The importance of the c-kit system in the germ cell is discussed
further in Chapter One, section 1.4.
4.1.2.3. Dazl
Dazl encodes an RNA binding protein essential for spermatogenesis (Ruggiu et al.,
1997; Schrans-Stassen et al., 2001). Dazl is expressed in the mouse testis from
embryonic day 12.5 and in the adult testis, expression of Dazl is seen mainly in the
spermatogonia and primary spermatocytes (Ruggiu et al., 1997). Adult Dazl
knockout mice are infertile and males lack germ cells apart from spermatogonia due
to failure of the Aai spermatogonia to differentiate into Ai spermatogonia (Ruggiu et
al., 1997). A recent report showed that germ cells from Dazl knockout males were
unable to progress beyond the leptotene stage of meiotic prophase I during the first
wave of spermatogenesis (Saunders et al., 2003).
4.1.2.4. GFRa-1
Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming
growth factor-P family (Lin et al., 1993). GDNF is produced by the Sertoli cells and
is thought to regulate the fate of undifferentiated spermatogonia, including
spermatogonial stem cells (Meng et al., 2000). GDNF binds to and activates a
receptor complex consisting of GDNF family receptor (GFR) and Ret receptor
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tyrosine kinase (Airaksinen and Saarma, 2002; Airaksinen et al., 1999; Saarma and
Sariola, 1999). A GDNF dimer first binds to a dimer of GFR-al, which dimerises
two molecules of Ret inducing transphosphorylation of the tyrosine kinase domains
(Sariola and Meng, 2003). In the testis, GDNF is expressed by the Sertoli cells.
GFRa-1 mRNA expression is restricted to undifferentiated spermatogonia and like
GDNF, its receptors show the highest levels of expression postnatally, remaining
detectable in the adult testis (Meng et ah, 2000). It has been observed that GFRa-1
positive spermatogonia are rare and are almost never found in close proximity to
other GFRa-1 positive spermatogonia (Dettin et ah, 2003; von Schonfeldt et ah,
2004).
Mice which have targeted deletions of GDNF (Moore et ah, 1996), GFR-al
(Enomoto et ah, 1998) or Ret (Schuchardt et ah, 1994) show similar phenotypes.
They exhibit normal testicular morphology but do not survive for more than a day
after birth due to severe defects in the renal system. The GDNF heterozygote mice
are fertile, but show degeneration of spermatogenesis resulting in a Sertoli-cell-only
histology in the tubules (Meng et ah, 2001). Transgenic mice which overexpress
GDNF in the testes under the control of the translation elongation factor 1 promoter
are infertile (Meng et ah, 2001), this promoter targets transgene expression
specifically to male germ line cells (Mizushima and Nagata, 1990). Overexpression
ofGDNF results in an accumulation of undifferentiated spermatogonia from 2 weeks
of age (Meng et ah, 2000). These undifferentiated cells form large clusters, which
express the germ line marker TRA98 and the spermatogonial marker EE2. No
expression of Sertoli or Leydig cell markers is seen and the clusters do not express c-
kit, which is a marker of differentiated spermatogonia (Meng et ah, 2000; Schrans-
Stassen et ah, 1999). From this information, it has been suggested that when GDNF
levels in the testis are low, spermatogonia will enter a differentiation pathway
however, at high levels, spermatogonia mainly self renew resulting in increased
numbers of stem spermatogonia (Meng et ah, 2000).
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4.1.2.5. Oestrogen receptor p
Oestrogens have been shown to inhibit the development of gonocytes, Leydig and
Sertoli cells in fetal rat testis in vitro (Lassurguere et al., 2003) however, a positive
direct effect of oestrogens on gonocyte development has been shown in purified
gonocyte cultures (Li et al., 1997). It has been previously shown that ER(3 is
expressed in the germ cells of the rodent testis (Saunders et al., 1998; Zhou et al.,
2002). A recent study by Delbes et al. (2004) has suggested that endogenous
oestrogens can inhibit germ cell growth in the male as |3ERKO neonates have more
gonocytes in their testis than wild-type littermates. This study also proposed that
oestrogens exert their effects on male fetal gametogenesis via ER|3 (Delbes et al.,
2004).
4.1.3. Identification and enrichment of spermatogonia! stem cells
Development of the germ cell transplantation technique by Brinster and colleagues in
1994 (described in detail in section 1.8) has provided a functional test for the
identification of spermatogonial stem cells (Brinster and Zimmermann, 1994;
Brinster and Avarbock, 1994). The efficiency of the technique has been significantly
improved by using populations of germ cells enriched for stem cells (Shinohara et
al., 2000). Examples include populations of germ cells obtained from young animals
or those isolated using immunobeads (Giuili et al., 2002; Shinohara et al., 1999;
Shinohara and Brinster, 2000). For example, in 1999 Shinohara et al. showed that
isolating germ cells expressing a6/|31 integrins, which were thought to be putative
stem cells, enhanced the efficiency of transplantation 166 fold. The same study
showed that selecting cells that expressed c-kit did not result in stem cell enrichment,
providing evidence that c-kit is a marker of differentiated spermatogonia but not
spermatogonial stem cells (Shinohara et al., 1999).
4.1.4. Germ cell lines
Several cell lines have been established from germ cells at various stages of
differentiation. The GC-1 and GC-2 cell lines were prepared by immortalisation of
spermatogonia and spermatocytes respectively (Hofmann et al., 1994; Hofmann et
al., 1992) with the GC-2 line being reported to undergo meiosis in vitro (Hofmann et
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al., 1994). Although subsequent investigation of the cell line showed that the cells
were no longer able to differentiate in vitro (Wolkowicz et al., 1996). A further germ
cell line, GC-4 has been characterised as being at the stage between preleptotene and
early pachytene spermatocytes (Tascou et al., 2000). To date, only two reports of cell
lines being established from rodent spermatogonial stem cells exist. In the first, a cell
line was established by transfecting As (stem cells), Apr and Aai spermatogonia from
the rat with the SV40 large T antigen. Two cell lines were established and upon
characterisation, were found to express the germ cell markers Hsp90 and Oct-4. No
expression of c-kit, normally expressed in differentiated spermatogonia could be
detected in either cell line (van Pelt et al., 2002). These cells were transplanted into
infertile mice and were seen to migrate to the basement membrane and re-colonise
the seminiferous epithelium. The second report came in 2002, with Feng et al.
showing that retroviral infection of mouse spermatogonia with telomerase could
immortalise the cells. The cells were shown to express the germ cell markers Oct-4
and culture with SCF induced the cells to differentiate. However, no transplantation
studies have been carried out in these cells, which would be a test of whether they
have maintained their stem cell characteristics (Feng et al., 2002).
4.1.5. RNA interference
RNA interference is a powerful tool that can cause sequence specific gene silencing
(Elbashir et al., 2001). The development of vector-based delivery systems has
allowed more stable expression of siRNAs. When placed in a vector, siRNAs are
expressed as fold-back hairpin-loop structures that give rise to siRNAs after
intracellular processing (Tuschl, 2002). Transfection of plasmid DNA, rather than
synthetic siRNAs, is advantageous in many ways, overcoming problems with RNase
contamination and the costs of chemically synthesized siRNAs or siRNA
transcription kits. By using a vector based delivery system, longer-term knockdown
can also be achieved.
Lipid-based transfection reagents are typically used for siRNA delivery in
immortalized cell lines. However these reagents have been shown to be inefficient
for siRNA delivery to most primary cell types and to cells grown in suspension.
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Electroporation has been used as an alternative to chemical transfection to deliver
siRNAs into primary cells in suspension and other hard-to-transfect cell types
(Walters and Jelinek, 2002) and involves applying an electric field pulse to induce
the formation of microscopic pores in the cell membrane which allow molecules,
ions, and water to traverse the membrane (Hamm et al., 2002). Under specific pulse
conditions, the pores reseal and the "electroporated" cells recover and resume
growth. A distinct advantage of electroporation over chemical methods is that it is
not dependent on cell division (Chu et al., 1987; Hamm et al., 2002).
Most existing electroporation protocols were developed to deliver plasmid DNA to
the cell nucleus but these protocols often result in high cell mortality (Chu et al.,
1987; Hamm et al., 2002). Since siRNAs only need to be delivered to the cytoplasm,
milder electroporation conditions can be used that minimize cell death but still
ensuring highly efficient siRNA delivery (Gehl, 2003). A report by Walters and
Jelinek (2002) investigated the knockdown efficiency of various transfection
methods on adherent and non-adherent cells, the study concluded that electroporation
was the most effective method of transfection for cells in suspension (Walters and
Jelinek, 2002).
4.1.6. Aims
The studies described in this chapter set out to initially investigate the expression
profile of 2 germ cell lines, GC-1 and GC-2. Following this, establishment of a
reliable method for the isolation of highly purified murine spermatogonial stem cells
was attempted. Cells were characterised by investigating whether they expressed
stem cell markers. The level of expression of ER|3 mRNA in total testis extracts
compared with isolated stem cells was determined using Q RT-PCR. RNA
interference was used to investigate the impact of targeted gene knockdown on the
differentiation status of the germ cells.
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4.2. Materials and Methods
4.2.1. Cell culture
The GC-1 and GC-2 germ cell lines were obtained from ECACC. The cells were
maintained in culture at 37°C in 5% (v/v) CO2 in complete media (sections 2.3.1 and
2.14.2). Passaging of cells was performed every 3-4 days by trypsinisation (section
2.3.2).
4.2.2. Sterile isolation of spermatogonia! stem cells
Sterile instruments and solutions were used throughout the procedure.
The animals were sacrificed by cervical dislocation or by inhalation of CO2. The
testes were removed from the animal and placed into Hanks Buffered Salt Solution
(HBSS; Gibco). Under a dissection microscope, the tunica albuginae was removed,
the tubules carefully pulled apart and placed in 4.5mls HBSS. All subsequent steps
were performed in a class II tissue culture hood and all incubations were carried out
at 34°C on a roller.
To the tubules, 500pl collagenase type IV (0.0lg in 1ml HBSS) (Sigma) was added
and incubated for 10 minutes. After incubation, the tubules were shaken gently
before incubating for a further 5 minutes at 34°C; 50ql DNase 1 (0.007g in 1ml
HBSS; Roche) was added to the tubules and incubated for 5 minutes. The cell
suspension was centrifuged for 5 minutes at 500g, the supernatant removed and
discarded and the cell pellet re-suspended in 4mls HBSS. This step was repeated
twice, 0.5ml trypsin (Gibco) and 0.5ml EDTA (Gibco) was added and the cell
suspension incubated for 10 minutes. The cells were shaken to obtain a single cell
suspension and 0.5ml fetal calf serum added to stop any further action of trypsin. The
cells were filtered through a 70qm mesh filter (Falcon), centrifuged at 500g for 5
minutes and resuspended in lOmls of supplemented EBSS (section 2.17.2) and a cell
count performed.
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4.2.3. Immunomagnetic bead sorting
Isolation of spermatogonial stem cells was performed using specific antibodies and
magnetic beads coated with secondary antibodies based on the method described by
van der Wee in 2001 (van der Wee et al., 2001). As discussed earlier (section 4.1.3),
spermatogonial stem cells are known to express the cell surface markers a-6 integrin
and GFRa-1. By using antibodies directed against these proteins, populations of cells
enhanced or depleted for these markers were collected. Cells, pre-incubated with
antibodies were removed from the cell suspension using a secondary antibody which
was conjugated to magnetic beads. By incubating the cells with the immunomagnetic
beads and placing in a magnet, beads with the attached cells adhere to the magnet
allowing removal from the total cell population. In this study M-450 sheep anti-
mouse IgG and M-450 Sheep anti-rat IgG Dynabeads® (Dynal) were used.
4.2.3.1. Cell separation - indirect technique
Cells were isolated from single cell suspensions as this increased the efficiency and
specificity of the sorting. The cells were adjusted to 10 million cells/ml in
supplemented EBSS (section 2.13.3). A sample of unsorted cells was taken at this
stage and stored for further analysis. The cell suspension was incubated with the
specific primary antibody; Table 4.1 shows antibodies used.
Antibody Species Supplier Dynabeads
a-6 integrin Rat BD Biosciences Sheep anti-rat IgG
GFR-a-1 Rabbit Autogen Bioclear Sheep anti-rabbit IgG
Table 4.1 Antibodies and dynabeads used for immunomagnetic cell sorting
Figure 4.2 shows the steps involved in the sorting process using a-6 integrin as an
example. The primary antibody was added in excess to block all antigen-binding
sites on the cell surface. The cells were incubated in 2p.g of primary antibody for 30
minutes at 4°C on a rocking platform. After incubation, the cells were centrifuged at
1000 rpm for 10 minutes and the supernatant containing unbound immunoglobulin,
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was discarded. Cells were resuspended in PBS containing 0.1% BSA; this step was
repeated twice to thoroughly wash the cells of any excess antibody. The cells were
incubated with the appropriate dynabeads (Table 4.1); lxlO7 dynabeads per ml of
sample were used giving approximately 4 beads per target cell. Before adding to the
cell suspension the required volume of dynabeads were washed as follows: beads
were vortexed and transferred into a washing tube and placed in the magnet (Dynal)
for 2 minutes. The buffer was removed and the tube was removed from the magnet.
An excess volume of PBS containing 0.1% BSA (Sigma) was added and the beads
resuspended. This washing step was repeated twice and the washed beads were
resuspended in PBS containing 0.1% BSA (Sigma) to a concentration of 1 x 107
beads per ml. The washed beads were added to the antibody-covered cells and the
mixture was incubated for 30 minutes at 4°C on a rocking platform.
After the incubation period, the cells/dynabead suspension was placed in the magnet
and allowed to stand for 2 minutes. The supernatant, which contained cells that
remained unbound to the beads (unbound fraction), was removed and stored. The
cells which were antibody/bead positive (bound fraction) were resuspended in PBS
containing 0.1% BSA and stored for further analysis.
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Figure 4.2 Immunomagnetic sorting of spermatogonial stem cells using anti a-6 integrin.
4.2.4. RNA extraction from cultured ceils, d8 mouse testis and
immunomagnetically sorted testicular cell populations
GC-1 and GC-2 cells were trypsinised as in section 2.3.2 and the resulting cell pellet
resuspended in TRI reagent as described in section 2.5. RNA was extracted from the
cells (section 2.5) for RT-PCR (section 4.2.5).
To investigate the expression of germ cell mRNA's expressed throughout the first
wave of spermatogenesis, RNA was extracted from testes obtained from wild type
mice aged from dO to adult as described in section 2.5 and used for RT-PCR using
germ cell specific primers.
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Sorted cells obtained through immunomagnetic bead sorting were centrifuged for 10
minutes at 1000 rpm. The supernatant was removed and lOOpl of TRI reagent
(Sigma) was added. The samples were vortexed and homogenised before RNA was
isolated using the procedure detailed in section 2.5.
4.2.5. RT-PCR and nested RT-PCR
Oligo dT primed cDNA was prepared using standard procedures as in section 2.6.
RT-PCR was carried out as detailed in section 2.6.2.2 with 40 cycles of amplification
using RedTaq DNA polymerase (Sigma). Primer sequences used for RT-PCR are
shown in Table 4.2 PCR products were run on a 2% agarose gel (section 2.7).










































Table 42 RT-PCR primer sequences
Because of the low abundance of target material, nested PCR was carried out on the
sorted cell populations. Nested PCR involves re-amplification of a PCR product
using primers designed to fall within the original amplified region. Table 4.3 shows
sequences of the nested primers used in this study.
Chapter 4 Spermatogonia! stem cells 175
The nested RT-PCR reaction was set up as follows:
lOx PCR buffer 2.5pl
dNTP's 0.5p]
Nested primer (Sense) 0.5pJ
Nested primer (Antisense) 0.5pJ
RedTaq DNA Polymerase 0.5pJ
H20 19pl
Initial PCR product 1 [14,1
TOTAL VOLUME 25[xl







Products were run on a 2% agarose gel (section) alongside lOObp DNA ladder
(Promega)































Table 4.3 Nested RT-PCR primer sequences
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4.2.6. TaqMan Q-RT-PCR
Quantitative RT- PCR (section 2.12) was carried out on the immunomagnetic bead
sorted cells using primers and probes designed for ER(3 (section 2.12.2) and Assay-
on Demand primer/probe systems for both Oct-4 and c-kit (Applied Biosystems,
section 2.13.4). Synthesis of cDNA, the Q-RT-PCR reaction and subsequent analysis
was carried out as detailed in sections 2.12.5, 2.12.6 and 2.12.7 respectively.
4.2.7. Immunohistochemistry
Expression of several germ cell markers was investigated using sections taken from
Bouins-fixed day 8 mouse testis (section 2.1.1). Immunohistochemistry was carried
out as in section 2.2.
4.2.8. Culture of sorted cell populations
Following isolation, the spermatogonial stem cells were counted and 4 x 106 cells
were seeded per 25cm2 flask. The cells were cultured in Dulbecco's modified Eagles
medium (DMEM) containing 10% (v/v) fetal calf serum, lOOmM non-essential
amino acids, 6mM glutamine, 50p,g/ml penicillin/streptomycin and 0.5mM sodium
pyruvate. The cells were maintained at 34°C with 5% CO2 in a humidified incubator.
To investigate the impact of feeder cells on the maintenance of spermatogonial stem
cells, the cells were co-cultured on a layer of STO cells (Ware and Axelrad, 1972),
which were obtained from ECACC. These cells were treated with mitomycin C to
inhibit cell division (section 4.2.8.1). Spermatogonial stem cells were plated at a
density of 1 x 105 cells/ml on top of the feeder layers.
Evaluation of the effect of soluble factors on the maintenance and differentiation
status of spermatogonial stem cells was carried out by the addition of the growth
factors leukaemia inhibitory factor (LIF) and stem cell factor (SCF) and the steroid
hormone 17|3 oestradiol to the cultured cells. LIF (murine recombinant, Chemicon)
and SCF (Chemicon) were added to the culture medium at a concentration of
50ng/ml and 30ng/ml respectively, 17(1 oestradiol was added to the cultures at a final
concentration of lOOnM. All three were added to the cultures at the start of the
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culture period, termed day 0. The medium was replaced with fresh medium
containing the supplements every 2 days and the cultures harvested after 7 days for
RNA extraction and TaqMan analysis.
4.2.8.1. Mitomycin C treatment
Mitomycin C is a potent inhibitor of DNA synthesis and nuclear division and was
used to block cell division during the production of feeder layers for the culture of
spermatogonial stem cells. STO cells (section 2.3.1) were used as feeder cells and
were 70-80% confluent at the time of treatment. Mitomycin C (Sigma) was dissolved
in water to a final concentration of lmg/ml and protected from light. Cell monolayers
were washed in PBS and 10ml fresh complete medium containing a final
concentration of 200pg/ml mitomycin C was added per T75 flask. The cells were
incubated at 37°C for 2.5 hours. After treatment, the media was removed and the
cells washed with PBS before trypsinisation (section 2.3.2) and counting. The cells
were plated onto gelatin coated flasks or dishes which were prepared by adding
enough of 0.1% gelatin to cover the base of the vessel. The gelatin was removed
after 1 hours of incubation at room temperature. Cells from one T75 flask were
plated onto two gelatinised T25 flasks or four 6cm gelatinised dishes and allowed to
attach overnight forming a feeder monolayer. Alternatively, the cells were frozen
down after mitomycin C treatment and trypsinisation in freezing medium (section
2.13.2) and stored in liquid nitrogen for future use.
4.2.9. RNA interference
4.2.9.1. Preparation of plasmid vectors containing short hairpin RNA
The pSilencer 3.0 HI vector (Ambion, section 2.11.5) was used to express siRNA's
specific for murine Oct-4 and ER|3. The Oct-4 hairpin oligonucleotides were
designed based on the 19mer hairpin sequence published by Velkey and O'Shea
(2003) and are shown in Table 4.4. The ER(3 sequence (Table 4.4) was based on a
linear siRNA sequence that had been shown to give knockdown in the SKI 1 cell
line. Details of the construction of the vector constructs are given in Chapter 2,
section 2.11.5.
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Gene Sense oligonucleotide 5'-» 3' Antisense oligonucleotide 5'-* 3'
Oct-4 GATCCGTTTCTGAAGTGCCCG AGC 1 111CCAAAAAAU111C1GAA
AAGTTGAAGAGACTTCGGGCA GTGCCCGAAGTCTCTTGAACTTC
CTTCAGAAAC111 1 1 1GGAAA GGGCACTTCAGAAACG
ER(3 GATCCAAGAAGATAATGGTCA AGCTTTTCCAAAAAAGAAGATAA
AGCTTCTCAAGAGAAAGCTTG TGGTCAAGCTTTCTCTTGAGAAG
CCATTATCTTCII1 1 1 1 GGAAA CTTGACCATTATCTTCG
Table 4.4 Oct-4 and ERp shRNA oligonucleotide sequences. The 19mer Oct-4 sequence
specific siRNA sequence (sense and antisense) is underlined and shown in red with the loop
sequence shown in blue.
The oligonucleotides were annealed and ligated into the pSilencer vector as
described in sections 2.11.5.1 and 2.11.5.2. The vector was then transformed into
XL-1 Blue competent cells as in section 2.11.5.3. Colonies were picked, grown up
overnight in medium and plasmid minipreps prepared as in section 2.8.6. Sequencing
was carried out to confirm the correct insertion of the siRNA insert into the plasmid
(section 2.9) before CsCl banding of large-scale plasmid preparations (section 2.10)
was performed.
4.2.9.2. Transfection of spermatogonia! stem cells with an shOct-4
vector using oligofectamine
Transfection of the spermatogonial stem cells with the shOct-4 vector was performed
using oligofectamine as described in section 2.11.3.1. RNA was harvested from the
cells (section 2.5) 2 or 6 days after transfection and cDNA prepared for TaqMan Q-
RT-PCR as described in section 2.12.6.
4.2.9.3. Culture of spermatogonial stem cells with an shOct-4 vector
Sorted cells were cultured in the presence or absence of 20nM shOct-4 for a total of
2 or 6 days. RNA was extracted from the cells and TaqMan quantitative RT-PCR
performed on the treated and untreated cells.
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4.2.9.4. Electroporation of spermatogonia! stem cells with shRNA
vectors
Spermatogonial stem cells were centrifuged at 500 rpm for 5 minutes and washed in
supplemented EBSS (section 2.15.1) before resuspension in 400pl EBSS (no
supplements). lOpg of shRNA vector was diluted in lOOpl EBSS and added to the
cells. The cell/shRNA mixture was transferred to a 0.4 cm electroporation cuvette
(Bio-Rad) and incubated for 10 minutes at room temperature before electroporation
at 250V, 950pF using the Gene Pulserll electroporation system (Bio-Rad). The cells
were incubated at room temperature for 20 minutes before being transferred into a 6
well plate containing pre-warmed (34°C) DMEM supplemented with 20% FCS,
lOOmM non essential amino acids, 6mM glutamine, 50pg/ml penicillin/streptomycin
and 0.5mM sodium pyruvate. The cells were maintained at 34°C with 5% CO2 in a
humidified incubator. The cells were harvested for RNA extraction 2 or 6 days later
as shown in Figure 4.3.
Time (days) dO d1 d2 d3 d4 d5 d6 d7
I
Isolation Electroporation RNA extraction RNA extraction
I
RNA extraction
Figure 4.3 Time scale of isolation, electroporation and RNA extraction in spermatogonial
stem cells electroporated with an shRNA vector.
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4.3. Results
4.3.1. Germ cell development during the first wave of spermatogenesis
The expression of various germ cell markers was investigated in extracts of mouse
testis obtained from day of birth until adulthood using RT-PCR with specific primer
pairs. Oct-4, c-kit and ER|3 mRNAs were all detected at all ages from dO up to
adulthood (Figure 4.4 A, B and C). RBM and Dazl were absent from the dO and d4
samples with expression of both markers being seen from d8 onwards (Figure 4.4 D
and E).
4.3.1.1. Immunohistochemical localisation of germ cell markers in the
immature mouse testis.
Protein expression ofOct-4, c-kit, RBM and ER|3 was demonstrated in testis sections
taken from 8-day-old mice. Immunopositive staining for c-kit (Figure 4.5 B) and
RBM (Figure 4.5 C) was germ cell specific in the 8-day-old testis.
Immunohistochemistry using an anti ER|3 antibody detected staining in the germ
cells as well as other cell types, including the Sertoli cells (Figure 4.5 D).
4.3.2. Expression of germ cell markers in GC-1 and GC-2 cells
The expression pattern of a selection of germ cell markers in the GC-1 and GC-2 cell
lines was determined by RT-PCR using specific primer pairs in order to compare the
cell lines with the in-vivo situation. In each case, adult testis was used as a positive
control. Expression of GAPDH a housekeeping gene was used to establish the
quality of RNA synthesised was observed in both cell lines (Figure 4.6 H). No
expression of Oct-4 was observed in either cell line (Figure 4.6 B). Expression of c-
kit, Dazl, RBM and LDH-C4, all germ cell markers was also absent (Figure 4.6 A, C,
D and G). The expression of the steroid hormone receptors ERa and ER|3 was then
investigated. Figure 4.6 E and F show the lack of any expression of the receptors in
the GC-1 and GC-2 cell lines.
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Dazl
261 bp
Figure 4.4 RT-PCR of mouse testis from dO-adult using specific primers for (A) Oct-4, (B)
c-kit, (C) ERp, (D) Dazl and (E) RBM. In all cases, M represents DNA ladder, lane 1
represents dO mouse testis, lane 2 d4, lane 3 d8, lane 4 d 12, lane 5 d 16, lane 6 d21, lane 7
adult and lane 8 negative control.
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Figure 4.5 Immunohistochemistry on 8-day-old mouse testis using antibodies specific for
c-kit (A) Oct-4 (B), RBM (C) and ERfJ (D) antibodies. Arrows point to immunopositive
germ cells.













Figure 4.6 Expression of germ cell markers expressed in GC-1 and GC-2 cells by RT-PCR
using specific primer pairs. (A) c-kit, (B) Oct-4, (C) Dazl, (D) RBM, (E) ERa, (F) ER(3 (G)
LDH-C4 and (H) GAPDH. In all cases, M represents DNA ladder, lane 1 is dlO mouse
testis, lane 2 is GC-1 cells, lane 3 is GC-2 cells and lane 4 is a negative control sample.
Chapter 4 Spermatogonia! stem cells 184
4.3.3. Isolation of spermatogonia using immunomagnetic beads
Once the expression pattern of spermatogonia had been established in the mouse, the
aim was to isolate a population of cells enriched for spermatogonial stem cells,
allowing more detailed evaluation of the spermatogonial stem cell without any
contamination with other cell types. To perform this, a total germ cell population
obtained from 8 day old mice was sorted using immunomagnetic bead sorting using
either an anti-GFRa-1 antibody or anti a-6 integrin antibody (section 4.2.2). After
sorting, a sample of each sorted population was placed on a glass slide and
photographed (Figure 4.7)
Due to the low amount of target mRNAs in the sorted cell populations, nested RT-
PCR was performed using primer pairs specific for Oct-4, c-kit, GFRa-1 and ER(3.
Expression of all the mRNAs was detected in the unsorted control sample (Figure
4.8). In the population of cells, which were bound to the beads, GFRa-1, Oct-4 and
ERp were all expressed, c-kit expression was seen in low levels in the bound
population of cells. No expression of Oct-4 or GFRa-1 mRNA expression was
detected in the population of germ cells which remained unbound after
immunomagnetic sorting. ER(3 was observed in the unsorted, bound and unbound
cell populations.
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Figure 4.7 A. and C show spermatogonial stem cells bound to immunomagnetic beads after
incubation with either anti-a6 integrin (A) or anti GFRal (C) antibodies. B and D show
cells that remained unbound to the immunomagnetic beads after sorting with either anti-a6
integrin (B) or anti GFRal (D). Black arrows point to the spermatogonia, white arrows point
to immunomagnetic beads.
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M T U/B B -ve
243 bp
M T U/B B -ve
Nanog
363 bp
M T U/B B -ve
Oct-4
327 bp
M T U/B B -ve
ER0 306 bp
Figure 4.8 RT-PCR analysis of bound, unbound and unsorted spermatogonia! cells using
primers for (A) c-kit, (B) GFRa-1, (C) Nanog, (D) Oct-4 and (E) ER(3. In all cases, M
represents DNA Hyperladder, T shows the unsorted population, U/B an unbound cell
population, B the magnetically bound population and -ve is the negative control.
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4.3.4. Quantification of mRNAs in sorted compared to unsorted germ
cell populations
The results from the semi-quantitative RT-PCR were not sensitive enough to
determine differences in mRNA levels between the sorted and unsorted cells. In
order to quantify the amount of specific mRNAs expressed in the sorted and unsorted
germ cell populations, TaqMan quantitative RT-PCR was performed using RNA
obtained from unsorted and immunomagnetic sorted, (bound, a-6 integrin positive
and unbound, a-6 negative) cells. RNA extraction and cDNA synthesis was carried
out and the expression of Oct-4 and c-kit mRNA was investigated in order to assess
the differentiation status of the bound and unbound populations.
4.3.4.1. Oct-4 mRNA expression
Compared to the unsorted population, the bound population showed a greater
proportion (1.7 fold increase compared to an unsorted population) of Oct-4 positive
cells were present in the sorted, bound, cell population than in the unbound, where
the levels ofOct-4 were almost undeterminable (Figure 4.9 panel A).
4.3.4.2. c-kit mRNA expression
Compared to the unsorted population, c-kit expression was greater in the unbound
cells (8-fold increase) than in the bound cells where the levels of c-kit were very low,
(Figure 4.9 panel B).
4.3.4.3. ERp mRNA expression
The expression of ER|3 mRNA was determined in the same bound, unbound and
unsorted cell populations used for the analysis of Oct-4 and c-kit mRNA expression.
Figure 4.9 C shows that the bound population of cells (thought to contain the stem
cell population) express more ER|3 mRNA than the unbound population (2 fold
compared to 1.3 fold over control).




















Figure 4.9 Panel A shows the relative amounts of Oct-4 mRNA in bound and unbound
spermatogonial stem cells isolated using immunomagnetic beads compared to an unsorted
population. The relative amounts of c-kit (panel B) and ER(3 (panel C) in the same
populations of cells are shown. Results are ± SEM n=3. Statistical analysis was performed
by the use of one-way ANOVA. * P < 0.05; ** P < 0.01: *** P < 0.001.
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4.3.5. Oct-4, c-kit and ERp expression in sorted cells after culture
In order to assess treatment effects in the sorted cells, the bound and unbound
populations were maintained in culture for up to 7 days (section 4.2.8). Oct-4 (Figure
4. 10A), c-kit (Figure 4.10 B), and ER|3 mRNA (Figure 4.10 C) levels as determined
by Taqman quantitative RT-PCR were assessed before and after the culture period to
check for any culture-induced changes in gene expression. After 7 days of culture, no
change in the levels of Oct-4 (Figure 4.10 A), c-kit (Figure 4.10 B) and ERp (Figure
4.10 C) mRNA levels was observed.
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dO dO bound d7 d7 bound
unbound unbound
Figure 4.10 Effect of culturing the spermatogonial cells for 7 days on the relative levels of
expression of Oct-4 (A), c-kit (B) and ER(3 (C) in sorted, bound cell populations at dO and d7
compared to an unsorted dO population. Results are ± SEM n=3. Statistical analysis was
performed by the use of one-way ANOVA.
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4.3.6. Impact of ligands, growth factors and feeder cells on the
differentiation status of the spermatogonia! stem ceil
The impact of ligands, growth factors and feeder cells that have previously been
suggested to play a role in the differentiation of stem cells was investigated using the
immunobead sorted cell populations. Cells were either cultured with LIF, SCF or E2
alone or on top of a feeder layer ofmitotically inactivated STO cells for 7 days prior
to RNA analysis and Taqman analysis.
4.3.6.1. LIF
Treatment with LIF, which has been shown to maintain stem cells in an
undifferentiated state, had no statistically significant effect on Oct-4 mRNA
expression in the sorted, bound cell population showing compared to an untreated,
sorted cell population (Figure 4.11 A). No change was observed in c-kit levels or
ER|3 mRNA levels (Figure 4.11 B and C) compared to the untreated sorted cell
population.
4.3.6.2. SCF
Culturing the sorted, bound population of cells for 7 days in the presence of SCF had
no effect on the expression of Oct-4 mRNA compared to pre-treatment cells (Figure
4.12 A). Treatment with SCF also resulted no statistically significant difference in
both c-kit and ER|3 mRNA expression (Figure 4.12 B and C) as shown by Taqman
quantitative RT-PCR.
4.3.6.3. 17p oestradiol
The effect of the exposure to 17(3 oestradiol on the differentiation status of the bound
cell population was investigated. The relative amounts of Oct-4, c-kit and ER|3
mRNA were not significantly different after treatment with E2 (Figure 4.13 A, B and
C).
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4.3.6.4. Co-culture with STO cells
After isolation and immunomagnetic sorting (section 4.2.2), the bound population
were cultured for 7 days on mitomycin-c treated STO cells (section 4.2.7.1). The
STO cells do not divide due to the mitomycin-c treatment and form a monolayer for
the cells to sit upon. After the culture period, RNA was extracted from the cells and
Taqman quantitative RT-PCR was performed and levels of Oct-4, c-kit and ER(3
mRNA levels were also measured in were cells maintained in culture for 7 days
without STO feeder cells and expression was compared to bound, uncultured
population (Figure 4.14). Levels of Oct-4 (Figure 4.14.A), c-kit (Figure 4.14.B) and
ER|3 (Figure 4.14 C) mRNA were found to be unchanged in the cells cultured on the
STO feeders.
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d7 sorted d7 sorted + LIF
Figure 4.11 Effect of 7 days of LIF treatment in culture on the relative levels ofOct-4 (A), c-
kit (B) and ER(3 (C) on sorted, bound cell populations compared to a bound, untreated
population. Results are ± SEM n=3. Statistical analysis was performed using a student's t-
test.





















d7 sorted d7 sorted + SCF
Figure 4.12 Effect of 7 days of SCF treatment in culture on the relative levels of Oct-4 (A),
c-kit (B) and ER|3 (C) on sorted, bound cell populations compared to a bound, untreated
population. Results are ± SEM n=3. Statistical analysis was performed using a student's t-
test.
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d7 sorted d7 sorted + E
Figure 4.13 Effect of 7 days of 17(3 oestradiol treatment in culture on the relative levels of
Oct-4 (A), c-kit (B) and ER|3 (C) on sorted, bound cell populations compared to a bound,
untreated population control. Results are ± SEM n=3. Statistical analysis was performed
using a student's t-test.
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d7 sorted d7 sorted + STO cells
Figure 4.14 Effect of 7 days of culture with or without STO feeder cells on the relative
levels of Oct-4 (A), c-kit (B) and ER|3 (C) on sorted, bound cell populations compared to a
uncultured, bound population. Results are ± SEM n=3. Statistical analysis was performed
using a students t-test.
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4.3.7. Impact of shRNA knockdown on the differentiation status of the
spermatogonia! stem cell
The experiments described in the previous sections (4.3.6) were designed to
investigate whether the cells could be pushed into differentiating or proliferating in
culture with the aid of various growth factors. As this was not achieved in this study,
the effect of targeted depletion of Oct-4 or ER(3 from the sorted cell population was
assessed using shRNAs designed for Oct-4 and ER(3 cloned into the pSilencer vector.
Sequencing was performed to confirm the presence of the siOct-4 and the hairpin
sequence (Figure 4.15). The siOct-4 sequence is underlined and shown in red. The
hairpin sequence is shown in blue and the Bam HI /Hind III sites shown in green
with a portion of the pSilencer sequence surrounding the insert shown in black.
Sequencing revealed a G-*C base change within the hairpin loop. As sequence
specific knockdown is not dependant on the loop sequence, only the siRNA
sequence, this error can be disregarded. The hairpin vector was introduced into
immunomagnetic bead sorted spermatogonial stem cells using transfection using
oligofectamine (Figure 4.16) or electroporation (Figure 4.17) 24 hours after cell
isolation. Total RNA was recovered from the cells 2 or 6 days later (total of 3 and 7
days in culture) and levels compared to those of sorted cells not treated with shRNA.
Relative expression of Oct-4, c-kit and ER(3 as determined by Taqman quantitative
RT-PCR established the effects of either Oct-4 or ER(3 knockdown on the
differentiation status of the cells.
4.3.7.1. Oct-4 shRNA
After 3 or 7 days in culture, Oct-4 mRNA levels were unchanged in the stem cell
population transfected with the shOct-4 vector using oligofectamine compared to
untransfected cells (Figure 4.16 A blue bars). No change in c-kit mRNA levels was
observed in the transfected cells (Figure 4.16 A pink bars). Cells cultured with the
shOct-4 vector did not show any alteration in Oct-4 mRNA (Figure 4.16 B, blue
bars) or c-kit mRNA (Figure 4.16 B, pink bars).
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After 3 or 7 days in culture, Oct-4 levels were successfully reduced in the stem cell
population which were electroporated with the shOct-4 containing plasmid compared
with un-electroporated cells (Figure 4.17, blue bars). Knockdown of Oct-4 was
associated with an increase in c-kit mRNA in the cells (Figure 4.17 A, pink bars).
The increase in the relative expression of c-kit in the sorted cells suggests that a
proportion of the cells may have differentiated. After Oct-4 knockdown, ER|3 mRNA
expression was reduced compared to that of the untransfected spermatogonial stem
cells (Figure 4 17 B).











GTT TCT GAA GTG CCC GAA G
CAA AGA CTT CAC GGG CTT C
Figure 4.15 A shows the sequence of the shOct-4 hairpin containing pSilencer vector. The
siOct-4 sense and antisense sequence are underlined and shown in red. The hairpin loop
sequence is shown in blue with the BamHl/Hindlll sites used to clone the hairpin insert
shown in green. A portion of the pSilencer sequence at either side of the insert is shown in
black. B shows how the hairpin folds up with the loop sequence shown in blue and the siER(3
sense and antisense sequences shown in red. In both cases, the G^»C base change within the
loop sequence is shown in brown and underlined.







































Figure 4.16 A shows the expression of Oct-4 (blue bars) and c-kit (pink bars) mRNAs in
sorted spermatogonial stem cells after transfection with shOct-4 using oligofectamine after 3
and 7 days in culture compared to an untransfected sorted cell population Results are ± SEM
n=3. B shows the expression of Oct-4 (blue bars) and c-kit (pink bars) mRNAs in sorted
spermatogonial stem cells after culture with shOct-4 after 3 and 7 days in culture compared
to an untreated sorted cell population Results are n=l. Statistical analysis was performed by
the use of one-way ANOVA. * P < 0.05; ** P < 0.01: *** P < 0.001.
























































Figure 4.17 Panel A shows the expression of Oct-4 (blue bars) and c-kit (pink bars) mRNAs
in sorted spermatogonial stem cells after electroporation with shOct-4 after 3 and 7 days in
culture (d3 and d7) compared to an un-electroporated sorted cell population. Panel B shows
relative ER|3 mRNA expression at d3 and d7 in the same cells after Oct-4 knockdown
compared to an untransfected sorted cell population. Results are ± SEM n=3. Statistical
analysis was performed by the use of one-way ANOVA. * P < 0.05; ** P < 0.01: *** P <
0.001.
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4.3.7.2. ER0 shRNA
As ER(3 was shown to be expressed in the stem cell population (section 4.3.4.3), the
effect of knocking down ER|3 levels within the sorted cell population was assessed
using an shRNA designed for ER|3. The hairpin vector was introduced into the cells
using electroporation. ER|3 mRNA levels were reduced in the sorted cells treated
with shER(3 both 3 and 7 days after electroporation (Figure 4.18), compared to a
sorted cell population which were not electroporated. Expression of Oct-4 (Figure
4.19 B, blue bars) and c-kit levels (Figure 4.19 B pink bars) in the same cells after
electroporation with shER(3 were unchanged compared un-electroporated cells.









Figure 4.18 Reduction in ER(3 mRNA levels after electroporation of sorted cell populations
with shER(3, 3 and 7 days after treatment, n = 1.








Figure 4.19 Oct-4 (blue bars) and c-kit (pink bars) mRNA levels in the sorted cell population
after electroporation with an shERp vector, n = 1.
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4.4. Discussion
Stem cells of different organs share many characteristics. For example, they usually
reside on the basement membrane and continue to self renew throughout adult life
(Spradling et al., 2001). Spermatogonial cell lines could greatly facilitate research on
spermatogonial stem cells, enabling analysis of mRNA and protein expression and
would allow investigations into mechanisms that regulate stem cell proliferation and
differentiation. Initial studies in this chapter used two germ cell lines, (GC-1 and
GC-2); the preparation of which was originally described about 10 years ago
(Hofmann et al., 1994; Hofmann et al., 1992). The GC-1 cells, when cultured
alongside immortalised Sertoli cells, Leydig cells and peritubular myoid cells, were
reported to form structures that resembled seminiferous tubules with the GC-1 cells
aggregating in the centre of the "tubule" with the Sertoli cells (Hofmann et al.,
1992). The GC-2 cell line, are under the control of the temperature sensitive SV40
large-T antigen and when cultured at the permissive temperature, the cells were
reported to undergo meiosis in vitro (Hofmann et al., 1994). This was demonstrated
by the use of flow cytometry, which showed a change in the cells from being a
diploid population to a cell line with a haploid DNA content (Hofmann et al., 1994).
However only two years later, it was discovered that over time, the cells had de¬
differentiated and the haploid phenotype of the cells was no longer seen. In the
present study RT-PCR analysis of both cell lines did not result in detection of any of
the germ cell markers previously identified in the cells (Wolkowicz et al., 1996).
Furthermore, semi-quantitative RT-PCR revealed that the GC-1 and GC-2 cells did
not express mRNA for the stem cell marker Oct-4. This result was not unexpected as
the GC-1 cells were derived from B-type spermatogonia and spermatocytes and the
GC-2 cells were reported to resemble spermatids. When the GC-1 cells were first
isolated they were reported to express alkaline phosphatase mRNA (Hofmann et al.,
1992), which is associated with germ cells (McCoshen and McCallion, 1975).
Although the results obtained confirmed that neither cell line expressed the expected
range of germ cell markers (e.g. c-kit, Dazl, rbm), the cells may still provide a useful
tool. For example, the cells did not express ER|3 and therefore represent a testicular
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cell line that was devoid of steroid receptors, which could be used for transfection
studies. Unfortunately, preliminary transfection studies using the GC-1 cells failed to
result in steroid responsiveness (not shown). This could have been due to problems
in the transfection procedure or because the cells did not contain the necessary
machinery to exert a response. The studies with this cell line were discontinued.
Following the preliminary work using the immortalised germ cells cell lines, further
investigations focussed on using spermatogonial stem cells which were freshly
isolated from the mouse testis. Testes from 8-day-old animals were used as the
source of germ cells for these studies because mice of this age have a higher
percentage of undifferentiated spermatogonia than adult animals. Analysis of 8 day
old testes using immunohistochemistry and RT-PCR detected the expression of both
the stem cell marker Oct-4 and the differentiated spermatogonial marker c-kit.
Studies carried out by Brinster and colleagues using germ cell transplantation
methods have demonstrated that the efficiency of the technique was improved when
cells were pre-selected using antibodies directed against the surface markers a-6 and
(31 integrin (Shinohara et al., 1999). As the only cells that will repopulate the testes
after germ cell transplantation are the spermatogonial stem cells, this data was taken
as evidence that these proteins were expressed on the surface of these cells. In the
present study taking this information into account, magnetic bead sorting was carried
out using anti a-6-integrin and anti GFRa-1 antibodies and the germ cell population
bound to the magnetic beads was characterised. The efficiency of both antibodies
was comparable so it was decided to conduct all subsequent experiments using the
anti a-6-integrin antibody
Semi-quantitative RT-PCR was not sensitive enough to pick up changes in the
mRNA levels within the sorted cell populations so quantitative RT-PCR was
performed by TaqMan. After immunomagnetic bead isolation, the bound population
of cells, presumed to contain the stem cell population, was analysed and the presence
of mRNA for the stem cell marker Oct-4 was confirmed. The amount of Oct-4
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mRNA was higher in this population than in the unbound population showing
evidence of successful isolation of the cells. The unbound population was assumed to
contain differentiated spermatogonia. Expression of c-kit mRNA within the putative
stem cell population was negligible and c-kit expression in the unbound population
was increased 8 fold compared to the pre-sorted population of cells. These results
confirm that cell sorting using immunomagnetic beads is an effective way of
isolating the Oct-4 positive, spermatogonial stem cell population. Furthermore, c-kit
mRNA was very low in this population of cells, which is in agreement with the
studies by Schrans-Stassen et al. (1999) and Shinohara et al. (1999) that reported
spermatogonial stem cells do not express c-kit.
The expression of ER|3 mRNA and protein has been reported to occur in the
testicular germ cells of rodents, primates and the human (Saunders et al., 1998;
Saunders et al., 2001; Zhou et al., 2002) however, it was not clear if the
spermatogonial stem cell population expressed ER(3. In the present study, the Oct-4
positive cell population was also positive for ER|3 mRNA and furthermore, the levels
were higher than in the unbound cells. These results demonstrate for the first time
that ERp is expressed in the murine spermatogonial stem cell population. Further
studies will be needed to establish if this is true of spermatogonial stem cells of other
species.
Many studies have shown that spermatogonial stem cells can be cultured for long
periods of time (Brinster and Nagano, 1998; Dirami et al., 1999; Kanatsu-Shinohara
et al., 2003; Nagano et al., 1998; Nagano et al., 2003; Parks et al., 2003). However,
attempts to make the cells proliferate have met with limited success suggesting that
either the proliferation rate of the stem cell population is very slow or the culture
conditions are suboptimal. Some of the studies described in this chapter have used
growth factors and feeder cells to investigate whether the differentiation status of the
cells could be manipulated. Previous studies have used similar approaches to
manipulate murine ES cells (Evans and Kaufman, 1981; Williams et al., 1988).
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In the present studies, before experiments were carried out investigating the effects
of growth factors, the expression of Oct-4, c-kit and ER|3 mRNAs were measured in
the cells both before and after culture for 3 or 7 days in medium alone. No
differences in the levels of expression were observed suggesting that the culture
system per se did not affect cell function.
The two growth factors chosen for study were LIF and SCF. LIF is commonly used
to maintain mouse embryonic stem cells in an undifferentiated state (Murray and
Edgar, 2001; Williams et ah, 1988). Culture on a feeder layer of fibroblast cells also
achieves the same result, with the removal of feeder cells or LIF from cultures
resulting in differentiation of the cells (Evans and Kaufman, 1981). SCF is a Sertoli
cell-produced paracrine regulator and acts as a survival factor for spermatogonia in
the rat and pig (Dirami et al., 1999; Hakovirta et al., 1999). It has been shown that
the spermatogonial stem cell proliferation can be significantly enhanced by the
addition of SCF at 30 ng/ml (Yin and Li, 2002), furthermore, SCF has been shown to
stimulate DNA synthesis in spermatogonial cells (Rossi et al., 1993). In the newt,
recombinant human SCF was found to stimulate spermatogonial proliferation, but
not the initiation of meiosis (Abe et al., 2002).
Addition of LIF to the sorted, bound cells did not result in any change in the
expression ofOct-4, c-kit or ER(3 mRNA suggesting that LIF does not alter the status
of the stem cell population. This finding would be consistent with maintenance of
stem cell characteristics by LIF which has been shown for ES cells (Williams et al.,
1988). Addition of SCF to the cultured cells resulted no change in Oct-4 mRNA
expression. Expression of ER(3 mRNA was also unaltered. Although not significant,
slight changes in mRNA expression were observed and more studies will have to be
performed in order to increase n numbers to deterime whether a statistically
significant difference can be observed to assess if cells are differentiating. A study
performed by Godin et al. in 1991 using an in vitro assay system, showed that
treatment of PGCs isolated from wild-type mouse embryos with SCF increased the
number of PGCs (Godin et al., 1991) so it is also possible that the increase in c-kit
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levels is due to an overall increase in cell number. This aspect could be investigated
using cell proliferation studies. As well as supporting the maintenance of stem cells,
additional roles for LIF and SCF have been proposed. The study by Pesce et al., in
1993 reported that treatment with LIF or SCF prevented proliferating PGCs from
undergoing apoptosis in vitro. It is speculated that failure of this apoptotic event in
vivo could result in an accumulation of aberrant survival of germ cells, which in turn
could lead to the development of teratocarcinoma stem cells (Pesce et al., 1993). This
information could be important in investigations into the causes of germ cell cancers
in the testis, which are believed to be associated with problems in the differentiation
and proliferation of spermatogonial stem cells.
Oestrogens have been shown to inhibit the development of gonocytes and Leydig
and Sertoli cells in fetal rat testis in vitro (Lassurguere et al., 2003). However, other
studies using isolated neonatal gonocytes, have reported that oestrogens can have a
positive effect on gonocytes development (Li et al., 1997). The studies carried out by
Atanassova et al. in 2000 in the rat have provided evidence that although high doses
of potent oestrogens, such as DES, are inhibitory to testicular development, and
treatment with low doses result in a stimulatory effect (Atanassova et al., 2000). It
has been also been shown that 17(3 oestradiol can stimulate spermatogonial stem cell
renewal in the Japanese eel (Miura et al., 1999). It is with this background, combined
with the evidence presented in this thesis that ER(3 mRNA is expressed in the
spermatogonial stem cell population in the prepubertal testis that the effect of adding
17(3 oestradiol to cultured murine spermatogonial stem cells was investigated. In
these experiments, although amounts of Oct-4 and ER(3 mRNA were slightly
increased by addition of 17(3 oestradiol, this was not statistically significant. No
change was observed in c-kit mRNA expression suggesting that oestrogen exposure
did not induce stem cells to differentiate and increases in mRNAs may therefore be
due to an increased numbers of cells. Further studies are required to determine if this
is the cause.
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Murine and human ES cells are commonly grown on a feeder layer of fibroblast
cells. These cells secrete factors that maintain the undifferentiated phenotype of the
cells. Culturing the cells on a feeder layer of STO fibroblasts had no effect on the
relative expression of Oct-4, c-kit or ER(3 and therefore had no effect on the
differentiation status of the cells. It has been proposed that LIF is one of the factors
secreted by feeder fibroblasts as mouse ES cells grown on feeders do not require
exogenous LIF in order to remain undifferentiated. However, totipotentiality of
human ES cells does not depend totally on LIF (Thomson et al., 1998) and it has also
been shown that maintenance of totipotency in human ES cells is STAT3
independent (Humphrey et al., 2004) indicating that in the human, LIF is not
involved in the maintenance of undifferentiated cells suggesting that other factors
secreted by the feeder cells may contribute to their maintenance. Similar findings
have been reported in the primate where it has been shown that the LIF/STAT3
pathway functions in embryonic stem cells made from cynomolgus monkeys but this
system is not essential for the maintenance of self-renewal. These studies together
suggest that the primate ES cells are also maintained in an undifferentiated state
through LIF/STAT3-independent signalling (Sumi et al., 2004).
The study by Velkey and O'Shea in 2003 demonstrated that in vitro differentiation of
murine ES cells could be induced by RNA interference. They showed that when Oct-
4 expression was knocked down in the cells using a short hairpin RNA specific to
Oct-4, this triggered differentiation of the cells containing the shRNA into
trophectoderm cells (Velkey and O'Shea, 2003). In the current study, knockdown of
Oct-4 mRNA using a plasmid vector containing an shRNA based on the one
published by Velkey and O'Shea was carried out on the using the putative
spermatogonial Oct-4 positive stem cell population. After the vector was constructed,
a single base change was detected in the hairpin loop section of the insert. As this
part of the hairpin should have no effect on gene silencing (only the sequence
specific Oct-4 19mer sequence causes knockdown), it was decided to proceed with
this vector. Transfection of the cells using oligofectamine, a standard transfection
reagent, had no effect on the levels of Oct-4 mRNA in the cells. Incubating the cells
with the shRNA alone also had no effect on Oct-4 mRNA expression. However, after
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electoporation, a reduction in the expression of Oct-4 mRNA was observed at both
time points (3 and 7 days). In the same cells, this was accompanied by an increase in
the expression of c-kit mRNA showing that by reducing the expression of Oct-4,
cells in the stem cell population had entered a differentiation pathway. When the
expression of ER|3 mRNA was investigated, it was shown that at both time points, a
reduction in Oct-4 was accompanied by a reduction in ER(3 mRNA. This result
supports the finding that the Oct-4 positive stem cell population express higher levels
of ER|3 mRNA than the c-kit positive differentiated spermatogonial population.
Further experiments could be carried out to try and block Oct-4 knockdown induced
cell differentiation using LIF or other compounds. The molecular mechanisms
necessary for maintenance of self-renewal in response to LIF signalling have been
investigated using murine ES cells. To date, Stat3 and Nanog (Chambers et al., 2003;
Mitsui et al., 2003) together with Oct-4 seem to play key roles (Niwa, 2001). Further
studies using siRNA to independently manipulate levels of expression of Nanog and
STAT3 in spermatogonial stem cells are planned.
After electroporation with the shER(3 containing vector, ER|3 levels in the sorted cell
population were reduced showing that the hairpin vector was causing sequence
specific knockdown of receptor levels. The reduction in ER(3 had no effect on the
levels of Oct-4 or c-kit suggesting that ER|3, although present in the stem cell
population, does not play a role in the regulation of differentiation. What role ER(3
plays in the spermatogonial stem cell remains unknown and further studies are
planned to investigate this.
In conclusion, the studies performed in this chapter have shown that the
spermatogonial stem cell population can be isolated and successfully enriched using
immunomagnetic beads. This population, which has been shown for the first time to
be ER|3 positive can be manipulated using RNA interference and can be induced to




Spermatogenesis, the process whereby diploid spermatogonia! stem cells divide and
differentiate to become mature spermatozoa is a precisely regulated process in which
the germ cells closely interact with the somatic Sertoli cells of the testis. These
interactions between germ cells and Sertoli cells play a major role in the
establishment and maintenance of spermatogenesis and fertility in the male. Steroid
hormones regulate cell function via receptors, which are expressed within their target
tissues. Both oestrogen receptors (a and (3) and the androgen receptor (AR) have
been immunolocalised to the male reproductive tract of many species. Sertoli cells
express both ER|3 and AR while murine germ cells only express ER(3 (Bremner et
al., 1994; McKinnell et al., 2001; Nie et al., 2002; Saunders et ah, 1998; Saunders et
ah, 2001; Zhou et ah, 2002).
5.2. Role of steroid hormones in spermatogenesis
The generation of knockout mice for the steroid hormone receptors and the enzymes
responsible for steroid synthesis gave new insight to how these function within the
reproductive system (Couse et ah, 1999; Dupont et ah, 2000; Eddy et ah, 1996;
Fisher et ah, 1998; Krege et ah, 1998; Lubahn et ah, 1993; Yeh et ah, 2002). In the
case of the oestrogen receptor knockout animals, male ERa knockout mice (ERKO)
are infertile and have major abnormalities in the seminiferous epithelium. ERa is
expressed in high levels in the efferent ducts of most species and the knockouts
exhibit atrophic testes caused by abnormal fluid reabsorbtion in the efferent ductules
resulting in impaired spermatogenesis (Lubahn et ah, 1993). Male ER|3 knockout
mice ((3ERKO) (Dupont et ah, 2000; Krege et ah, 1998) are fertile and show no
major alterations in reproductive tract function (Couse and Korach, 1999). In
humans, one ERa deficient patient has been described: this patient had a normal
sperm count but the viability of the sperm was reduced (Smith et ah, 1994). To date
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no individuals lacking ER|3 have been identified although polymorphisms in the ER|3
gene have been associated with some fertility problems in women as well as
problems in the bone and with blood pressure (Ogawa et al., 2000a; Ogawa et al.,
2000b; Sundarrajan et al., 2001). Studies using the double knockout ERa|3KO mice
have suggested that the primary role of ER(3 is to modulate gene regulation via ERa
(Weihua et ah, 2000). Studies in the hpg mouse have suggested that treatment with
oestrogen is sufficient to restore spermatogenesis (Ebling et ah, 2000). A number of
patients with defects in the aromatase gene have been identified and mouse models
with a targeted deletion of the cyp 19 gene created (Fisher et ah, 1998; Murata et ah,
2002; Robertson et ah, 2001; Toda et ah, 2001). Notably, ArKO male mice, which
lack the ability to synthesise oestrogen, become infertile and show an increase in
levels of apoptosis in round spermatids. The phenotype of these mice is in marked
contrast to the double ERKO/pERKO male mice, which have a phenotype
resembling the ERKO male (showing dilation of the seminiferous tubules, and
ovaries in which the granulosa cells develop characteristics of Sertoli cells (Couse et
ah, 1999; Dupont et ah, 2000)). Excess amounts of oestrogens, occur in the EST
knockout mice; these animals suffer from a progressive and age dependant reduction
in fertility caused by unmetabolised oestrogen (Qian et ah, 2001; Tong and Song,
2002). Flowever, given the variation in the results obtained with the different murine
models and the gross disturbance in the levels of other hormones (gonadotrophins
and androgens) seen in some cases, questions remain as to the exact role of
oestrogens in the regulation of spermatogenesis.
In humans, the absence of the X-linked AR gene results in androgen insensitivity
syndrome, this condition describes a range of phenotypic abnormalities of male
sexual development in humans, which are described fully in the review by Quigley
(1995). Male patients present with predominantly female phenotypic development
and are infertile (Quigley et ah, 1995). Mice with naturally occurring mutations in
AR (Charest et ah, 1991; Murphy et ah, 1994) as well as those in which complete
ablation of AR has been induced by cross-breeding mice containing a floxed AR
allele with mice expressing CRE recombinase under the control of a ubiquitous
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promoter (Chang et al., 2004; De Gendt et al., 2004; Holdcraft and Braun, 2004)
have been described. In both cases, germ cell development had been impaired and
very few haploid cells were found. The mice developed an abnormal urogenital tract
with the testis failing to descend into the scrotum and the mice were infertile.
Because cryptorchidism in mice results in impaired spermatogenesis associated with
meiotic arrest of the germ cells, it is unclear whether the loss of the androgen
receptor is causing the defect in spermatogenesis or if it merely a consequence of the
cryptorchidism (Holdcraft and Braun, 2004). The results obtained from the study of
the selective Sertoli cell knockouts clearly show that it is the loss of AR that causes
fertility problems in these animals; the testis are correctly positioned in the testis but
still show impaired spermatogenesis (Chang et al., 2004; De Gendt et al., 2004).
These findings demonstrate a clear role for AR expression in Sertoli cells influencing
germ cell function in adulthood. Whether local oestrogen biosynthesis and/or
expression of ER(3 in testicular cells play a role in male fertility remains a topic for
debate as yet no cell selective knockouts of ER(3 have been attempted.
5.3. Findings of this thesis
This studies described in this thesis set out to investigate the role of steroid
hormones, in particular oestrogens, in modulating the function of germ cells and the
somatic cells of the testis in an attempt to achieve better understanding of how
oestrogens might contribute to the process of spermatogenesis and male fertility.
During the course of the studies presented in this thesis, techniques for the
application of RNA interference in mammalian systems were first described
(Elbashir et al., 2001). As this presented a way to actively manipulate gene
expression in the cells under study, this technique was utilised and has proved to be
very useful in the current studies for reducing the levels of specific genes in both
germ cells and Sertoli cells.
In Chapter 3, studies focussed on the role of steroid hormones in Sertoli cell
function. The studies in this chapter were carried out using the SK11 cell line
(Walther et al., 1996), and the results obtained highlighted the usefulness of this cell
line in the study of the Sertoli cell in vitro. One of the advantages of using these cells
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is that they can be maintained in both an undifferentiated and differentiated state due
to the presence of the SV40 large T antigen. Initial characterisation of the cells
showed that although they had been in use in our laboratory for several years, they
still expressed many proteins identified in Sertoli cells in vivo including both ER(3
and AR. The expression of both receptors in these cells made it possible to conduct
studies in which the steroid responsiveness of the cells was tested. Androgen
stimulation led to an increase in AR mRNA as shown by TaqMan RT-PCR.
Similarly, stimulation with 17(3 oestradiol led to an increase in ER(3 mRNA. Reporter
constructs containing EREs or AREs were activated following addition of steroid
ligands in the cells. Therefore a key finding from the current experiments was that
not only did the SK11 cells contain a functional ER(3 and AR, but also that one
consequence of ligand stimulation was a direct up-regulation of their respective
receptor genes. Further studies are required to see if this also occurs in vivo but if it
does, it could have consequences for the impact of steroids on testicular function.
RNA interference by means of a linear siRNA, as well as an shRNA delivered in a
plasmid vector, was effective in inducing target selective knockdown of ER(3 in the
Sertoli cells. The increase in expression of ER13 mRNA that is usually observed
following exposure of cells to oestradiol was blocked and no activation of the ERE
containing reporter was observed. Attempts to perform similar experiments with the
androgen receptor failed, as an effective siAR sequence was not found in the course
of these investigations. These findings illustrate that although RNA interference can
be an effective technique, currently there are limitations in our ability to pick the
correct sequence for targeting with 100% success. New algorithms are being tested
and better web based design tools have already become available so it is likely that a
suitable sequence to target AR will be found.
In addition, silencing gene expression by RNAi requires efficient delivery of siRNAs
into cells and this can be particularly problematic when primary cells or tissue
fragments are being used. New methods focussing on delivery of shRNAs in viral
vectors in vitro and in vivo (Barton and Medzhitov, 2002; Devroe and Silver, 2002;
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Tiscornia et al., 2003) have recently been described. In the context of the current
studies it is notable that injection of adenoviral vectors directly into the testis results
in a preferential uptake in somatic cells (Blanchard and Boekelheide, 1997; Scobey
et al., 2001). Additional studies using adenoviral vectors have confirmed that the
route of injection has an effect on the uptake of the virus. After an intratubular
injection, adenoviral transgene expression was observed in the Sertoli cells, however,
after intratesticular injection, adenoviral expression was observed only in the Leydig
cells (Kojima et al., 2003). No germ cell expression of the adenovirus was observed
in either study demonstrating that delivery of an shRNA in an adenoviral vector
could be a useful way to directly target gene expression in the somatic cells of the
testis.
A further example of how viral vectors can be used to target Sertoli cells has been
reported using the SI (Steel, Kit-ligand deficient) mutant mouse, which is infertile
due to defective Sertoli cells. In this case, an adenoviral vector carrying the SI gene
was able to partially rescue spermatogenesis resulting in production of round
spermatids and spermatozoa in the seminiferous tubules. After intracytoplasmic
sperm injection (ICSI), normal fertile offspring were produced. (Kanatsu-Shinohara
et al., 2002). Importantly, the offspring did not show any germline transmission of
the adenoviral DNA giving evidence that adenovirus-mediated gene transfer has a
minimal risk for male germline transmission which is a factor to consider if these
treatments were ever to be transferred to a human clinical situation. A similar study
was carried out investigating restoration of kit ligand in Sertoli cells using lentiviral
gene transfer (Ikawa et al., 2002). Again, restoration of spermatogenesis was
observed and after ICSI, none of the offspring carried the lentiviral transgene. This
opens up the possibility that introduction of shRNA via a lentiviral vector could offer
an alternative to the adenoviral method.
Using this information and the results presented in this thesis, adenoviral mediated
delivery of siRNA seems to be an exciting way to both target and knockdown
expression of ER(3 or AR in the Sertoli cells of the testis, in vivo. By knocking down
each receptor in turn, investigations into what effect this would have on signalling
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via the other receptor could be carried out. This approach could help us determine
whether ER/AR crosstalk is occurring in the Sertoli cell and this will be the subject
of future experiments.
Chapter 4 of this thesis focussed on the spermatogonial populations of the murine
testis. Spermatogenesis depends on the ability of the subpopulation of
spermatogonial stem cells to divide and to embark on the process of differentiation,
which ultimately leads to the production of mature spermatozoa. The stem cell
population must also remain stable in number throughout adult life. To date our
ability to understand the process of germ cell development has been hindered by the
limited availability of cells which can be studied in vitro. In the course ofmy studies
I found that neither the GC-1 and GC-2 germ cell lines had maintained
characteristics of the germ cells from which they were originally derived. The most
promising report of a spermatogonial stem cell line came in 2002. The cells, which
were immortalised using telomerase, were shown to maintain stem cell
characteristics (Oct-4 expression, diploid phenotype) after many months in culture
(Feng et al., 2002). However, to date, no transplantation studies have been carried
out on these cells, which would be the true test of whether they have retained their
totipotentiality and claims that they can be induced to differentiate in vitro have not
been independently validated. In the fish, there has been a report of the derivation of
a spermatogonial cell line from mature medakafish testis without immortalization.
After 140 passages during 2 years of culture, this cell line retained a diploid
phenotype and a gene expression pattern consistent with spermatogonial stem cells.
The cells are stable but exhibit growth factor-dependent proliferation and the line has
been shown to be capable of undergoing meiosis and spermiogenesis to generate
motile sperm (Hong et al., 2004a; Hong et al., 2004b).
Isolation of an enriched population of spermatogonial stem cells was first shown
after the discovery of the expression of the surface markers a-6 and |3- 1 integrin on
the cells (Shinohara and Brinster, 2000; Shinohara et al., 2000). Using similar
methods, in Chapter 4 of this thesis I was able to demonstrate enrichment of
spermatogonial stem cells as shown by a higher proportion of Oct-4 positive cells, in
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those bound to magnetic beads after incubation with antibodies directed against a6
and 131 integrins. Using this population of cells, attempts were made to induce the
stem cells to proliferate and differentiate in culture. The growth factors LIF and SCF
were used but addition of these factors did not seem to have any effect on the
cultured cells. The stem cell population was found to express ER|3 mRNA. It has
been shown in the past that ER|3 mRNA and protein is expressed in the germ cells of
the testis (Zhou et al., 2002) and exposure to oestrogens has been claimed to affect
the function of gonocytes (Lassurguere et al., 2003; Li et al., 1997). Therefore the
impact of 17(3 oestradiol on the stem cell population was investigated; a slight
increase in expression of Oct-4 and ER(3 mRNAs was observed but there was no
effect on expression of c-kit levels suggesting that oestrogens alone are not able to
induce spermatogonial stem cells to enter the differentiation pathway.
Culture of the stem cell population on feeder fibroblasts did not have any impact on
Oct-4 or c-kit levels. A recent study using spermatogonia from rats expressing GFP
exclusively in the germline showed that in specific culture conditions male germ
cells lose, or maintain, stem cell activity depending on what type of feeder cells they
are maintained upon. When cultured on STO cells, stem cell characteristics were lost
however, when cultured on MSC-1 cells, a Sertoli cell line, the cells maintained stem
cell activity as determined by flow cytometry (Kent Hamra et al., 2004). This
information is not surprising as the close relationship between the Sertoli cell and the
germ cell is well documented. It is possible that the stem cells require a factor
produced by the Sertoli cells in order to proliferate and differentiate in vitro. Further
work is proposed to look at this in the mouse, using the Sertoli cell line, SK11,
utilised in this thesis.
After the success of using siRNA to knockdown gene expression in the Sertoli cells,
the technique was used to investigate the effect of removing Oct-4 or ER(3 on the
pattern of gene expression in the enriched stem cell population. In 2003, a report
showed that the differentiation status of murine ES cells could be altered using an
shRNA directed against Oct-4 (Velkey and O'Shea, 2003). Utilising an shRNA based
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on this sequence, Oct-4 mRNA expression was successfully knocked down in the
stem cell population and this was shown to induce an increase in expression of c-kit
mRNA, which is only expressed once spermatogonia have become committed to
differentiation (Schrans-Stassen et al., 1999). In addition, as a complement to the
experiments in which oestradiol was added to germ cell cultures, expression of ERB
mRNA was knocked down with a specific shRNA. The consequent reduction in ER(3
expression did not have any effect on the expression of Oct-4 mRNA, neither did it
induce expression of c-kit. These results suggest that oestrogens acting via ERB are
not involved in determining the differentiation status of the murine stem cells.
Although relatively little is known about what controls the
maintenance/differentiation of the spermatogonial stem cell population, it is clear
from my studies that Oct-4 is a key regulatory protein. Recently, studies on murine
ES cells have led to the discovery of several new factors including Nanog, which has
been reported to be involved in the relationship between Stat3 and LIF (Chambers et
al., 2003; Mitsui et al., 2003) and the transcriptional repressor Plzf, which has been
identified as a spermatogonia-specific transcription factor that is required to regulate
self renewal and the maintenance of the stem cell population (Costoya et al., 2004).
Nanog is expressed in the testis and together with Oct-4 is highly expressed in
testicular germ cell tumours (Almstrup et al., 2004) therefore further studies
manipulating levels ofNanog are planned as this may shed light on how this factor
contributes to spermatogonial stem cell function.
Evidence that the delicate balance that exists between spermatogonial stem cell self
renewal and differentiation must be maintained to ensure normal fertility has come
from studies showing that testis degeneration can be induced by an increase in
spermatogonial proliferation. One consequence of this is an increased entry of germ
cells into meiosis and activation of meiotic checkpoints, which in turn can result in
an increase in germ cell apoptosis (de Rooij and de Boer, 2003). Over the past fifty
years, the incidence of testicular cancer has increased in a number of developed
countries (Toppari et al., 1996) and increased exposure to natural and synthetic
oestrogens has been cited as one potential cause of this increase (Sharpe and
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Skakkebaek, 1993; Weir et al., 2000). These ideas have been supported by studies
showing that high concentrations of oestrogens can stimulate PGC growth in vitro
and this aberrant growth can result in the tumorigenic transformation of these cells
(Moe-Behrens et al., 2003). This report did not investigate the expression of ER|3 in
the PGCs but suggests further studies on the impact of oestrogens on germ cell
function are warranted.
5.4. Future studies
The studies presented in this thesis have shown that the SKI 1 cell line is a good
system to study Sertoli cell function in vitro. The development of viral vectors
expressing the shRNAs, thereby increasing the transfection efficiency and the levels
of knockdown achieved in the cells, is planned. The transfer of the siRNA
technology from in vitro studies in the SK11 cell line to in vivo experiments targeting
the Sertoli cells is an exciting prospect which should yield interesting results.
Knockdown of androgen receptor expression in the SKI 1 cell line was attempted but
a sequence that achieved good levels of knockdown was not obtained. Further work
is required to design an efficient siRNA for AR to investigate the reduction ofAR in
the Sertoli cell, thereafter, in vivo studies allowing the acute ablation of Sertoli cell
specific AR should provide a useful complement to the studies already underway
with the SCARKO mice where loss of AR expression is life-long (De Gendt et al.,
2004).
In comparison with the Sertoli cell, no suitable germ cell line was found. The results
obtained by the use of primary spermatogonial stem cells has however been
encouraging and future studies will focus on ways to induce proliferation of these
stem cells. Notably it has been reported that addition of GDNF together with
epidermal growth factor, basic fibroblast growth factor, and leukaemia inhibitory
factor, was able to induce proliferation of murine gonocytes in vitro over a 5-month
period 1014 fold. Furthermore, germ cell transplantation was used to show that the
cells remained functionally active and were able to restore fertility to infertile
recipient mice (Kanatsu-Shinohara et al., 2003). In the current studies, neither LIF,
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SCF, nor oestradiol alone, had any effect on the proliferation or differentiation status
of the isolated spermatogonia so further studies are necessary to establish whether
addition of GDNF will influence cell survival/replication. Culture of murine ES cells
on feeder fibroblast layers is a well-established technique. The presence of a feeder
layer when the spermatogonial stem cells were cultured in this study did not have
any effect. Reports have suggested that co-culture with Sertoli cells could influence
spermatogonial stem cell proliferation and studies of this nature using the SKI 1 cell
line are planned. Studies using RNAi mediated knockdown will be extended to
investigate the role(s) of other genes such as Nanog (Chambers et al., 2003; Mitsui et
al., 2003), which has been identified from studies in murine ES cells. This
will add to the current understanding of the Stat3/Oct-4/LIF/Nanog
relationship which is known to be important in the regulation of stem cell renewal in
murine ES cells (Chambers et al., 2003; Mitsui et al., 2003).
If the cells can be induced to proliferate in vitro attempts will then be made to
immortalise the stem cells. One report claiming to have achieved this using murine
cells already exists (Feng et al., 2002), but doubts exist as to whether the cells have
maintained an undifferentiated phenotype. It has however been achieved in other
species, for example the medaka fish (Hong et al., 2004a; Hong et al., 2004b).
The role of ER|3 in the stem cell population remains unknown. From these studies it
seems likely that the role of ER|3 is not in maintenance of the stem cell in an
undifferentiated state but further studies are required to elucidate the role of ER|3 in
the spermatogonial stem cell.
5.5. Conclusion
Since the discovery that steroid hormones were produced in the testis (reviewed in
Hess, 1997), much research has been undertaken to determine the role of steroid
hormones, in particular oestrogens, in the male reproductive tract. The SK11 cell line
has been shown to provide an excellent model for the investigation of the regulation
of gene expression by steroid hormones and with the use of RNAi, manipulation of
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gene expression has been made possible without the problems associated with
generation of a knockout model.
These studies have shown for the first time that ER(3 is expressed in the
spermatogonial stem cell population. The use of RNAi in the spermatogonial stem
cell population has resulted in alteration of the differentiation status of the cell and
future studies will focus on the mechanism by which stem cell renewal and
differentiation may be determined, and what role ER(3 may play in this process.
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